Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3013742	s-prealb	mg/l (g/l)	14416	33614	0.00%
3013742	s-prealb	g/l (g/l)	11243	27869	0.00%
3013742	p-prealb	g/l (g/l)	8815	15481	0.29%
3013742	s-prealb	— (—)	3630	6119	100.00%	Distribution not available
3013742	p-prealb	— (—)	1415	1985	100.00%	Distribution not available
3013742	prealb	g/l (g/l)	1276	1471	0.00%
3013742	s-prealbumiini	g/l (g/l)	137	167	0.00%
3013742	p-prealb	mg/l (g/l)	103	116	0.00%
3013742	prealb	— (—)	85	87	100.00%	Distribution not available
3013742	p-prealbumiini	g/l (g/l)	67	103	0.00%
3013742	prealbumiini,plasma	g/l (g/l)	37	58	0.00%
3013742	prealbumiini	g/l (g/l)	7	9	0.00%	Distribution not available	Distribution not available
3013742	s-prealbl	mg/l (g/l)	7	9	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Mood disorders

6922

27749

1.72

323.31

2.4

2.3

0.22

g/l

7.44

6294

25972

Type 2 diabetes, definitions combined

6401

22751

1.76

322.53

2.4

2.2

0.22

g/l

0.30

5926

21200

Depression

6420

26545

1.75

322.35

2.4

2.3

0.22

g/l

5.23

5846

24896

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2478

5094

2.57

322.23

2.5

2.0

0.22

0.23

g/l

5.85

2323

4762

Asthma, unspecified (mode), excluding more controls

3441

13487

2.13

320.40

2.3

2.2

0.21

0.22

g/l

6.86

3218

12604

Anxiety disorders, excluding more controls

5402

20482

1.84

319.88

2.6

2.3

0.22

g/l

5.25

4962

19342

Abnormal findings on examination of blood, without diagnosis

3428

16335

2.14

319.66

2.7

2.3

0.21

g/l

0.80

3191

15114

Insulin medication

4180

19259

1.98

319.43

2.8

2.3

0.20

0.21

g/l

39.64

3840

17894

Fall on same level

7767

27126

1.67

318.11

2.4

2.3

0.21

0.22

g/l

14.38

7108

25408

Type 2 diabetes, strict (exclude DM1)

6424

22995

1.75

315.90

2.4

2.2

0.22

g/l

0.43

5945

21429

Diabetes, insulin treatment (Kela reimbursement)

6861

25639

1.72

315.80

2.4

2.3

0.21

0.22

g/l

6.17

6330

23884

Acute tubulo-interstitial nephritis

4140

19851

1.97

314.29

2.4

2.2

0.20

0.21

g/l

21.86

3793

18448

Dyspnoea

5984

27383

1.76

314.02

2.3

0.21

g/l

6.58

5527

25458

Other heart diseases, wide

6148

22665

1.76

313.75

2.4

0.21

0.22

g/l

29.32

5713

21247

Hypo-osmolality and hyponatraemia

1460

5217

3.24

311.68

2.8

2.1

0.19

0.20

g/l

9.57

1326

4849

Malignant neoplasm of colon

1358

4717

3.44

310.85

2.5

2.1

0.20

g/l

0.05

1303

4342

Mucosal proctocolitis

1157

3630

3.74

310.78

3.4

2.3

0.23

0.22

g/l

7.90

1100

3388

Benign neoplasm of colon, rectum, anus and anal canal

4314

21529

1.94

309.83

2.6

2.1

0.21

g/l

8.20

4034

19877

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2662

4311

10.72

307.65

4.9

2.1

0.16

0.21

g/l

130.79

2389

4019

Implicit bacterial Sepsis

3642

11760

3.28

307.65

3.0

2.0

0.19

0.21

g/l

35.58

3289

10921

Benzodiazepine use

6932

28887

1.80

307.65

2.4

2.2

0.22

0.21

g/l

0.13

6343

26925

KRA_PSY_EATING, excluding more controls

792

1326

7.14

307.65

3.1

2.6

0.23

g/l

0.49

721

1261

Complications of medical and surgical care

5833

26131

2.31

307.65

2.8

2.2

0.21

g/l

5.28

5476

24195

Ascites

1163

1887

9.86

307.65

4.5

1.9

0.15

0.21

g/l

96.59

1036

1753

Viral hepatitis

877

1935

5.96

307.65

2.9

2.3

0.20

0.23

g/l

19.75

797

1816

Viral Sepsis

1568

5624

3.19

307.65

3.2

2.1

0.21

g/l

2.29

1433

5239

Other nutritional deficiencies

4832

22493

2.28

307.65

2.4

2.3

0.22

g/l

0.93

4498

21046

Hypertensive diseases

5560

16960

1.96

307.65

2.5

2.3

0.22

g/l

0.34

5186

15908

Used for control exclusion in common control thyroid runs

7430

21898

1.80

307.65

2.8

2.2

0.22

g/l

0.11

6940

20309

Explicit Sepsis

3972

13571

3.22

307.65

3.1

2.1

0.19

0.21

g/l

61.95

3623

12622

Bacterial infection, other or unspecified

4861

16085

3.11

307.65

2.8

2.1

0.19

0.21

g/l

58.08

4450

14946

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4758

22437

2.31

307.65

2.8

2.1

0.21

g/l

2.46

4471

20776

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6595

23759

1.78

307.65

2.5

2.3

0.21

0.22

g/l

6.03

6090

22168

Other viral hepatitis

823

1578

7.17

307.65

2.9

2.4

0.20

0.23

g/l

23.36

749

1485

Malignant neoplasm, wide definition for exclusion

8051

17311

3.06

307.65

2.5

2.2

0.22

g/l

2.63

7714

15829

Benign neoplasms

4831

13182

2.18

307.65

2.6

2.2

0.22

g/l

3.71

4547

12042

Malignant neoplasm of digestive organs

4545

12269

4.58

307.65

3.2

2.0

0.20

g/l

6.05

4355

11199

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4355

21311

2.23

307.65

2.7

2.2

0.21

g/l

2.55

4080

19757

Malignant neoplasm

7938

18270

2.85

307.65

2.4

2.2

0.22

g/l

1.74

7601

16744

L04AD Calcineurin inhibitors

1202

3255

4.75

307.65

6.4

2.4

0.23

0.22

g/l

3.12

1167

3055

Bacterial Sepsis

4109

13288

3.15

307.65

3.0

2.1

0.19

0.21

g/l

43.89

3724

12348

Benign neoplasm: Colon

3531

10349

2.89

307.65

2.6

2.1

0.21

g/l

3.32

3302

9373

Diseases of liver

5931

10717

8.31

307.65

4.0

2.0

0.20

0.22

g/l

50.93

5420

9997

Chronic pancreatitis

1610

3446

6.44

307.65

3.8

2.1

0.20

0.21

g/l

12.43

1520

3175

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3803

15723

2.70

307.65

2.5

2.3

0.20

0.22

g/l

28.21

3373

14707

5487

19370

2.84

307.65

2.9

2.2

0.20

0.22

g/l

61.45

4920

18103

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6898

25960

1.91

307.65

3.0

2.2

0.21

0.22

g/l

5.37

6460

24113

Fibrosis and cirrhosis of liver

1662

2024

19.36

307.65

5.2

1.9

0.17

0.21

g/l

57.09

1531

1895

Cholecystectomy

4865

24237

1.89

307.65

2.6

2.1

0.21

g/l

0.41

4604

22412

Type 2 diabetes

6865

23484

1.83

307.65

2.4

2.2

0.21

0.22

g/l

1.30

6340

21894

Septicaemia

3864

12813

3.35

307.65

3.1

2.1

0.19

0.21

g/l

61.20

3522

11890

First line medication for Crohn's disease

9101

23413

2.28

307.65

2.9

2.1

0.22

g/l

1.84

8590

21634

Cholelithiasis

6078

21836

2.09

307.65

2.6

2.0

0.21

g/l

5.08

5745

20124

Implicit viral Sepsis

1567

5608

3.20

307.65

3.2

2.1

0.21

g/l

2.30

1432

5225

5301

18853

2.90

307.65

2.9

2.2

0.20

0.22

g/l

64.38

4748

17621

Disorders of gallbladder, biliary tract and pancreas

9063

23899

2.71

307.65

3.1

2.0

0.21

0.22

g/l

21.21

8577

22054

Hypothyroidism and >3 levothyroxin purchases

1555

2261

4.23

307.65

2.6

2.1

0.22

0.23

g/l

5.81

1449

2132

IBD patients in KELA-register

1942

7153

3.07

307.65

3.7

2.3

0.23

0.22

g/l

15.92

1850

6669

Pneumonia, organism unspecified

6879

25688

2.07

307.65

2.5

2.3

0.20

0.22

g/l

43.06

6325

23985

Malaise and fatigue

3908

13610

2.63

307.65

2.4

2.1

0.20

0.21

g/l

23.16

3540

12648

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7373

27451

2.01

307.65

2.5

2.3

0.20

0.22

g/l

41.02

6790

25642

Any event in cancer register

7766

19032

2.64

307.65

2.4

2.2

0.22

g/l

3.74

7411

17489

Any reimbursement code in KELA

4181

7325

3.06

307.65

2.8

1.9

0.22

0.23

g/l

2.64

3943

6751

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

893

1342

10.06

307.65

5.4

1.9

0.17

0.20

g/l

12.91

843

1202

Other anaemias

3583

13893

2.82

307.65

2.8

2.1

0.19

0.21

g/l

15.82

3268

12828

Certain infectious and parasitic diseases

7539

19051

2.10

307.65

2.6

2.1

0.21

0.22

g/l

35.53

7001

17792

Condition for Implicit Sepsis (Organ dysfunction codes)

6833

23059

2.34

307.65

2.8

2.1

0.20

0.22

g/l

56.53

6240

21542

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3219

9043

2.42

307.65

3.3

2.2

0.20

0.23

g/l

51.32

2998

8531

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1897

4606

5.09

307.65

2.5

2.0

0.20

g/l

0.51

1826

4138

Cirrhosis of liver, NAS

1118

1403

20.30

307.65

5.4

1.9

0.16

0.21

g/l

70.91

1010

1311

Depression medications

2012

2438

4.45

307.65

2.4

2.2

0.23

0.24

g/l

2.79

1868

2298

Persons encountering health services in other circumstances, wide

8977

25856

1.90

307.65

2.5

2.3

0.21

g/l

0.20

8350

24006

Implicit Sepsis

6216

20847

2.56

307.65

2.8

2.1

0.20

0.22

g/l

52.62

5639

19425

Mental and behavioural disorders due to alcohol

4219

17634

2.57

307.65

2.5

2.3

0.20

0.22

g/l

28.28

3756

16494

Iron deficiency anaemia

3550

14008

2.83

307.65

2.9

2.1

0.20

0.21

g/l

18.11

3261

12970

Colorectal adenocarcinoma

2024

6371

3.90

307.65

2.5

2.1

0.21

0.20

g/l

2.25

1957

5847

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

3084

8137

2.71

307.65

1.7

2.1

0.23

0.22

g/l

18.51

2969

7446

Other and unspecified iron deficiency

2727

10615

2.91

307.65

2.9

2.1

0.20

0.21

g/l

8.58

2493

9845

Other and unspecified anaemias

3559

13779

2.83

307.65

2.8

2.1

0.19

0.21

g/l

15.35

3245

12719

Alcoholic liver disease

1627

2684

9.76

307.65

4.6

2.0

0.16

0.21

g/l

94.48

1441

2509

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

5975

9747

6.28

307.65

3.1

2.1

0.20

0.21

g/l

8.52

5740

8812

Malignant neoplasm of head and neck

952

2504

5.02

307.65

2.5

2.2

0.23

0.21

g/l

13.76

923

2319

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1367

4406

3.51

307.65

1.8

2.0

0.22

0.21

g/l

2.33

1299

3988

Colorectal cancer

2405

7624

3.85

307.65

2.5

2.1

0.21

0.20

g/l

0.88

2323

7004

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4546

22863

1.98

307.65

2.5

2.2

0.21

g/l

2.17

4218

21154

Ulcer of lower limb, not elsewhere classified

1372

4241

3.98

307.65

2.2

0.19

0.20

g/l

5.43

1250

3926

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

1028

2207

6.03

307.65

2.4

2.0

0.21

0.20

g/l

3.74

1001

1981

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

685

1263

7.20

307.65

3.3

1.9

0.20

g/l

1.25

659

1129

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

2089

4258

6.53

307.65

2.7

2.0

0.19

0.21

g/l

8.66

2002

3852

Hypertensive diseases (excluding secondary)

3933

9771

2.52

307.65

2.5

2.2

0.22

0.23

g/l

3.74

3692

9225

Diseases of arteries, arterioles and capillaries (FINNGEN)

1971

5049

3.04

307.65

2.4

2.2

0.21

0.22

g/l

14.00

1819

4750

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1867

5784

3.78

307.65

2.4

2.0

0.19

0.21

g/l

9.44

1779

5242

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6951

21886

2.13

307.65

2.5

2.2

0.21

0.22

g/l

30.22

6408

20429

6951

21886

2.13

307.65

2.5

2.2

0.21

0.22

g/l

30.22

6408

20429

Pneumonias (Asthma/COPD co-morbidities)

7539

27478

2.03

307.65

2.5

2.3

0.21

0.22

g/l

39.22

6954

25665

Autoimmune diseases excluding thyroid diseases, strict definition

7598

22630

1.98

307.65

2.9

2.2

0.21

0.22

g/l

0.67

7114

21003

Other diseases of the digestive system

2666

10757

2.80

307.65

3.3

2.1

0.19

0.21

g/l

20.95

2443

9915

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

985

1853

7.21

307.65

3.6

1.9

0.19

0.20

g/l

1.60

938

1664

Primary biliary cholangitis (PBC)

489

569

20.89

307.65

5.2

1.9

0.21

0.22

g/l

2.72

468

541

Autoimmune diseases excluding thyroid diseases

7797

23241

1.97

307.65

2.9

2.2

0.21

0.22

g/l

0.52

7301

21590

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

4031

10199

4.11

307.65

2.6

2.1

0.20

0.21

g/l

18.97

3830

9243

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

451

559

14.07

307.65

6.0

1.9

0.17

0.19

g/l

7.01

427

491

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9065

26094

2.77

307.65

2.8

2.2

0.20

0.22

g/l

56.37

8389

24296

Hernia of abdominal wall, postoperative

1655

2802

7.11

307.65

3.3

1.5

0.21

0.22

g/l

5.37

1584

2515

Acute pancreatitis

1866

5844

3.79

307.65

3.6

2.0

0.20

0.21

g/l

10.09

1779

5365

Other diseases of pancreas

955

2074

6.45

307.65

3.5

1.9

0.22

0.21

g/l

0.93

918

1915

Alcohol use disorder, Swedish definition

5160

17993

3.01

307.65

2.9

2.2

0.20

0.22

g/l

62.93

4619

16813

Ulcerative colitis

1985

7930

2.80

307.65

3.6

2.3

0.23

0.22

g/l

10.62

1873

7381

Other diseases of intestines

8057

24170

2.06

307.65

2.7

2.2

0.22

g/l

0.13

7534

22487

Cardiovascular diseases (excluding rheumatic etc)

4453

11894

2.29

307.65

2.8

2.3

0.22

0.23

g/l

8.62

4185

11210

Hypertension

5556

16948

1.96

307.65

2.5

2.3

0.22

g/l

0.40

5182

15896

Noninfective enteritis and colitis

3730

16580

2.47

307.65

3.3

2.3

0.22

0.21

g/l

9.38

3507

15419

Mood disorders, excluding more controls

6531

22250

1.88

307.65

2.4

2.3

0.22

g/l

3.79

5929

20961

Diseases of the digestive system

3784

16356

2.57

307.65

3.4

2.2

0.20

0.21

g/l

21.13

3488

15136

All pneumoniae

7569

27571

2.02

307.65

2.5

2.3

0.21

0.22

g/l

37.94

6984

25755

Anaemias

2735

2178

10.08

307.65

3.5

2.3

0.21

0.23

g/l

27.28

2560

2055

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

653

998

10.10

307.65

2.3

2.0

0.23

0.20

g/l

9.89

633

894

Benign neoplasm of other and ill-defined parts of digestive system

1512

4179

4.31

307.65

2.8

2.0

0.22

0.21

g/l

11.70

1426

3787

Atrial fibrillation and flutter

2368

6444

2.61

307.65

2.4

2.2

0.20

0.23

g/l

30.82

2208

6064

Benign neoplasm of colon, rectum, anus and anal canal

4061

11039

2.90

307.65

2.6

2.1

0.22

0.21

g/l

3.57

3795

10008

Dialysis, with operation codes

1349

3810

4.45

307.65

4.7

2.3

0.21

g/l

0.05

1283

3547

General symptoms and signs

8597

21164

2.17

307.65

2.6

2.2

0.21

0.22

g/l

13.66

7971

19757

Neoplasms

5552

12357

2.57

307.65

2.6

2.3

0.22

g/l

3.40

5278

11282

Cholelithiasis, broad definition with cholecystitis

6422

22159

2.13

307.65

2.6

2.0

0.21

g/l

9.02

6065

20422

Obesity, other/unspecified

2487

10650

2.57

307.65

2.4

2.3

0.21

0.22

g/l

2.30

2338

9969

Aplastic and other anaemias

3891

14929

2.80

307.65

2.8

2.1

0.19

0.21

g/l

17.17

3549

13791

Cholangitis (primary sclerosing, PSC), with reimbursement 202

458

467

29.20

307.65

7.2

2.4

0.21

0.22

g/l

3.11

451

437

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

8050

17305

3.06

307.65

2.5

2.2

0.22

g/l

2.64

7713

15824

Diabetes, varying definitions

7134

24670

1.82

307.65

2.5

2.3

0.21

0.22

g/l

3.47

6582

23020

Other diseases of liver

2680

5083

7.63

307.65

3.5

2.0

0.22

g/l

0.89

2476

4771

Paralytic ileus and intestinal obstruction

2188

8151

3.05

307.65

2.9

2.1

0.20

0.21

g/l

1.81

2045

7507

Diabetes medication

6966

25585

1.73

307.65

2.4

2.2

0.21

0.22

g/l

3.71

6424

23864

Influenza and pneumonia

7871

27494

2.00

307.65

2.5

2.3

0.21

0.22

g/l

35.22

7270

25688

Persons encountering health services for specific procedures and health care

8820

25931

2.27

307.65

2.6

2.3

0.21

0.22

g/l

30.52

8214

24106

Endocrine, nutritional and metabolic diseases

5713

14872

2.06

307.65

2.6

2.3

0.22

g/l

0.35

5311

13952

Colorectal cancer, excluding all cancers (controls excluding all cancers)

3139

6915

5.57

307.65

2.4

2.0

0.21

0.20

g/l

2.66

3030

6239

Chronic hepatitis, not elsewhere classified

665

824

16.03

307.65

5.8

2.0

0.21

0.22

g/l

2.51

627

782

Medical observation and evaluation for suspected diseases and conditions

4964

13155

2.04

307.65

2.7

2.0

0.22

g/l

0.19

4583

12226

Nutritional anaemias

4149

16641

2.72

307.65

2.9

2.1

0.20

0.21

g/l

20.85

3811

15415

Diabetes mellitus

7148

24742

1.81

307.65

2.4

2.3

0.21

0.22

g/l

3.69

6595

23088

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8113

25729

1.90

307.65

2.5

2.3

0.22

g/l

0.28

7617

23908

Other medical care

3730

13323

3.14

307.65

2.6

2.1

0.19

0.21

g/l

61.01

3486

12302

Any mental disorder

7908

23063

1.80

307.65

2.4

2.3

0.21

0.22

g/l

1.27

7211

21704

Examination and observation for other reasons

4657

13065

2.33

307.65

3.0

2.0

0.22

g/l

0.48

4360

12150

Bleeding

5989

24014

1.94

307.65

2.8

2.2

0.20

0.21

g/l

44.55

5507

22302

Opioids

7329

19316

2.11

307.65

2.5

2.1

0.22

g/l

2.83

6836

17941

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

8049

17312

3.05

307.65

2.5

2.2

0.22

g/l

2.64

7712

15831

Substance abuse, excluding more controls

4810

16674

2.80

307.65

2.5

2.3

0.20

0.22

g/l

22.35

4295

15699

Obesity and other hyperalimentation

4526

21875

2.21

307.65

2.3

0.22

g/l

0.18

4217

20464

Heart failure and antihypertensive medication

2330

4973

3.55

307.65

2.5

2.3

0.19

0.22

g/l

34.19

2138

4647

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1466

2879

6.79

307.65

2.3

2.0

0.21

0.20

g/l

7.11

1424

2595

Psychiatric diseases

7760

22468

1.81

307.65

2.4

2.3

0.21

0.22

g/l

1.88

7079

21158

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

1067

2280

6.07

307.65

2.4

2.0

0.21

0.20

g/l

3.20

1038

2049

Transplanted organ and tissue status

1091

2841

4.96

307.65

6.8

2.4

0.22

g/l

1.46

1062

2658

Nonalcoholic fatty liver disease

1401

2724

7.73

307.65

2.8

2.2

0.24

0.22

g/l

12.76

1311

2557

All-cause Heart Failure

4249

15408

2.17

307.65

2.2

0.19

0.21

g/l

63.28

3832

14290

Heart failure,strict

4120

13472

2.44

307.65

2.2

0.19

0.21

g/l

75.10

3735

12540

Alcohol dependence

2210

8915

2.78

307.65

2.6

2.3

0.20

0.22

g/l

15.85

1962

8360

Mental and behavioural disorders due to psychoactive substance use

4950

20258

2.54

307.65

2.5

2.3

0.20

0.22

g/l

27.33

4422

18967

Complications of surgical and medical care, not elsewhere classified

8024

27046

2.31

307.65

2.6

2.2

0.21

0.22

g/l

6.70

7508

25057

Complications of procedures, not elsewhere classified

6493

26106

2.34

307.65

2.7

2.2

0.21

0.22

g/l

3.64

6090

24187

Other bacterial diseases

8677

24467

2.72

307.65

2.8

2.2

0.20

0.22

g/l

114.68

7995

22814

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

1073

2634

5.00

307.65

2.6

2.0

0.20

g/l

1.27

1029

2373

Obesity

4505

21774

2.22

307.65

2.3

0.22

g/l

0.25

4200

20368

Dentinal caries

2270

7158

3.71

307.65

3.9

2.3

0.21

g/l

0.97

2143

6676

Erysipelas

3913

17563

2.20

307.65

2.4

2.1

0.20

0.22

g/l

37.16

3568

16316

GASTRO-related operations

7551

8788

4.78

307.65

2.8

1.6

0.22

0.23

g/l

34.40

7118

7926

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

2024

4739

5.35

307.65

2.5

2.0

0.21

0.20

g/l

2.76

1957

4275

Symptoms and signs involving the digestive system and abdomen

7750

19559

2.11

307.65

2.7

2.1

0.21

0.22

g/l

12.43

7248

18124

Unspecified jaundice

668

1251

7.48

307.65

4.8

1.8

0.17

0.21

g/l

21.47

612

1157

Autoimmune diseases

7828

23383

1.79

307.65

2.8

2.2

0.22

g/l

0.35

7294

21723

Other diseases of biliary tract

1184

2386

7.14

307.65

5.4

1.9

0.19

0.21

g/l

13.75

1130

2188

Oesophageal varices

878

1128

18.09

307.65

6.5

2.1

0.15

0.21

g/l

70.16

802

1058

Hypertension, essential

5612

16472

2.07

307.65

2.4

2.3

0.22

g/l

0.05

5212

15440

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

2208

7018

2.82

307.65

1.7

2.1

0.23

0.21

g/l

18.93

2125

6402

Fever of other and unknown origin

4847

16928

2.96

307.65

3.1

2.2

0.20

0.22

g/l

34.62

4541

15774

Abnormalities of breathing

6166

21374

1.80

307.65

2.3

2.4

0.21

0.22

g/l

1.82

5681

19965

Chronic viral hepatitis

708

1277

7.74

307.65

2.7

2.4

0.20

0.23

g/l

21.67

638

1205

Oedema, not elsewhere classified

2425

9491

2.84

307.65

2.5

2.1

0.20

0.21

g/l

15.07

2215

8850

Any gastric operation

7551

8788

4.78

307.65

2.8

1.6

0.22

0.23

g/l

34.40

7118

7926

Nausea and vomiting

2191

7708

3.14

307.65

3.0

2.1

0.21

g/l

3.05

2013

7108

Abdominal and pelvic pain

7310

19546

1.98

307.65

2.6

2.1

0.22

g/l

2.07

6853

18112

Chronic kidney disease

2212

9391

2.61

307.65

2.8

2.1

0.21

0.20

g/l

8.34

2024

8623

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

1187

2299

6.88

307.65

2.4

2.0

0.23

0.20

g/l

17.85

1152

2075

Codeine

6455

19030

1.96

307.65

2.2

2.1

0.22

g/l

0.40

5975

17676

Alcohol use disorder, ICD-based

3508

14514

2.70

307.65

2.5

2.4

0.20

0.22

g/l

22.77

3118

13558

Oxycodone

3719

11153

3.83

307.65

2.8

2.1

0.20

0.21

g/l

19.71

3488

10304

Budesonide

1241

3853

3.79

307.65

4.3

2.1

0.23

0.22

g/l

10.58

1176

3578

Hypothyroidism (congenital or acquired)

1581

2277

4.27

307.65

2.6

2.1

0.22

0.23

g/l

5.71

1476

2148

Metabolic disorders

7393

23278

2.12

307.65

2.5

2.3

0.21

0.22

g/l

1.18

6821

21703

Diseases of oesophagus, stomach and duodenum

8379

25533

2.14

307.65

2.7

2.2

0.21

0.22

g/l

6.88

7783

23752

Renal failure

3811

13937

2.84

307.65

2.9

2.1

0.20

0.21

g/l

0.78

3485

12842

Other disorders of skin and subcutaneous tissue

4791

24200

1.94

307.65

2.5

2.2

0.21

g/l

9.59

4402

22452

Colectomy operation

1768

5507

3.98

307.65

2.8

2.2

0.21

g/l

2.64

1696

5098

Cardiovascular diseases

3957

10526

2.15

307.65

2.7

2.4

0.22

0.23

g/l

4.72

3727

9932

Other heart diseases

3502

9981

2.49

307.65

2.5

2.3

0.21

0.23

g/l

26.87

3274

9413

Azathioprine

1451

4355

3.94

307.65

4.4

2.2

0.23

0.22

g/l

12.60

1391

4055

Hypothyroidism, levothyroxine purchases

1555

2261

4.23

307.65

2.6

2.1

0.22

0.23

g/l

5.81

1449

2132

Parasetamol

5453

15125

1.93

307.65

2.2

2.5

0.22

g/l

0.69

5080

14046

Autoimmune diseases related-to ILD

6167

29264

1.97

307.65

2.9

2.2

0.22

0.21

g/l

8.71

5788

27141

Oral corticosteroids

8038

25545

2.03

307.65

2.6

2.2

0.22

0.21

g/l

0.22

7531

23666

ILD medications: immunosuppressive drugs

4846

21536

2.34

307.65

3.7

2.1

0.22

g/l

8.31

4605

20022

Heart failure, not strict

6626

19523

2.61

307.65

2.8

2.2

0.19

0.22

g/l

84.98

6099

18238

Acute pancreatitis (for exclusion)

1866

6612

3.32

307.65

3.6

2.2

0.20

0.21

g/l

8.46

1779

6123

Chronic periapical parodontitis

1743

6558

3.03

307.65

3.2

2.1

0.21

g/l

1.95

1641

6121

Other antidepressants

7357

21999

1.83

307.65

2.3

0.22

0.21

g/l

5.60

6691

20610

Other septicaemia

3488

11479

3.47

307.65

3.1

2.1

0.19

0.21

g/l

53.98

3183

10651

Renal tubulo-interstitial diseases

7061

25263

2.33

307.65

2.6

2.2

0.20

0.22

g/l

33.03

6492

23532

Inflammatory bowel disease, strict (require KELA)

1942

7358

2.98

307.65

3.7

2.3

0.23

0.22

g/l

15.31

1850

6859

5-aminosalicylic acid

1756

6468

3.05

307.65

3.6

2.2

0.23

0.22

g/l

11.43

1665

6009

Cholangitis (primary sclerosing, PSC)

1046

1606

10.83

307.65

6.2

2.0

0.20

0.21

g/l

7.06

1020

1477

Heart failure, strict

4349

15678

2.18

307.65

2.2

0.19

0.21

g/l

65.36

3927

14538

Nephropathy related operations

1279

3839

4.17

307.65

4.8

2.4

0.21

g/l

0.66

1215

3579

Inflammatory bowel disease treatment related agents

8886

26179

2.05

307.65

2.8

2.2

0.22

g/l

2.26

8347

24255

ILD medications

8851

24918

2.08

307.65

3.0

2.1

0.22

0.21

g/l

3.59

8338

23068

ILD medications: azathioprine

1451

4282

4.01

307.65

4.4

2.1

0.23

0.22

g/l

13.32

1391

3980

Other disorders of fluid, electrolyte and acid-base balance

2819

9463

3.35

307.65

2.8

2.2

0.19

0.21

g/l

12.86

2544

8791

Infections, IBD-co-morbidities

1410

3312

3.48

307.65

3.3

2.3

0.21

0.22

g/l

1.60

1305

3138

Viral hepatitis, IBD co-morbidity

805

1070

10.35

307.65

2.8

2.4

0.20

0.22

g/l

13.92

729

1019

Dental caries

2567

8131

3.66

307.65

4.0

2.2

0.21

g/l

1.10

2423

7588

ILD medications: prednisolone, methylprednisolone, prednisone

8576

24593

2.10

307.65

3.0

2.1

0.22

0.21

g/l

2.20

8065

22766

Gastrointestinal diseases

4401

7915

2.98

307.65

2.8

1.6

0.22

g/l

5.79

4147

7314

Obesity due to excess calories

3446

15735

2.40

307.65

2.3

0.22

g/l

0.59

3206

14723

Constipation

6141

25592

1.82

307.65

2.7

2.2

0.21

g/l

8.73

5642

23813

Acute renal failure

2073

6431

3.92

307.65

3.1

2.1

0.19

0.21

g/l

8.95

1888

5929

Eating disorder

795

1813

5.19

307.65

3.1

2.6

0.23

g/l

0.53

724

1699

Mood [affective] disorders

6919

27698

1.72

307.65

2.4

2.3

0.22

g/l

7.28

6292

25929

Other or unspecified ileus, impaction or obstruction

1600

5484

3.37

307.65

3.0

2.1

0.20

0.21

g/l

1.40

1495

5046

GI-bleeding

2609

10768

2.72

307.65

3.3

2.1

0.19

0.21

g/l

23.00

2385

9917

Type 2 diabetes, wide definition

5913

19876

2.08

307.65

2.3

2.1

0.21

g/l

3.98

5427

18447

Hepatic failure, not elsewhere classified

638

907

12.86

307.65

6.0

2.0

0.16

0.22

g/l

35.86

576

847

Intestinal stricture

2683

10449

2.95

307.65

3.0

2.1

0.20

0.21

g/l

2.02

2519

9655

Inflammatory bowel disease

2614

10609

2.75

307.65

3.6

2.3

0.23

0.22

g/l

13.90

2472

9886

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

3085

8138

2.71

307.65

1.7

2.1

0.23

0.22

g/l

18.58

2970

7447

Diseases of pulp and periapical tissues

2689

11858

2.49

307.65

3.0

2.2

0.21

0.22

g/l

2.74

2518

11065

Other inflammatory liver diseases

896

1746

7.37

307.65

4.9

1.9

0.20

0.22

g/l

10.89

847

1643

Substance abuse

4810

19890

2.54

307.65

2.5

2.3

0.20

0.22

g/l

27.38

4295

18612

Tramadol

6572

17933

2.57

307.65

2.7

2.1

0.21

0.22

g/l

1.85

6103

16661

Type 2 diabetes, definitions combined, including avohilmo

6391

22801

1.74

307.44

2.4

2.2

0.22

g/l

0.49

5915

21252

Intestinal infectious diseases

6225

29424

1.73

306.10

2.7

2.3

0.21

0.22

g/l

2.71

5762

27349

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1017

3031

4.24

304.56

2.4

2.1

0.21

0.20

g/l

1.51

992

2801

Crohn disease

1177

3795

3.63

302.40

4.0

2.3

0.23

0.22

g/l

6.94

1119

3551

Diarrhoea and gastroenteritis of presumed infectious origin

4681

24166

1.86

301.50

2.8

2.3

0.21

0.22

g/l

2.88

4340

22464

Codeine or tramadol medication

7616

26617

1.65

300.07

2.1

2.3

0.22

0.21

g/l

5.26

7046

24749

Asthma, excluding more controls

4909

14651

1.87

295.38

2.3

0.22

g/l

1.51

4602

13702

Depression or dysthymia

4811

15061

1.88

295.17

2.4

2.3

0.22

0.21

g/l

2.82

4377

14211

Chronic periodontitis

1308

4566

3.35

293.94

3.3

2.1

0.21

g/l

0.72

1232

4253

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1806

7331

2.67

291.03

2.4

2.3

0.22

g/l

1.83

1646

6951

Exposure to unspecified factor

6378

30650

1.69

290.46

2.4

2.3

0.21

0.22

g/l

0.61

5841

28578

Other disorders of teeth and supporting structures

1693

6775

2.81

288.12

3.0

2.1

0.21

g/l

0.89

1600

6304

Adenocarcinoma and papilloma adenocarcinoma of rectum

973

2923

4.20

287.84

2.5

2.1

0.21

0.20

g/l

1.93

950

2703

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

596

1271

6.71

285.39

5.6

2.1

0.17

0.20

g/l

12.11

565

1175

Asthma, unspecified (mode)

3501

14530

2.02

285.15

2.3

2.2

0.21

0.22

g/l

3.75

3269

13544

Gastro-oesophageal reflux disease

4487

22697

1.85

284.23

2.4

2.1

0.22

0.21

g/l

2.57

4173

21102

Malignant neoplasm of rectum

969

2928

4.16

283.76

2.4

2.1

0.21

g/l

1.98

945

2704

Malignant neoplasm of breast

3413

12841

2.07

281.41

1.7

2.2

0.23

0.21

g/l

33.86

3283

11868

Substance use, excluding alcohol

1472

5566

2.96

279.03

2.4

2.3

0.21

0.22

g/l

4.83

1317

5253

Insulin, intermediate and long-acting

3796

20526

1.94

277.53

2.7

2.2

0.19

0.21

g/l

40.46

3481

19014

Benign neoplasm of other and ill-defined parts of digestive system

1512

5894

2.98

276.63

2.8

2.2

0.22

0.21

g/l

11.68

1426

5479

Atrial fibrillation and flutter with reimbursement

1957

5206

2.64

274.74

2.3

2.2

0.20

0.22

g/l

24.10

1814

4905

Cardiac arrhythmias

3903

14000

1.94

273.42

2.4

2.3

0.21

0.22

g/l

18.57

3645

13203

Antihypertensive medication - note that there are other indications

3762

10843

1.98

273.38

2.6

2.4

0.23

0.22

g/l

0.15

3535

10191

General examination and investigation of persons without complaint and reported diagnosis

4438

13139

1.88

273.11

2.7

2.0

0.21

0.22

g/l

1.40

4168

12215

Other (not insulin) diabetes medications

6348

23776

1.68

272.37

2.3

2.2

0.22

g/l

0.00

5865

22148

Malignant neoplasm of breast, HER2-negative

3318

12756

2.06

272.13

1.7

2.2

0.23

0.21

g/l

34.28

3190

11791

Insulin, combination of fast acting with intermediate-acting or long-acting

4181

21945

1.87

270.53

2.8

2.2

0.20

0.21

g/l

39.61

3841

20330

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

384

567

10.79

270.24

2.3

1.9

0.23

0.20

g/l

7.40

371

507

Use of hypnotics and sedatives

7051

25976

1.64

269.92

2.4

2.3

0.22

0.21

g/l

1.18

6506

24216

Malignant neoplasm of oral cavity

504

994

8.11

269.17

2.3

2.2

0.23

0.21

g/l

6.56

487

922

Non-invasive ventilation

1467

5230

2.88

268.87

2.6

2.3

0.20

0.22

g/l

22.48

1383

4968

Infections of the skin and subcutaneous tissue

3806

21156

1.90

265.63

2.6

2.4

0.21

0.22

g/l

12.10

3529

19733

Asthma

5046

15809

1.79

263.68

2.3

2.2

0.22

g/l

0.20

4720

14753

COPD/asthma related infections

6916

21903

1.64

262.97

2.4

2.2

0.21

0.22

g/l

11.96

6410

20444

COPD/asthma/ILD related infections

6916

21903

1.64

262.97

2.4

2.2

0.21

0.22

g/l

11.96

6410

20444

Personality disorders, excluding more controls

1653

6762

2.64

262.26

2.3

0.22

g/l

0.12

1487

6420

Continuous positive airway pressure

1404

4528

2.96

261.82

2.4

0.21

0.22

g/l

3.76

1293

4303

Diseases of the skin and subcutaneous tissue

6822

21614

1.64

260.05

2.5

2.3

0.21

0.22

g/l

3.74

6335

20091

Eating disorders

861

2485

3.98

260.02

3.0

2.5

0.23

0.22

g/l

0.77

785

2327

Anxiety (asthma-related co-morbidities)

3651

15738

1.92

258.93

2.5

2.4

0.23

0.22

g/l

1.32

3345

14872

In situ neoplasms

2029

8700

2.39

257.81

2.1

2.0

0.22

0.21

g/l

9.20

1901

7886

Other eating disorders

510

1002

6.29

257.80

3.2

2.7

0.23

g/l

0.02

460

945

Polyarthropathies

4652

18111

1.80

257.52

2.4

2.3

0.21

g/l

1.80

4313

16903

Other functional intestinal disorders

2969

14746

2.05

254.76

2.5

2.2

0.21

g/l

0.24

2736

13653

Gastroduodenal ulcer

1920

8555

2.46

254.00

3.1

2.0

0.19

0.20

g/l

11.33

1746

7869

Excluding asthma or asthma-COPD overlap

5334

15946

1.75

253.48

2.4

2.2

0.21

0.22

g/l

6.44

4956

14881

Hypothyroidism, drug reimbursement

801

1463

4.21

252.84

2.2

2.1

0.22

0.23

g/l

5.24

753

1387

Other pulmonary diagnosis

5329

15946

1.74

252.36

2.4

2.2

0.21

0.22

g/l

6.04

4951

14881

Ulcerative colitis, NAS

1173

4177

3.22

252.25

4.2

2.3

0.23

0.22

g/l

3.43

1111

3898

Diverticular disease of intestine

4654

18199

1.79

251.26

2.4

2.1

0.21

g/l

1.89

4298

16872

Cerebrovascular diseases (FINNGEN)

2118

6842

2.38

250.83

2.4

2.2

0.21

0.23

g/l

12.57

1968

6452

Hypokalaemia

1013

3351

3.57

250.59

3.2

2.2

0.20

0.21

g/l

3.54

914

3138

Artificial opening status

622

1519

5.55

250.14

3.6

2.2

0.21

g/l

0.39

593

1420

Benign neoplasm: Colon

3575

19626

1.92

249.45

2.6

2.1

0.21

g/l

7.97

3344

18125

Other soft tissue disorders, not elsewhere classified

6031

23386

1.66

248.64

2.3

2.4

0.22

0.21

g/l

2.45

5562

21759

Injuries to the head

7038

29907

1.59

247.95

2.4

2.3

0.21

0.22

g/l

9.81

6392

27949

Convulsions, not elsewhere classified

1622

6691

2.60

246.44

2.7

2.3

0.21

0.22

g/l

5.09

1455

6245

Glucagon-like peptide-1 (GLP-1) analogues

3755

17512

1.89

244.36

2.4

2.2

0.21

g/l

0.47

3437

16230

Colon adenocarcinoma

1073

3752

3.42

243.37

2.6

2.1

0.20

g/l

0.33

1029

3459

Diseases of arteries, arterioles and capillaries

4427

19527

1.79

243.01

2.3

2.2

0.20

0.21

g/l

6.17

4050

18072

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1288

4927

2.95

240.44

3.6

2.4

0.23

0.22

g/l

7.56

1223

4610

Benign neoplasms

6299

22392

1.63

238.15

2.5

2.3

0.22

0.21

g/l

8.14

5892

20709

Other gastritis (incl. Duodenitis)

1697

7414

2.54

237.73

3.0

2.1

0.20

0.21

g/l

2.20

1575

6872

L04AA Selective immunosuppressants

1659

7212

2.57

236.39

4.5

2.3

0.22

g/l

4.05

1595

6760

Ulcerative colitis (strict definition, require KELA)

1316

5141

2.88

235.28

3.6

2.3

0.23

0.22

g/l

8.57

1244

4806

Recurrent or chronic depression

2601

9412

2.11

235.08

2.4

0.23

0.22

g/l

2.83

2379

8946

Disorders of lipoprotein metabolism and other lipidaemias

5287

20531

1.70

234.86

2.1

2.2

0.22

0.21

g/l

2.98

4884

19105

Other Crohn's disease

671

1777

4.61

234.80

4.0

2.2

0.24

0.22

g/l

4.75

639

1661

Second line medication for Crohn's disease

3727

21485

1.84

233.97

3.1

2.3

0.22

g/l

9.04

3528

20041

Benign neoplasm: Colon, unspecified

1467

5988

2.68

233.79

2.7

2.0

0.21

0.20

g/l

5.27

1358

5411

COPD differential diagnosis

5251

15988

1.71

232.91

2.4

2.2

0.21

0.22

g/l

6.95

4880

14921

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6213

26060

1.62

232.72

2.8

2.1

0.20

0.22

g/l

43.36

5731

24259

ILD differential diagnosis

5245

15986

1.71

231.71

2.4

2.2

0.21

0.22

g/l

6.97

4875

14919

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1392

5628

2.76

231.41

3.5

2.3

0.23

0.22

g/l

9.95

1317

5267

Total colectomy operation

518

1166

6.13

231.08

3.6

2.3

0.23

0.22

g/l

2.10

499

1091

Total colectomy

518

1166

6.13

231.08

3.6

2.3

0.23

0.22

g/l

2.10

499

1091

Pain in limb

5068

22647

1.69

230.20

2.3

0.22

0.21

g/l

1.45

4648

21075

Intracranial trauma

3765

16053

1.84

229.78

2.4

0.21

0.22

g/l

5.94

3428

15031

Heart failure and bmi 25plus

2499

8661

2.18

228.77

2.2

2.3

0.19

0.21

g/l

39.53

2270

8062

Osteopathies and chondropathies

3624

19771

1.85

227.96

2.6

2.2

0.21

g/l

7.92

3331

18382

Poisoning by drugs, medicaments and biological substances

1674

7371

2.48

227.92

2.4

0.22

g/l

1.91

1513

6904

Iron deficiency anaemia secondary to blood loss (chronic)

1271

4987

2.90

226.88

3.2

2.1

0.19

0.21

g/l

12.79

1172

4615

Biguanides

6110

24245

1.62

226.76

2.2

0.22

0.21

g/l

0.67

5620

22560

Neurotic, stress-related and somatoform disorders

5606

25327

1.64

225.49

2.6

2.3

0.22

g/l

9.03

5156

23717

Asthma (mode)

4826

15986

1.73

225.46

2.3

2.2

0.22

g/l

0.04

4521

14919

Anxiety disorders

5665

25605

1.63

224.38

2.6

2.3

0.22

g/l

9.40

5208

23968

Autoimmune hepatitis

200

170

40.09

224.08

6.8

2.0

0.20

0.22

g/l

0.94

195

162

Non-ischemic cardiomyopathy

2159

8645

2.25

222.23

2.3

2.2

0.18

0.21

g/l

34.98

1948

8028

Selective serotonin reuptake inhibitors

6479

22166

1.59

221.29

2.3

0.22

0.21

g/l

7.79

5918

20775

Deposits [accretions] on teeth

717

1999

4.26

221.06

5.6

2.6

0.21

g/l

0.55

688

1883

Alcohol abuse, main dg, excluding more controls

1089

3988

3.06

219.61

2.4

0.20

0.22

g/l

6.30

982

3764

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

404

766

7.17

217.33

2.9

2.0

0.20

g/l

0.11

390

687

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

1011

3587

3.18

217.15

2.4

2.1

0.20

0.21

g/l

1.46

955

3254

Pain in throat and chest

5360

20633

1.65

216.59

2.3

0.22

g/l

0.24

4960

19275

Other diseases of pleura

2993

14628

1.95

215.96

2.6

2.2

0.19

0.21

g/l

26.29

2742

13498

Asthma (only as main-diagnosis), excluding more controls

4168

14651

1.76

214.60

2.3

0.22

g/l

0.91

3911

13702

Persons encountering health services in other circumstances

2417

12538

2.05

211.58

2.5

2.3

0.21

g/l

1.41

2200

11681

Symptoms and signs concerning food and fluid intake

849

2787

3.53

210.69

2.6

2.3

0.21

g/l

0.94

777

2615

Care involving use of rehabilitation procedures

3924

22319

1.75

210.46

2.4

2.2

0.22

g/l

0.72

3649

20730

Covid-19 confirmed case

1946

9424

2.25

210.01

2.6

2.3

0.21

g/l

0.63

1811

8749

All anxiety disorders

3708

17472

1.79

209.85

2.5

2.3

0.23

0.22

g/l

3.29

3399

16407

Falls/tendency to fall

7080

23753

1.54

207.76

2.4

2.3

0.21

0.22

g/l

6.58

6516

22260

Other reaction to severe stress, and adjustment disorders

2273

11623

2.08

207.39

2.8

2.3

0.22

g/l

0.08

2109

10933

Gastric ulcer

1329

5550

2.67

206.29

3.1

2.0

0.19

0.20

g/l

8.19

1215

5108

Malignant neoplasm of liver and intrahepatic bile ducts

420

879

6.91

206.09

5.9

2.2

0.17

0.20

g/l

9.99

396

808

Poisoning by medicine

1504

6609

2.49

205.92

2.4

0.22

g/l

1.81

1361

6196

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

374

703

7.38

203.97

4.1

1.9

0.18

0.20

g/l

3.12

357

636

Gout

1931

8569

2.24

202.83

2.3

0.21

0.20

g/l

0.82

1766

7919

Other anxiety disorders

2698

12946

1.95

202.36

2.5

2.3

0.23

0.22

g/l

2.83

2476

12143

L04AX Other immunosuppressants

3549

21023

1.79

201.90

3.1

2.3

0.22

g/l

6.90

3358

19621

Exclusions for E4_PCOS_CONSORTIUM

4447

17134

1.70

200.45

2.4

2.3

0.22

g/l

1.06

4138

15996

Pain (limb, back, neck, head abdominally)

4801

14853

1.68

200.01

2.5

2.3

0.21

g/l

0.43

4460

13797

Dysphagia

1591

7249

2.39

199.74

2.3

1.9

0.21

g/l

0.59

1470

6701

Crohn's disease NAS

615

1724

4.33

198.55

4.8

2.3

0.23

0.22

g/l

2.83

581

1612

Other noninfective gastroenteritis and colitis

1705

8027

2.32

197.56

3.2

2.3

0.21

g/l

1.19

1590

7451

Benign neoplasm: Pancreas

317

531

8.89

196.72

2.9

1.8

0.23

0.20

g/l

9.83

309

476

Behavioural syndromes associated with physiological disturbances and physical factors

1985

9866

2.15

196.69

2.6

2.4

0.23

0.22

g/l

5.01

1820

9222

Volume depletion

766

2479

3.61

195.70

3.0

2.2

0.20

g/l

1.07

691

2289

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

293

459

9.83

194.71

2.1

2.0

0.23

0.20

g/l

5.76

284

415

Pure hypercholesterolaemia

4557

19151

1.67

194.23

2.1

2.2

0.22

0.21

g/l

3.17

4223

17801

Pain, not elsewhere classified

1691

7959

2.28

193.95

2.5

2.1

0.22

g/l

0.53

1570

7433

Missing teeth due to accident, extraction or parodontitis

948

3481

3.15

193.90

3.3

2.1

0.21

g/l

0.52

899

3247

Other diseases of urinary system

6451

24354

1.54

193.69

2.3

0.21

g/l

1.69

5939

22713

Other disorders of urethra and urinary system

4292

19935

1.69

193.60

2.3

2.2

0.21

g/l

2.20

3940

18597

Syncope and collapse

2696

13166

1.92

191.47

2.4

2.1

0.21

g/l

3.66

2442

12220

Decubitus ulcer and pressure area

565

1545

4.59

191.25

2.3

2.1

0.18

0.20

g/l

10.79

511

1422

Other special examinations and investigations of persons without complaint or reported diagnosis

4283

13156

1.71

191.15

2.6

2.0

0.21

0.22

g/l

0.80

4007

12227

COPD (mode)

2067

8265

2.14

191.03

2.1

0.20

0.21

g/l

9.52

1881

7695

Symptoms and signs involving cognition, perception, emotional state and behaviour

5996

28139

1.55

190.15

2.3

0.21

0.22

g/l

5.07

5480

26253

Other diseases of intestine

956

3556

3.08

190.02

3.3

2.1

0.20

0.21

g/l

1.20

896

3294

Other symptoms and signs involving the digestive system and abdomen

1159

4729

2.71

187.93

2.5

1.9

0.21

0.22

g/l

1.65

1079

4390

Direct fill therapy

1071

4244

2.88

187.77

4.1

2.5

0.22

g/l

0.02

1020

3986

Benign neoplasm: Rectum, anus and anal canal

1169

4789

2.68

187.21

2.4

2.0

0.22

0.20

g/l

6.01

1088

4332

Benign neoplasm: Rectum

1065

4181

2.82

187.11

2.4

2.0

0.22

0.21

g/l

6.20

996

3783

Asthma (only as main-diagnosis)

4254

15809

1.69

186.86

2.3

2.2

0.22

g/l

0.02

3988

14753

Benign neoplasm: Sigmoid colon

1088

4330

2.78

185.69

2.5

2.0

0.22

0.20

g/l

7.40

1027

3912

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

264

389

10.47

185.30

5.5

1.8

0.18

0.20

g/l

4.44

252

346

Cutaneous abscess, furuncle and carbuncle

1692

8140

2.25

185.24

2.7

2.3

0.21

0.22

g/l

5.37

1558

7587

Malignant neoplasm of stomach

534

1450

4.69

183.45

3.3

2.1

0.20

g/l

0.06

512

1340

Medicines for HER+ breast cancer

2318

12183

2.00

182.98

1.7

2.1

0.23

0.21

g/l

28.18

2228

11299

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1167

4838

2.66

182.82

2.5

2.3

0.22

0.23

g/l

2.90

1059

4540

Symptoms and signs involving the circulatory and respiratory systems

6360

21447

1.53

182.71

2.4

0.22

g/l

0.04

5889

20031

Gout, FINNGEN

1931

9832

2.14

182.40

2.3

2.2

0.21

0.20

g/l

1.08

1766

9045

Chronic gastritis

1872

9422

2.15

181.85

2.8

2.0

0.20

0.21

g/l

0.39

1691

8714

Malignant neoplasm of pancreas

608

1813

4.18

181.43

3.6

2.0

0.19

0.20

g/l

3.87

575

1680

Headache

3679

18680

1.71

181.35

2.4

2.2

0.23

0.22

g/l

2.65

3405

17477

Acute alcohol intoxication, ICD10

1389

6251

2.44

180.97

2.5

2.4

0.20

0.22

g/l

7.10

1246

5853

Insulin, fast-acting

2342

12702

1.97

180.53

2.9

2.3

0.19

0.21

g/l

44.24

2145

11836

Osteoporosis

1750

8228

2.23

180.35

2.8

2.0

0.20

0.21

g/l

4.04

1596

7619

Factors influencing health status and contact with health services

2071

5091

2.13

179.57

2.4

1.9

0.21

0.22

g/l

2.76

1924

4726

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1806

8972

2.15

179.48

2.4

2.3

0.22

g/l

1.79

1646

8397

Suicide or other Intentional self-harm

1625

7792

2.26

178.94

2.4

2.3

0.22

g/l

1.99

1472

7278

Asthma-related infections

3572

21563

1.71

175.75

2.5

2.3

0.21

g/l

0.46

3323

19987

Asthma, hospital admission 2, infections

3572

21563

1.71

175.75

2.5

2.3

0.21

g/l

0.46

3323

19987

Haemorrhage from respiratory passages

2270

11411

1.97

173.71

2.5

2.3

0.20

0.21

g/l

4.59

2066

10586

Hernia

5791

26585

1.53

173.31

2.5

2.2

0.21

0.22

g/l

0.73

5412

24672

Symptoms and signs involving the urinary system

4756

24047

1.60

172.33

2.4

2.3

0.21

g/l

3.63

4345

22345

Hepatocellular carcinoma

291

520

8.91

171.85

6.5

2.2

0.17

0.20

g/l

6.23

280

477

Peripheral artery disease

2804

13016

1.85

171.08

2.1

2.2

0.20

g/l

3.18

2550

11984

Acute alcohol intoxication

1669

8224

2.19

170.97

2.4

0.20

0.21

g/l

6.26

1500

7695

Gout, idiopatic and unspecified

1643

8102

2.23

170.81

2.3

2.2

0.21

0.20

g/l

1.59

1501

7480

Diseases of oral cavity, salivary glands and jaws

5793

19925

1.54

170.66

2.5

2.2

0.21

g/l

0.21

5372

18493

Reimbursement for rheumatic diseases

3609

22359

1.69

170.62

3.3

2.2

0.21

g/l

0.97

3401

20786

Other diseases of blood and blood-forming organs, wide

1544

7453

2.28

169.87

2.7

2.3

0.20

0.21

g/l

4.31

1428

6942

Crohn's disease of small intestine

595

1808

3.90

169.06

3.9

2.2

0.23

0.22

g/l

3.56

577

1687

Persons encountering health services for specific procedures, not carried out

621

1934

3.75

168.75

2.7

2.3

0.21

0.22

g/l

1.55

554

1813

Care involving dialysis

661

2151

3.64

168.63

3.1

2.3

0.22

0.21

g/l

1.54

622

2011

Coagulation defects, purpura and other haemorrhagic conditions

1338

6118

2.41

168.40

3.1

2.3

0.20

0.21

g/l

8.04

1252

5699

Malignant neoplasm of breast, HER-positive

2181

11701

1.98

168.22

1.7

2.1

0.23

0.21

g/l

30.09

2098

10853

Abnormal findings on diagnostic imaging of lung

2979

17238

1.79

167.98

2.4

2.2

0.20

0.21

g/l

1.42

2770

15945

External causes of morbidity and mortality

4236

13279

1.65

167.24

2.4

2.3

0.21

0.22

g/l

3.57

3926

12433

Problems related to lifestyle

760

2659

3.22

167.23

2.5

2.2

0.21

0.22

g/l

4.05

671

2485

Cholecystitis

986

3957

2.78

166.52

3.1

1.9

0.18

0.21

g/l

15.77

923

3617

Abnormal results of function studies

728

2524

3.39

166.44

3.1

2.3

0.21

0.22

g/l

0.31

653

2351

Codes for special purposes

2680

15497

1.83

165.70

2.5

2.3

0.22

g/l

0.03

2492

14437

Alcohol withdrawal state with delirium

639

2074

3.74

165.40

2.8

2.4

0.19

0.22

g/l

13.93

553

1939

L02BG Aromatase inhibitors

1902

9983

2.07

165.17

1.7

2.1

0.23

0.21

g/l

28.51

1831

9267

Provisional assignment of new diseases of uncertain etiology

2674

15472

1.82

164.96

2.5

2.3

0.22

g/l

0.04

2487

14412

Disorders of adult personality and behaviour

1734

8758

2.11

164.52

2.4

0.22

g/l

0.04

1558

8206

Concussion

3032

15591

1.76

164.34

2.4

0.21

0.22

g/l

3.02

2771

14590

Explicit bacterial Sepsis

769

2747

3.19

164.01

3.0

2.1

0.19

0.21

g/l

14.17

710

2567

Sleep disorders (combined)

6008

27120

1.50

163.57

2.2

2.3

0.22

0.21

g/l

12.44

5568

25270

Primary_lymphoid and hematopoietic malignant neoplasms

1324

6055

2.36

163.52

2.4

2.1

0.20

0.21

g/l

4.22

1217

5470

Pulmonary heart disease, diseases of pulmonary circulation

2050

11041

2.00

162.91

2.5

2.1

0.20

0.21

g/l

3.17

1899

10182

Cystitis

5160

21030

1.55

162.50

2.3

2.2

0.21

g/l

0.23

4752

19614

Mental and behavioural disorders due to opioids

366

809

5.62

162.33

2.4

0.20

0.24

g/l

12.47

319

751

Finngen Rheumatological endpoints

5963

23264

1.51

162.28

2.4

2.3

0.22

g/l

0.01

5534

21684

923

3627

2.83

162.13

2.8

2.2

0.22

g/l

0.28

847

3392

Other bacterial intestinal infections

1251

5648

2.44

162.06

2.9

2.1

0.21

g/l

0.15

1142

5241

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

284

514

7.86

162.02

2.8

2.0

0.24

0.21

g/l

10.02

276

462

Neurological diseases, wide definition

1978

4974

2.09

161.75

2.4

2.6

0.22

g/l

0.30

1847

4709

Other CVD (FINNGEN)

810

2282

3.13

161.67

2.3

2.2

0.20

0.22

g/l

10.16

730

2145

Early onset COPD, excluding more controls

1359

6325

2.33

161.63

2.3

2.2

0.21

0.22

g/l

1.31

1249

5908

Personality disorders

1653

8269

2.14

161.31

2.3

2.4

0.22

g/l

0.10

1487

7749

Persons encountering health services for examination and investigation

4172

13157

1.64

161.19

2.5

2.0

0.21

0.22

g/l

0.79

3905

12228

Ventral hernia

1622

8113

2.18

161.12

2.9

2.1

0.21

g/l

0.84

1546

7530

Alcohol-induced chronic pancreatitis

604

1930

3.82

160.81

3.1

2.4

0.19

0.22

g/l

9.82

559

1805

Invasive ventilation

647

2150

3.62

160.58

2.9

2.3

0.20

0.21

g/l

2.47

581

2007

Insulin, fast-acting or short human

2355

13261

1.89

160.51

2.9

2.3

0.19

0.21

g/l

41.64

2156

12350

Gout, unspecified

1384

6559

2.34

160.45

2.3

2.2

0.21

0.20

g/l

1.14

1262

6045

Anorexia (incl.atypical)

499

1391

4.17

159.78

3.6

2.4

0.23

0.22

g/l

0.48

456

1305

Parodontitis or operation codes

5485

27595

1.52

159.76

2.4

2.2

0.21

g/l

0.00

5077

25676

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

837

2241

3.06

159.07

2.3

2.2

0.21

g/l

0.31

785

2119

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1290

5664

2.36

158.67

1.7

2.0

0.23

0.21

g/l

9.69

1237

5147

Chronic periodontitis, complicated

792

2959

3.15

158.63

3.2

2.3

0.21

g/l

0.13

759

2773

Fentanyl

749

2680

3.15

158.45

3.2

2.0

0.19

0.20

g/l

3.87

696

2460

Parodontitis

5474

27599

1.52

158.38

2.4

2.2

0.21

g/l

0.01

5067

25679

Hernia of abdominal wall

2840

16944

1.78

158.34

2.9

2.2

0.21

g/l

0.02

2675

15726

Sequelae of external causes of morbidity and mortality

1671

8505

2.14

158.15

2.5

2.2

0.21

g/l

0.37

1565

7907

Low back pain

4456

22509

1.58

158.02

2.3

0.22

0.21

g/l

1.65

4118

20972

Chronic periodontitis, including avohilmo

5447

27594

1.52

156.89

2.4

2.2

0.21

g/l

0.03

5045

25675

Asthma, hospital admissions 3, pneumonia

2245

12550

1.90

156.32

2.4

2.2

0.21

g/l

0.29

2079

11581

Asthma-related pneumonia or sepsis

2245

12550

1.90

156.32

2.4

2.2

0.21

g/l

0.29

2079

11581

Malignant neoplasm of tongue

291

574

8.27

156.28

2.4

2.3

0.23

0.21

g/l

4.38

279

536

Intestinal adhesions without obstruction

678

2337

3.39

156.08

3.2

2.0

0.20

0.21

g/l

1.66

638

2172

Asthma-related pneumonia

2240

12521

1.90

156.05

2.4

2.2

0.21

g/l

0.32

2076

11554

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1047

4479

2.62

155.08

2.7

2.2

0.20

0.21

g/l

4.17

973

4176

Streptococcal septicaemia

655

2225

3.41

154.08

3.0

2.1

0.19

0.21

g/l

12.75

603

2073

Venous thromboembolism

3308

20031

1.69

153.42

2.4

2.2

0.20

0.21

g/l

3.52

3053

18503

Other external causes of accidental injury

5264

17700

1.54

152.78

2.4

2.3

0.21

0.22

g/l

3.76

4842

16621

Disorders of mineral metabolism

666

2303

3.39

152.76

3.3

2.2

0.21

g/l

0.72

622

2166

Asthma (diagnoses ohter than nonallergic)

5174

30249

1.51

152.63

2.3

0.22

0.21

g/l

1.33

4841

28058

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

541

1642

3.79

152.16

2.2

2.5

0.21

0.23

g/l

6.96

476

1533

Diaphragmatic hernia

2297

13095

1.88

151.58

2.5

2.1

0.21

g/l

3.25

2128

12155

Valvular heart disease excluding rheumatic fever

2915

12769

1.76

150.66

2.3

0.20

0.22

g/l

33.64

2672

11922

Chronic hepatitis NAS

221

345

11.15

150.37

5.2

2.3

0.21

0.22

g/l

1.24

201

327

Obesity related asthma

2105

11718

1.92

150.16

2.2

2.3

0.22

0.21

g/l

2.99

1966

10941

Intracranial injury

3398

20688

1.66

149.41

2.4

2.3

0.21

g/l

3.58

3084

19266

Crohn disease (strict definition, require KELA)

543

1684

3.80

149.34

4.1

2.3

0.24

0.22

g/l

3.94

528

1578

Alcohol abuse, main dg

1089

4814

2.50

148.51

2.4

0.20

0.22

g/l

7.01

982

4502

Chronic lower respiratory diseases

7342

28643

1.43

148.42

2.3

2.4

0.21

0.22

g/l

0.47

6841

26634

Pain in joint

3413

14028

1.67

148.39

2.5

2.2

0.23

0.22

g/l

13.04

3162

13077

Crohn disease (strict definition, require KELA, min 2 HDR)

533

1642

3.83

148.15

4.1

2.4

0.24

0.22

g/l

3.60

518

1542

Dorsalgia

6118

23154

1.47

147.69

2.3

0.22

0.21

g/l

3.18

5660

21561

Purpura and other haemorrhagic conditions

976

4139

2.65

147.65

3.3

2.3

0.19

0.21

g/l

12.42

912

3855

Cellulitis

1424

7016

2.21

146.98

2.5

2.3

0.20

0.21

g/l

4.96

1312

6532

Chronic ulcer of skin, not elsewhere classified

589

1957

3.61

146.02

2.6

2.1

0.19

0.21

g/l

5.17

548

1818

Open wound of head

3112

19047

1.69

145.90

2.4

2.3

0.20

0.21

g/l

9.33

2806

17742

Crohn's disease of large intestine

468

1344

4.19

145.66

4.4

2.3

0.24

0.22

g/l

3.28

438

1257

Abnormal serum enzyme levels

1967

10713

1.96

145.64

2.8

2.3

0.22

0.20

g/l

9.15

1846

9899

Non-rheumatic valve diseases

2879

12670

1.75

145.60

2.3

0.20

0.22

g/l

33.46

2637

11825

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

561

1805

3.63

144.93

4.0

2.3

0.24

0.22

g/l

3.77

546

1691

Immunodeficiencies

467

1356

4.28

144.92

3.9

2.5

0.23

0.22

g/l

4.27

444

1277

Immunodeficiency with predominantly antibody defects

314

689

6.29

144.59

4.1

2.6

0.23

0.22

g/l

2.73

303

652

Fungal Sepsis

371

921

5.19

144.24

3.5

2.1

0.21

g/l

0.81

346

868

Unspecified kidney failure

741

2800

3.03

143.24

2.8

2.0

0.20

g/l

0.14

678

2571

Hyperkalaemia

472

1384

4.12

142.81

3.0

2.1

0.19

0.20

g/l

1.44

422

1285

6899

26182

1.43

141.73

2.4

2.2

0.21

g/l

0.71

6384

24315

Accidents

5196

17700

1.51

141.49

2.4

2.3

0.21

0.22

g/l

3.83

4781

16621

Adenocarcinoma and ductal carcinoma of pancreas

374

964

5.25

140.68

4.1

2.1

0.18

0.20

g/l

5.21

357

894

Bacterial intestinal infections, IBD co-morbidities

1237

5888

2.30

140.58

2.9

2.2

0.21

g/l

0.21

1129

5459

Ulcerative ileocolitis

395

1038

4.70

140.57

3.6

2.2

0.23

0.22

g/l

0.51

381

966

DVT of lower extremities and pulmonary embolism

2538

15135

1.77

139.86

2.4

2.1

0.20

0.21

g/l

1.77

2343

14002

Polyneuropathies and other disorders of the peripheral nervous system

1433

7233

2.17

139.53

2.7

2.2

0.21

g/l

0.15

1334

6702

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

296

630

6.14

139.18

3.3

2.0

0.21

0.20

g/l

1.73

285

570

Noninfectious colitis NAS

946

4053

2.59

138.80

3.4

2.2

0.21

g/l

0.32

879

3765

Gingivitis and periodontal diseases

5519

19727

1.49

138.74

2.5

2.2

0.21

g/l

0.88

5100

18315

Specific personality disorders

1415

7086

2.14

137.83

2.4

0.22

g/l

0.03

1275

6651

Amputation

749

2906

2.94

137.29

2.2

2.1

0.18

0.20

g/l

7.34

675

2675

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

272

543

6.39

136.56

3.3

1.9

0.20

g/l

0.28

264

480

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

632

2248

3.20

135.94

1.6

2.0

0.22

0.21

g/l

7.38

607

2028

Other diseases of lip and oral mucosa

1087

4980

2.40

135.91

2.5

2.1

0.21

g/l

1.00

1047

4632

Pulmonary embolism

1828

10056

1.95

135.83

2.5

2.1

0.20

0.21

g/l

1.88

1692

9286

Atherosclerosis, excluding cerebral and coronary sclerosis

2532

12091

1.77

135.70

2.1

2.2

0.20

g/l

1.68

2303

11113

Gout, strict definition

1193

5710

2.32

135.08

2.3

2.2

0.21

0.20

g/l

1.30

1086

5271

Vocal cord dysfunction

820

3040

2.70

135.03

2.4

2.2

0.21

0.22

g/l

1.80

774

2888

Benign neoplasm: Pancreas

317

753

6.09

134.62

2.9

2.1

0.23

0.21

g/l

6.59

309

707

Ulcerative colitis (strict definition, all Crohn cases excluded)

980

4319

2.49

134.12

3.5

2.3

0.23

0.22

g/l

7.68

928

4040

Pulmonary heart disease

1828

10109

1.94

133.56

2.5

2.1

0.20

0.21

g/l

1.72

1692

9330

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

467

1410

3.86

133.25

1.8

2.1

0.20

0.21

g/l

2.47

440

1287

Sequelae with surgical and medical care as external cause

1318

6592

2.19

131.75

2.5

2.2

0.21

g/l

0.25

1229

6116

Dermatitis

3560

23393

1.59

131.20

2.5

2.3

0.21

g/l

0.10

3303

21765

Disorders of other endocrine glands

2583

15504

1.72

130.81

2.7

2.3

0.22

0.21

g/l

5.15

2409

14417

Parodontitis and operation codes

5050

27501

1.48

129.99

2.4

2.2

0.21

g/l

0.22

4684

25594

Thrombocytopenia, unspecified

582

2054

3.35

129.49

3.4

2.3

0.19

0.21

g/l

9.94

537

1918

Portal vein thrombosis

216

381

8.87

128.91

4.9

2.1

0.18

0.22

g/l

9.22

202

355

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2696

11201

1.71

128.33

2.2

2.1

0.21

g/l

0.25

2510

10146

Lower back pain or/and sciatica

6005

30011

1.43

128.27

2.2

2.3

0.22

0.21

g/l

1.67

5537

27911

Genitourinary diseases

3735

12126

1.59

127.86

2.7

2.4

0.22

g/l

0.02

3490

11311

Bronchitis

6252

29711

1.42

127.50

2.5

2.3

0.21

0.22

g/l

0.28

5786

27599

Injuries to the abdomen, lower back, lumbar spine and pelvis

2293

13578

1.77

127.20

2.4

2.2

0.21

g/l

2.74

2069

12568

Benign neoplasm: Stomach

606

2180

3.13

127.08

2.8

2.0

0.21

g/l

1.82

560

1967

Any operation in hilmo

231

139

8.89

126.73

2.7

1.4

0.23

0.24

g/l

0.56

212

128

Attention to artificial openings

370

1005

4.62

126.66

2.8

2.3

0.20

0.21

g/l

0.33

350

932

2565

15624

1.71

126.19

2.5

2.4

0.22

g/l

0.80

2397

14532

Emotionally unstable personality disorder

762

3083

2.70

124.99

2.4

2.3

0.23

g/l

0.22

691

2901

STROKE

3457

15672

1.60

123.69

2.3

0.21

0.22

g/l

8.30

3226

14641

Toxic liver disease

202

344

8.78

123.67

3.9

2.1

0.20

0.22

g/l

3.84

186

325

Other diseases of anus and rectum

1750

9738

1.91

123.65

2.5

2.1

0.21

g/l

1.67

1609

8995

Laparoscopic right hemicolectomy

504

1704

3.68

123.63

2.2

2.1

0.22

0.20

g/l

3.80

490

1592

Implicit fungal Sepsis

329

839

5.00

123.29

3.3

2.1

0.21

g/l

0.38

305

793

Diseases of the respiratory system

4002

13311

1.55

122.55

2.4

2.2

0.21

0.22

g/l

5.64

3733

12418

Misadventures to patients during surgical and medical care

930

4176

2.46

122.48

3.1

2.1

0.21

g/l

0.98

873

3880

Neurological diseases

5372

19042

1.46

122.30

2.4

0.22

g/l

1.05

5002

17778

Enterocolitis due to Clostridium difficile

771

3201

2.71

122.26

3.0

2.1

0.20

0.21

g/l

0.97

691

2960

Intestinal malabsorption

410

1218

4.10

122.15

4.0

2.2

0.21

0.22

g/l

1.88

378

1144

Bipolar affective disorders

1103

5290

2.23

120.62

2.4

2.3

0.23

0.22

g/l

2.72

1013

4994

Glomerular diseases

1190

5919

2.19

120.50

2.5

2.3

0.22

0.21

g/l

1.55

1115

5510

Other and unspecified polyneuropathies, also in other diseases

1239

6262

2.16

120.45

2.7

2.2

0.21

g/l

0.28

1152

5805

Hypothyroidism, strict autoimmune

4149

18674

1.52

120.19

2.3

2.1

0.22

0.21

g/l

0.30

3828

17322

Other acute lower respiratory infections

3078

19026

1.61

119.97

2.6

2.3

0.21

g/l

0.97

2849

17600

Dermatitis and eczema

6348

30564

1.40

119.37

2.5

2.3

0.22

0.21

g/l

2.04

5878

28415

COPD

2731

14200

1.67

118.91

2.2

0.20

0.21

g/l

2.75

2483

13130

Benign neoplasm: Transverse colon

603

2244

3.02

118.73

2.7

2.0

0.21

0.20

g/l

1.36

569

2026

Peripheral artery operations in Hilmo

867

3841

2.49

117.65

2.2

0.19

0.20

g/l

5.41

789

3542

Nonalcoholic steatohepatitis

149

201

15.51

117.50

3.9

2.4

0.22

g/l

0.09

139

186

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

259

569

5.90

117.27

4.0

1.8

0.18

0.20

g/l

3.00

245

512

Injuries to the thorax

2602

16364

1.67

116.97

2.4

2.3

0.20

0.21

g/l

6.28

2352

15173

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

225

444

6.92

116.42

2.8

2.0

0.24

0.21

g/l

5.41

219

400

Sleep apnoea

5395

26340

1.43

116.24

2.2

2.3

0.22

0.21

g/l

9.71

5006

24536

Cardiomyopathy

1110

5449

2.21

115.61

2.2

2.3

0.20

0.21

g/l

9.51

1023

5100

Peripheral arterial reconstruction

1093

5357

2.24

115.49

1.9

2.1

0.20

g/l

0.34

1000

4911

Adjustment and management of implanted device

1107

5432

2.21

115.38

2.2

2.1

0.20

g/l

1.08

1011

4996

Malnutrition

249

549

6.49

115.18

3.5

2.9

0.18

0.21

g/l

7.75

234

516

Secondary hypertension

531

1852

3.17

114.95

2.9

2.3

0.23

0.22

g/l

2.58

503

1743

Unspecified fall

2823

18016

1.62

114.75

2.3

0.21

g/l

2.89

2560

16723

6-mercaptopurine

279

657

5.20

114.25

3.5

2.3

0.25

0.22

g/l

4.51

266

609

Other chronic obstructive pulmonary disease, including avohilmo

3162

17302

1.59

114.16

2.1

2.2

0.20

0.21

g/l

3.33

2882

16019

Other diseases of the respiratory system

1277

6626

2.08

114.15

2.8

2.2

0.20

g/l

2.24

1185

6086

Other respiratory disorders and diseases

1277

6626

2.08

114.15

2.8

2.2

0.20

g/l

2.24

1185

6086

Follow-up examination after treatment for conditions other than malignant neoplasms

2580

10449

1.68

113.99

2.4

2.0

0.22

g/l

0.01

2409

9747

Pleural effusion

1012

4847

2.30

113.75

2.5

2.1

0.18

0.20

g/l

21.38

929

4465

Postprocedural disorders of digestive system, not elsewhere classified

330

899

4.73

113.55

4.5

2.2

0.21

g/l

0.21

322

840

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2383

9993

1.70

111.38

2.3

2.1

0.21

g/l

0.06

2200

9038

Other chronic obstructive pulmonary disease

2605

13719

1.66

111.33

2.1

2.2

0.20

0.21

g/l

2.71

2366

12688

Benign neoplasm: Ascending colon

714

2975

2.64

110.80

2.5

2.0

0.22

0.20

g/l

4.52

672

2680

Injury, poisoning and certain other consequences of external causes

3332

10880

1.58

110.80

2.4

2.3

0.21

0.22

g/l

2.53

3108

10178

Other ulcerative colitis

457

1530

3.47

110.49

4.1

2.2

0.23

0.22

g/l

1.89

432

1424

Other and unspecified dermatitis

2900

18935

1.60

110.30

2.5

2.3

0.21

g/l

0.03

2703

17636

Mental and behavioural disorders due to sedatives or hypnotics

504

1782

3.23

110.01

2.4

2.3

0.21

0.22

g/l

3.07

433

1668

Benign neoplasm: Caecum

598

2304

2.90

109.99

2.5

2.0

0.21

0.20

g/l

4.27

560

2082

Hard cardiovascular diseases

4664

21209

1.46

109.75

2.2

2.3

0.21

g/l

7.80

4300

19729

Extracorporeal dialysis

504

1807

3.32

109.70

3.2

2.3

0.22

0.21

g/l

0.95

475

1685

Malignant neoplasm of other and unspecified parts of tongue

208

417

8.03

109.68

2.1

2.2

0.23

0.21

g/l

2.35

200

393

Right hemicolectomy

496

1774

3.32

108.28

2.8

2.1

0.20

g/l

1.11

476

1646

Acute peritonitis

512

1858

3.22

107.94

3.7

2.2

0.19

0.21

g/l

7.72

485

1723

Weight loss

705

2991

2.67

107.51

2.4

2.3

0.21

g/l

0.01

636

2794

Episodal and paroxysmal disorders

6624

25339

1.37

106.67

2.3

2.4

0.22

0.21

g/l

7.32

6160

23549

Schizophrenia or delusion, excluding more controls

1592

8915

1.86

106.08

2.1

2.3

0.22

g/l

0.13

1429

8421

Diseases of peritoneum

723

3111

2.60

106.08

3.4

2.2

0.20

0.21

g/l

5.64

680

2898

Other and unspecified immunodeficiencies with predominantly antibody defects

183

336

8.60

105.25

4.1

2.6

0.24

0.22

g/l

2.81

183

319

Mycoses

1572

8927

1.88

105.10

2.7

2.3

0.21

g/l

2.45

1451

8310

Enlarged lymph nodes

941

4503

2.25

104.07

2.5

2.1

0.21

0.22

g/l

1.98

883

4219

Sleep apnoea, including avohilmo

5600

26759

1.40

104.03

2.1

2.3

0.22

0.21

g/l

10.32

5205

24915

Presence of cardiac and vascular implants and grafts

2627

12767

1.63

103.86

2.1

0.20

0.21

g/l

7.87

2411

11749

Mental and behavioural disorders due to use of other stimulants, including caffeine

249

577

5.23

103.75

2.3

2.5

0.20

0.24

g/l

8.56

217

537

malignant neoplasm of female genital organs

990

4890

2.23

103.24

1.9

2.0

0.21

g/l

0.73

940

4535

Other diseases of hard tissues of teeth

3602

18388

1.51

103.23

3.0

2.2

0.22

0.21

g/l

7.62

3356

17171

Diseases of pulp and periapical tissues, including avohilmo

6384

24768

1.37

102.92

2.3

0.22

0.21

g/l

0.16

5924

23003

Use of disulfiram, acamprosate or naltrexone

631

2592

2.74

102.53

2.4

0.22

g/l

0.44

567

2425

Certain disorders involving the immune mechanism

1217

6451

2.04

102.34

3.1

2.3

0.22

0.21

g/l

4.66

1152

6024

Glomerular disorders in diseases classified elsewhere

778

3509

2.46

102.07

2.5

2.3

0.21

g/l

0.20

728

3263

Acute bronchitis

2336

14470

1.65

102.02

2.4

2.2

0.21

g/l

0.55

2156

13361

Benign neoplasm: Small intestine

304

833

4.40

101.47

2.9

1.9

0.22

0.20

g/l

2.77

282

750

Dental pulpitis 4

6381

24807

1.37

101.44

2.3

0.22

0.21

g/l

0.23

5921

23041

Dental pulpitis 1

6382

24817

1.37

101.43

2.3

0.22

0.21

g/l

0.19

5923

23050

Alcohol-induced acute pancreatitis

348

1058

4.12

101.35

3.7

2.3

0.19

0.22

g/l

6.94

328

982

Disorders of lens

4030

17791

1.48

101.11

2.5

2.3

0.20

0.21

g/l

13.22

3725

16569

Fracture of rib(s), sternum and thoracic spine

1724

10155

1.80

101.07

2.4

2.2

0.20

0.21

g/l

2.48

1554

9411

Systemic connective tissue disorders

2052

12650

1.71

100.79

2.4

2.1

0.21

g/l

1.27

1908

11769

Other CVD

1160

6082

2.06

100.68

2.3

2.1

0.20

g/l

1.31

1038

5595

All influenza

1442

8067

1.89

100.50

2.7

2.3

0.21

g/l

1.85

1336

7517

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

720

3151

2.48

99.54

2.2

2.1

0.19

0.20

g/l

3.27

667

2848

Agranulocytosis

768

3488

2.46

99.52

2.8

2.3

0.20

0.21

g/l

5.75

715

3273

Crohn disease (strict definition, all UC cases excluded)

392

1275

3.57

99.51

3.7

2.2

0.24

0.22

g/l

3.04

381

1196

Other dorsopathies, not elsewhere classified

5936

23264

1.38

99.27

2.3

0.22

0.21

g/l

5.15

5498

21663

Spondylopathies

4691

20506

1.43

98.93

2.2

2.3

0.21

g/l

1.24

4327

19094

In situ neoplasms

2029

12536

1.70

98.71

2.1

0.22

0.21

g/l

12.27

1901

11606

Exposure to other specified factors

4090

27288

1.45

98.64

2.4

0.22

g/l

0.53

3745

25503

Abnormal weight loss

641

2717

2.68

98.19

2.3

0.21

g/l

0.11

583

2533

Injuries to the hip and thigh

2611

15608

1.60

98.01

2.2

0.20

0.21

g/l

11.74

2369

14400

Paroxysmal tachycardia

1236

5549

1.98

97.89

2.3

0.21

0.22

g/l

6.10

1164

5236

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2250

9670

1.67

97.80

2.2

2.0

0.21

g/l

0.23

2072

8741

Amputation of toe

528

2053

2.97

97.39

2.1

0.19

0.20

g/l

6.61

481

1900

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2277

9801

1.66

97.22

2.2

2.0

0.21

g/l

0.16

2096

8859

Retention of urine

1939

10002

1.73

96.48

2.2

0.20

g/l

3.17

1744

9233

Other complications of surgical and medical care, not elsewhere classified

634

2687

2.61

95.48

3.0

2.1

0.21

g/l

0.44

590

2508

COPD, early/later onset

2624

14564

1.59

95.37

2.1

2.2

0.20

g/l

2.67

2383

13460

Collagenous colitis

621

2624

2.67

95.22

3.0

2.2

0.21

g/l

0.18

587

2447

COPD, hospital admissions

2605

14480

1.60

95.16

2.1

2.2

0.20

g/l

2.37

2366

13379

Soft tissue disorders

6089

23749

1.36

94.51

2.3

2.4

0.22

0.21

g/l

2.29

5647

22096

Delirium, not induced by alcohol and other psychoactive substances

727

3285

2.44

94.33

2.4

2.1

0.19

0.20

g/l

4.61

637

3029

Other symptoms and signs involving cognitive functions and awareness

2503

15377

1.59

93.46

2.2

0.20

0.21

g/l

2.11

2252

14262

Other diseases of stomach and duodenum

477

1806

3.03

92.23

3.4

1.9

0.20

0.21

g/l

0.60

445

1676

Unspecified haematuria

2367

13136

1.61

91.79

2.4

2.2

0.20

0.21

g/l

0.75

2149

12164

Benign neoplasm: Colon, unspecified

1467

8514

1.84

91.75

2.7

2.2

0.21

0.20

g/l

4.58

1358

7895

Candidiasis

840

4066

2.25

91.53

2.9

2.2

0.20

0.21

g/l

3.03

783

3807

Bacterial pneumoniae

2259

12842

1.62

90.87

2.3

2.2

0.21

g/l

2.57

2061

11950

Emotional disorders starting during childhood or adolecense, excluding more controls

269

696

4.17

90.87

3.1

3.8

0.22

0.23

g/l

0.72

249

657

Benign neoplasm: Duodenum

223

533

5.31

90.80

3.0

1.9

0.22

0.20

g/l

1.91

210

484

Non-selective monoamine reuptake inhibitors

2198

13674

1.63

90.27

2.2

0.21

g/l

0.40

2032

12836

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

630

2711

2.51

89.68

2.4

1.9

0.21

0.20

g/l

3.58

577

2431

Benign neoplasm: Liver

194

417

5.85

89.47

2.4

2.1

0.23

0.21

g/l

1.80

187

385

Other specific joint derangements/joint disorders

4059

19482

1.44

89.39

2.4

0.23

0.22

g/l

12.24

3766

18212

Benign neoplasm: Liver/bile ducts

206

465

5.48

89.24

2.4

2.0

0.23

0.21

g/l

2.23

199

426

Cardiomyopathy (excluding other)

790

3769

2.28

89.09

2.2

2.3

0.20

0.21

g/l

9.58

721

3520

Adenocarcinoma and papillary adenocarcinoma of stomach

272

764

4.44

88.91

3.3

2.2

0.20

g/l

0.02

264

704

Irritable bowel syndrome

1467

8537

1.80

88.68

2.3

2.1

0.23

0.22

g/l

10.56

1358

7948

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

659

2949

2.50

88.58

3.3

2.2

0.21

g/l

0.05

632

2745

ILD, hospital admission 2, with pulmonary infections

623

2717

2.55

88.41

2.3

2.1

0.21

g/l

0.19

580

2523

Abnormal findings on diagnostic imaging of other body structures

820

3997

2.25

88.29

2.5

2.1

0.21

g/l

0.00

783

3714

COPD related to multimorbidity

2229

12112

1.63

88.28

2.1

2.2

0.20

g/l

2.79

2013

11176

Fracture of femur

1492

7969

1.81

88.09

2.1

0.19

0.20

g/l

13.37

1325

7290

Acute upper respiratory infections of multiple and unspecified sites

4103

22176

1.42

88.01

2.6

2.3

0.22

g/l

0.42

3824

20620

Benign neoplasm of other and unspecified endocrine glands

659

2928

2.44

87.87

2.3

2.1

0.22

0.21

g/l

1.94

620

2665

Cardiomyopathies, Primary/intrinsic

770

3659

2.29

87.79

2.2

2.3

0.19

0.21

g/l

9.10

704

3421

Senile cataract

3663

16043

1.47

87.39

2.4

2.2

0.20

0.21

g/l

12.15

3377

14939

Bulimia nervosa (incl. atypical)

238

602

4.53

87.11

2.7

2.5

0.23

g/l

0.66

218

575

Hypotension

985

5143

2.07

86.79

2.2

2.1

0.19

0.20

g/l

1.52

879

4721

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

627

2749

2.48

86.43

2.0

0.21

0.20

g/l

3.54

581

2473

Dental caries 1 and operation codes

5143

19584

1.38

86.43

2.3

2.2

0.21

g/l

0.33

4765

18140

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1405

8178

1.83

86.30

2.3

0.22

g/l

1.80

1307

7671

Early onset COPD

1359

7860

1.85

85.81

2.3

0.21

g/l

0.07

1249

7332

Bacterial pneumonia, not elsewhere classified

2132

12129

1.62

85.42

2.3

2.2

0.21

g/l

2.15

1944

11290

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

575

2466

2.59

84.54

2.7

2.1

0.21

g/l

1.42

537

2301

Nonhereditary hypogammaglobulinemia

147

269

8.34

84.36

4.9

2.3

0.23

0.22

g/l

0.88

141

253

Symptoms and signs involving the skin and subcutaneous tissue

3755

26979

1.43

84.17

2.3

0.22

0.21

g/l

11.62

3519

25049

Asthma, including avohilmo

6684

30127

1.32

84.11

2.3

2.4

0.22

0.21

g/l

2.99

6236

27967

Other systemic involvement of connective tissue (FG)

1480

8722

1.78

84.05

2.3

2.1

0.21

g/l

0.55

1366

8109

Osteomyelitis

465

1823

2.92

84.04

2.6

2.3

0.19

0.21

g/l

6.20

430

1703

Respiratory insufficiency

521

2137

2.69

83.75

2.5

2.1

0.19

0.20

g/l

2.35

478

1984

Carcinoma in situ of other and unspecified digestive organs

217

542

5.07

83.52

2.7

1.9

0.22

0.20

g/l

3.10

204

486

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

234

614

4.64

83.33

2.5

1.8

0.21

0.20

g/l

1.19

226

549

Disorders of thyroid, IBD co-morbidities

979

3655

2.04

83.24

2.3

2.2

0.22

g/l

0.32

923

3470

Diseases of the myoneural junction and muscle

774

3778

2.25

83.06

2.4

2.2

0.20

0.21

g/l

3.73

691

3513

Injuries to the knee and lower leg

6705

29834

1.31

82.90

2.3

0.22

g/l

0.29

6201

27758

Dental caries 1

4629

17395

1.40

82.64

2.3

2.2

0.21

g/l

0.62

4265

16136

Superficial injury of head

1265

7217

1.85

82.59

2.2

2.3

0.21

g/l

1.13

1146

6744

Leiomyoma of uterus

2059

7290

1.64

82.34

2.2

2.1

0.22

g/l

4.12

1940

6703

Dizziness and giddiness

4112

24427

1.41

82.33

2.2

2.3

0.21

g/l

0.38

3782

22740

Hydronephrosis

692

3241

2.33

82.05

2.5

2.1

0.20

0.21

g/l

4.37

644

3011

Other benign neoplasms of skin

1629

9741

1.71

81.81

2.3

2.1

0.21

g/l

1.84

1521

8825

Dental caries, including avohilmo

4619

17388

1.39

81.66

2.3

2.2

0.21

g/l

0.67

4256

16128

Conduction disorders

1615

8146

1.73

81.64

2.2

2.3

0.20

0.21

g/l

8.79

1481

7584

Kidney transplant status

408

1527

3.12

81.52

4.1

2.6

0.24

0.22

g/l

4.76

389

1430

Adenocarcinoma of pancreas

259

755

4.35

80.85

4.0

2.1

0.18

0.20

g/l

4.85

245

698

Pacemaker

1813

11133

1.67

80.50

2.0

2.1

0.19

0.20

g/l

5.35

1642

10238

Dental caries 3 and operation codes

5310

20538

1.36

80.49

2.3

2.2

0.21

g/l

0.15

4924

19044

Dorsopathies

5997

23462

1.33

80.28

2.3

2.4

0.22

0.21

g/l

4.95

5586

21855

Dental caries 3

4868

18528

1.38

80.10

2.3

0.21

g/l

0.52

4490

17197

Cerebrovascular diseases

4170

21978

1.40

80.09

2.2

0.20

0.21

g/l

7.33

3812

20383

Dental pulpitis 2

4160

15472

1.41

80.00

2.3

2.2

0.21

g/l

0.86

3843

14340

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

924

4360

2.02

79.25

3.0

0.23

g/l

0.63

844

4099

Panic disorder

771

3787

2.16

78.92

2.3

0.23

0.22

g/l

0.26

690

3550

Other and unspecified myopathies

577

2565

2.52

78.87

2.3

2.1

0.19

0.21

g/l

5.10

507

2388

Vascular disorders of the intestines

453

1804

2.83

78.58

2.8

1.9

0.19

0.20

g/l

1.79

420

1661

Hyperkinetic disorders, excluding more controls

437

1628

2.77

78.45

2.8

3.1

0.23

g/l

0.19

397

1548

Other respiratory diseases principally affecting the interstitium

1049

5777

1.95

78.44

2.3

2.1

0.21

0.20

g/l

1.54

980

5335

Elevated blood glucose level

558

2448

2.54

78.42

2.8

2.2

0.20

0.21

g/l

2.58

517

2278

Nerve, nerve root and plexus disorders

5908

28685

1.32

77.83

2.2

2.3

0.21

g/l

0.21

5484

26627

Assault

741

3618

2.19

77.78

2.5

2.4

0.22

0.23

g/l

4.42

678

3382

Later onset COPD, excluding more controls

1178

5173

1.89

77.76

2.0

0.19

0.20

g/l

9.08

1067

4803

Hypothyroidism, other/unspecified

4944

24654

1.36

77.49

2.3

2.2

0.22

0.21

g/l

1.49

4584

22890

Other disorders of glucose regulation and pancreatic internal secretion

555

2441

2.51

77.08

2.7

2.3

0.19

0.21

g/l

8.69

500

2269

COPD-related respiratory insufficiency

737

3632

2.22

77.06

2.2

0.20

g/l

1.14

678

3348

Vitamin B12 deficiency anaemia

678

3235

2.29

76.74

3.0

2.0

0.20

0.21

g/l

2.56

632

2984

Ulcerative enterocolitis

265

800

3.94

76.58

4.2

2.3

0.24

0.22

g/l

3.35

250

747

COPD, hospital admission 2, with asthma infections

1772

9564

1.66

76.51

2.2

0.20

g/l

2.24

1614

8825

Abnormalities of heart beat

1893

12094

1.61

76.01

2.3

2.2

0.21

g/l

0.52

1733

11271

Hypothyreosis and Thyroxine purchase for inclusion criteria

5085

25536

1.35

75.78

2.3

2.2

0.22

0.21

g/l

1.29

4710

23724

Fracture of lumbar spine and pelvis

1214

7026

1.83

75.76

2.4

2.1

0.19

0.21

g/l

5.63

1091

6497

Malignant neoplasm of other and unspecified parts of biliary tract

163

361

6.54

75.43

5.1

2.0

0.17

0.21

g/l

6.28

155

337

Non-follicular lymphoma, hilmo, excluding all cancers

503

2139

2.57

74.68

2.2

2.1

0.19

0.20

g/l

2.51

465

1935

Bacterial pneumonia (organism specified)

2423

15021

1.52

74.53

2.4

2.2

0.21

g/l

0.47

2213

13901

Presence of other functional implants

3125

15697

1.46

74.36

2.1

0.20

0.21

g/l

4.64

2842

14502

Undetermined asthma, excluding more controls

704

3425

2.20

74.32

2.3

2.2

0.22

g/l

0.03

652

3201

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

587

2663

2.37

74.22

2.1

1.8

0.20

0.19

g/l

3.17

546

2368

Other arthritis (FG)

1717

10907

1.65

74.12

2.4

2.3

0.22

0.21

g/l

0.41

1607

10169

Nonorganic sleeping disorders, excluding more controls

891

4705

2.00

74.04

2.4

2.3

0.23

0.22

g/l

3.37

817

4443

Dental pulpitis 2, only avohilmo

4222

15938

1.39

73.88

2.3

2.2

0.21

g/l

0.56

3893

14780

Benign neoplasm: Sigmoid colon

1088

6178

1.89

73.85

2.5

2.2

0.22

0.21

g/l

6.44

1027

5726

Other pleural conditions

651

3114

2.30

73.73

2.5

2.1

0.18

0.20

g/l

16.05

595

2871

Amenorrhoea

399

1524

2.84

73.61

3.3

2.4

0.22

g/l

0.13

367

1434

Diseases of the musculoskeletal system and connective tissue

3210

11321

1.46

73.53

2.5

0.22

g/l

0.88

2983

10621

Dental operations

3871

14465

1.41

73.51

2.3

2.2

0.21

g/l

0.12

3599

13316

Disorders of the thyroid gland

5256

26369

1.33

73.33

2.3

0.22

0.21

g/l

2.07

4879

24485

Biological medication for rheuma

882

4688

2.01

72.95

3.2

2.4

0.23

0.22

g/l

3.69

841

4410

Benign neoplasm: Rectum

1065

6035

1.90

72.93

2.4

2.2

0.22

0.21

g/l

6.29

996

5597

Osteoporosis with pathological fracture (FG)

467

1966

2.69

72.67

2.5

1.9

0.19

0.20

g/l

2.20

417

1821

Viral pneumonia

726

3621

2.16

72.47

2.6

2.3

0.21

g/l

0.29

665

3382

Acidosis

196

510

4.98

72.14

2.7

2.4

0.19

0.21

g/l

1.02

175

475

Benign neoplasm: Adrenal gland

410

1625

2.80

71.29

2.1

0.22

0.21

g/l

3.08

384

1479

Other disorders of veins

2103

14082

1.55

71.28

2.3

2.1

0.21

0.22

g/l

4.75

1917

13156

Benign neoplasm: Rectum, anus and anal canal

1169

6841

1.83

71.19

2.4

2.2

0.22

0.21

g/l

5.64

1088

6349

Fracture of shoulder and upper arm

1957

12928

1.58

70.81

2.4

2.3

0.20

0.21

g/l

5.44

1769

12007

Hypoglycaemia, other or unspecified

457

1919

2.66

70.77

2.7

2.4

0.19

0.22

g/l

9.53

409

1783

ILD, hospital admissions

884

4775

2.00

70.73

2.3

2.2

0.21

0.20

g/l

1.67

826

4413

Other interstitial pulmonary diseases

890

4822

2.00

70.46

2.3

2.2

0.21

0.20

g/l

1.63

831

4454

Malignant neoplasm of breast, HER-negative

1138

6611

1.83

70.38

1.7

2.1

0.23

0.21

g/l

15.09

1093

6110

Type 1 diabetes

1342

8106

1.73

70.24

2.5

2.4

0.19

0.22

g/l

31.72

1213

7586

Ischemic heart diseases

4440

21000

1.36

70.04

2.2

2.3

0.21

g/l

3.92

4095

19519

Other arrhythmias

3342

18559

1.42

69.90

2.2

2.3

0.21

0.22

g/l

7.92

3085

17370

Interstitial lung disease endpoints

890

4839

1.99

69.70

2.3

2.2

0.21

0.20

g/l

1.66

831

4470

Interstitial lung disease

890

4839

1.99

69.70

2.3

2.2

0.21

0.20

g/l

1.66

831

4470

Other acute viral hepatitis

140

287

6.64

69.64

3.3

2.7

0.19

0.23

g/l

7.04

129

268

Malignant neoplasm of oesophagus

241

742

4.14

69.59

2.9

2.2

0.19

0.21

g/l

2.82

231

681

Hypertensive heart and/or renal disease

1380

6481

1.73

69.38

2.1

2.2

0.20

g/l

0.78

1236

6008

Other specified/unspecified arthritis

1504

9414

1.67

69.24

2.3

0.22

0.21

g/l

0.52

1412

8816

Parodontitis or/and operation codes

3575

15558

1.41

68.56

2.4

2.3

0.22

g/l

0.68

3321

14560

Malignant neoplasm of small intestine

212

608

4.52

68.35

3.4

2.3

0.21

g/l

0.68

202

569

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1373

8312

1.70

68.22

3.0

2.5

0.22

g/l

0.64

1290

7809

Other systemic involvement of connective tissue

1523

9613

1.66

68.10

2.3

2.1

0.21

g/l

1.28

1409

8935

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

125

238

7.49

68.00

2.1

1.7

0.23

0.20

g/l

2.81

120

212

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

134

269

6.67

67.94

2.6

1.8

0.23

0.20

g/l

2.68

126

241

Other/unspecified dorsalgia

2026

13537

1.54

67.36

2.4

2.2

0.22

0.21

g/l

3.26

1854

12624

Asthma/COPD (KELA code 203)

5208

28503

1.31

67.24

2.2

2.4

0.22

g/l

0.09

4838

26500

Diagnoses used for exclusion with ILD

1411

8769

1.69

67.24

2.7

2.2

0.21

g/l

0.57

1291

8112

Generalized anxiety disorder

749

3856

2.05

67.14

2.7

2.4

0.23

0.22

g/l

1.61

689

3622

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

527

2393

2.38

66.93

2.0

0.21

0.20

g/l

3.45

492

2156

Functional dyspepsia

1387

8582

1.69

66.82

2.4

2.0

0.22

0.21

g/l

2.66

1289

7985

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

235

715

3.85

66.78

1.9

2.0

0.19

0.20

g/l

2.17

223

660

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1089

5257

1.82

66.48

2.2

2.0

0.20

g/l

0.38

1021

4727

Unspecified privation

658

3286

2.18

66.09

2.5

2.2

0.22

0.21

g/l

1.61

606

3067

Other viral diseases

1512

9541

1.65

66.03

3.4

2.5

0.22

g/l

0.30

1427

8921

Other embolism and thrombosis

761

3999

2.05

65.72

2.6

2.1

0.21

g/l

1.30

698

3719

Other cataract

2371

12705

1.50

65.71

2.4

2.2

0.20

0.21

g/l

5.65

2175

11815

ILD, hospital admissions 3, with pneumonia sepsis

510

2322

2.43

65.54

2.2

2.1

0.20

g/l

0.02

471

2160

Duodenal ulcer

651

3241

2.17

65.53

3.1

2.0

0.19

0.20

g/l

4.31

578

2982

Other problems related to primary support group, including family circumstances

649

3134

2.16

65.40

4.0

2.7

0.22

g/l

0.67

613

2961

Asthma, hospital admissions , main diagnosis only

4430

30416

1.33

65.33

2.3

0.22

0.21

g/l

2.41

4151

28245

Undetermined asthma

704

3593

2.09

65.23

2.3

2.1

0.22

0.21

g/l

0.45

652

3359

Phobic anxiety disorders

656

3255

2.13

65.21

2.7

2.5

0.22

0.23

g/l

0.91

597

3051

Complications of internal orthopaedic prosthetic devices, implants and grafts

1208

7285

1.75

65.13

2.0

0.20

0.21

g/l

1.94

1112

6721

Heart failure and coronary heart disease

1834

9012

1.59

65.09

2.0

2.1

0.18

0.20

g/l

13.25

1644

8264

Carcinoma in situ of breast, intraductal

438

1865

2.57

64.97

1.9

2.1

0.23

0.21

g/l

8.66

420

1710

Persistent mood disorders

1055

6124

1.82

64.90

2.3

2.2

0.22

0.21

g/l

2.13

955

5730

Post-traumatic stress disorder

411

1691

2.61

64.75

2.6

2.4

0.23

g/l

0.20

376

1591

Cough

2215

14629

1.50

64.75

2.5

2.4

0.22

0.21

g/l

2.50

2077

13666

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1623

10508

1.61

64.59

2.6

2.3

0.20

0.21

g/l

6.87

1486

9777

Other and unspecified drugs and medicaments

536

2507

2.36

64.56

2.7

2.2

0.21

g/l

1.38

503

2340

Pneumonitis due to solids and liquids

492

2216

2.44

64.48

3.0

2.1

0.18

0.20

g/l

6.66

432

2037

Hypothyroidism, strict autoimmune, 3 medication purchases required

4537

23724

1.33

64.43

2.3

2.2

0.21

g/l

0.36

4179

22057

Hypertension, portal

25.70

64.43

7.6

2.3

0.17

0.22

g/l

3.54

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

169

424

4.84

63.96

2.7

1.9

0.21

0.20

g/l

1.82

164

373

Extreme obesity with alveolar hypoventilation

308

1134

3.18

63.64

2.5

2.2

0.19

0.21

g/l

5.85

280

1068

Acute upper respiratory infections

5763

28530

1.29

63.56

2.4

2.2

0.22

0.21

g/l

1.11

5372

26461

Exclusions for E4_PCOS_BROAD

965

5506

1.86

63.55

2.7

2.5

0.22

g/l

0.63

900

5166

Disorders of calcium metabolism

411

1734

2.66

63.33

3.1

2.1

0.20

0.21

g/l

2.78

381

1629

Disorders of iron metabolism

151

357

5.61

63.29

2.9

2.3

0.23

0.22

g/l

1.91

141

333

Other specified and unspecified personality disorders

535

2504

2.31

63.28

2.5

2.3

0.22

g/l

0.70

498

2366

L01XE Protein kinase inhibitors

419

1799

2.68

63.28

2.7

2.2

0.20

0.21

g/l

2.24

392

1691

Stomatitis and related lesions

498

2268

2.39

63.17

3.0

2.2

0.21

g/l

0.09

456

2129

Fracture of skull and facial bones

1127

6717

1.76

62.93

2.4

0.21

0.22

g/l

0.82

1030

6283

Hepatomegaly and splenomegaly, not elsewhere classified

116

222

7.31

62.55

2.9

1.9

0.21

0.22

g/l

0.81

110

208

Drug-induced neutropenia

478

2173

2.47

62.37

2.4

2.2

0.20

0.21

g/l

5.16

457

2044

AV-block

922

4709

1.88

62.31

2.1

2.2

0.19

0.21

g/l

6.05

840

4374

Hypertensive Heart Disease

1220

6038

1.73

62.26

2.1

2.2

0.20

g/l

0.93

1095

5591

Benign neoplasm of mouth and pharynx

539

2540

2.28

62.24

2.6

2.1

0.22

0.21

g/l

2.60

507

2300

Papulosquamous disorders

2117

14624

1.50

61.69

2.4

2.3

0.22

0.21

g/l

0.86

1979

13630

Disorders of eyelid, lacrimal system and orbit

4557

27676

1.32

61.68

2.3

0.22

0.21

g/l

2.80

4196

25709

Traumatic subdural haemorrhage

714

3677

2.04

61.63

2.4

2.2

0.19

0.20

g/l

1.24

637

3383

Mixed and other personality disorders

471

2119

2.42

61.47

2.2

2.3

0.22

0.23

g/l

0.45

425

2008

ILD, hospital admissions 1, main diag only

782

4253

1.99

61.42

2.2

0.21

0.20

g/l

1.61

731

3940

Benign neoplasm: Descending colon

362

1454

2.76

61.32

2.8

2.0

0.21

0.20

g/l

1.97

344

1305

Other diseases of pericardium

311

1171

3.04

60.91

2.6

2.3

0.19

0.22

g/l

8.22

282

1106

Unspecified misadventure during surgical and medical care

377

1564

2.75

60.86

3.3

2.2

0.20

0.21

g/l

1.27

358

1465

Dental pulpitis 4, only avohilmo

6220

25931

1.28

60.80

2.3

0.22

0.21

g/l

1.53

5772

24095

Other retinal disorders

3369

20160

1.38

60.71

2.3

2.2

0.20

0.21

g/l

11.31

3066

18649

Endocarditis

259

886

3.39

60.66

2.9

2.5

0.19

0.21

g/l

6.84

235

834

Viral infections characterized by skin and mucous membrane lesions

2185

15206

1.49

60.63

2.8

2.4

0.21

g/l

0.07

2039

14158

Benign neoplasm: Liver

194

564

4.24

60.29

2.4

2.1

0.23

0.22

g/l

0.61

187

530

Primary_lymphoid and hematopoietic malignant neoplasms

1324

8335

1.67

60.29

2.4

2.3

0.20

0.21

g/l

5.16

1217

7716

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

369

1505

2.70

60.29

2.2

2.1

0.20

g/l

0.04

350

1355

Ischaemic heart disease, wide definition

4319

20773

1.34

60.25

2.2

2.3

0.21

g/l

3.13

3974

19312

Open wound of lower leg

817

4511

1.93

60.23

2.6

2.3

0.21

g/l

1.33

752

4189

Injuries to the shoulder and upper arm

4483

29164

1.32

60.19

2.3

0.21

g/l

4.03

4093

27115

Other and unspecified nonorganic psychotic disorders

983

5706

1.81

60.17

2.3

2.4

0.22

0.23

g/l

0.78

883

5357

Other diseases of oesophagus

572

2806

2.21

60.16

2.5

2.0

0.20

0.21

g/l

0.69

525

2597

Symptoms and signs involving the nervous and musculoskeletal systems

3017

22223

1.40

59.91

2.2

2.3

0.22

0.21

g/l

2.06

2801

20629

Congenital malformations, deformations and chromosomal abnormalities

2957

20761

1.40

59.81

2.7

2.4

0.22

g/l

0.27

2793

19379

Mental and behavioural disorders due to tobacco

525

2509

2.30

59.75

2.5

2.3

0.22

g/l

0.21

487

2353

Fracture of lower leg, including ankle

2922

21343

1.40

59.72

2.3

0.21

0.22

g/l

2.99

2696

19895

COPD, hospital admissions 3, with asthma pneumonia sepsis

1441

7839

1.64

59.45

2.1

0.20

g/l

1.83

1307

7199

Phlebitis and thrombophlebitis (not including DVT)

1216

7517

1.70

59.37

2.4

2.1

0.21

g/l

2.29

1125

7006

Psoriasis vulgaris

1045

6225

1.78

59.14

2.6

2.3

0.22

0.21

g/l

0.45

979

5802

Unspecified mental disorder

2091

14511

1.49

58.69

2.2

2.3

0.22

g/l

1.52

1889

13526

Other and unspecified local infections of skin and subcutaneous tissue

561

2767

2.20

58.35

2.9

2.3

0.21

0.22

g/l

1.90

519

2584

Smoking dependency

525

2541

2.27

57.84

2.5

2.3

0.22

g/l

0.19

487

2382

Other joint disorders

4842

20096

1.31

57.82

2.4

0.22

g/l

4.48

4478

18756

Anaemia in chronic diseases classified elsewhere

203

625

3.97

57.74

3.4

2.4

0.21

g/l

0.25

181

585

Psoriasis

1530

10039

1.59

57.63

2.5

2.3

0.22

0.21

g/l

1.09

1432

9366

Benign neoplasm: Liver/bile ducts

206

640

3.89

57.57

2.4

2.1

0.23

0.22

g/l

1.49

199

603

Disorders of choroid and retina

4320

24402

1.32

57.25

2.3

2.2

0.20

0.21

g/l

13.53

3966

22614

Diseases of the eye and adnexa

4639

18000

1.32

57.21

2.5

2.4

0.22

g/l

0.36

4313

16861

Disorders of skin appendages

2394

17099

1.44

57.14

2.4

0.22

g/l

2.85

2246

15954

Viral and other specified intestinal infections

1011

5842

1.76

56.98

3.1

2.5

0.22

g/l

1.33

945

5435

Polycystic ovarian syndrome, consortium definition

3556

16128

1.36

56.82

2.4

2.1

0.22

g/l

0.18

3317

15064

Abnormalities of gait and mobility

708

3827

2.00

56.78

2.2

2.3

0.21

0.20

g/l

0.82

660

3555

Dental pulpitis 1, only avohilmo

6199

26058

1.26

56.45

2.2

2.3

0.22

0.21

g/l

1.67

5751

24216

Diseases of spleen

166

457

4.63

56.45

3.7

2.3

0.20

0.21

g/l

0.83

156

429

Acute posthaemorrhagic anaemia

253

889

3.27

56.43

3.3

2.2

0.18

0.20

g/l

4.74

224

827

Other metabolic disorders

701

3761

1.98

56.42

2.6

2.2

0.22

g/l

1.36

663

3550

Ulcerative rectosigmoiditis

487

2304

2.29

56.31

2.6

2.2

0.23

0.22

g/l

4.07

455

2161

Transport accidents

2274

14254

1.45

56.23

2.3

2.4

0.22

g/l

0.25

2102

13411

Secondary uncertain malignant neoplasm

734

4017

1.97

56.22

2.1

2.2

0.18

0.21

g/l

11.08

683

3716

Melanocytic naevi

1183

7322

1.67

56.15

2.6

2.2

0.22

g/l

3.86

1123

6689

Hyperlipidaemia, other/unspecified

1992

13093

1.49

55.95

2.1

2.2

0.21

g/l

4.88

1817

12146

Benign neoplasm: Duodenum

223

747

3.69

55.81

3.0

2.1

0.22

0.21

g/l

0.76

210

698

Urticaria and erythema

1854

12715

1.51

55.72

2.5

2.4

0.22

g/l

0.70

1721

11868

Cardiomyopathy, other and unspecified

476

2249

2.31

55.51

2.2

2.3

0.20

0.22

g/l

3.60

445

2115

Amputation of foot

210

680

3.78

55.26

2.4

0.18

0.20

g/l

3.54

192

622

Arthropathies

5038

20175

1.29

55.19

2.4

0.22

g/l

0.77

4675

18833

Adalimumab

518

2529

2.22

55.18

3.4

2.4

0.23

0.22

g/l

2.79

496

2378

Cardiodefibrillation

1959

13633

1.50

55.03

2.1

2.2

0.20

g/l

3.88

1785

12588

Vitamin deficiency, wide

317

1265

2.81

54.95

3.3

2.2

0.19

0.21

g/l

5.65

297

1173

Vitamin deficiency

317

1265

2.81

54.95

3.3

2.2

0.19

0.21

g/l

5.65

297

1173

Benign neoplasm of ovary

761

4215

1.90

54.77

2.1

0.22

0.21

g/l

1.19

728

3831

Other local infections of skin and subcutaneous tissue

583

2982

2.11

54.72

2.8

2.3

0.21

0.22

g/l

1.92

539

2787

Tumor necrosis factor alpha inhibitors

756

4199

1.91

54.47

3.1

2.4

0.23

0.22

g/l

4.55

718

3945

Arthrosis

4038

17062

1.33

54.33

2.2

2.3

0.22

0.21

g/l

0.78

3746

15923

Benign neoplasm: Stomach

606

3171

2.09

53.98

2.8

2.1

0.21

g/l

0.90

560

2960

Other endocrine disorders

373

1554

2.58

53.93

3.4

3.3

0.21

g/l

0.02

357

1484

severe traumatic brain injury, does not include concussion

1158

7245

1.68

53.85

2.4

2.2

0.20

g/l

1.71

1047

6653

Cytomegalovirus infection, IBD co-morbidity

192

598

3.94

53.79

5.1

2.4

0.22

g/l

0.04

179

559

Acute sinusitis

2619

17847

1.40

53.79

2.6

2.3

0.22

g/l

0.03

2455

16647

Other intervertebral disc disorders

4507

21590

1.30

53.78

2.2

2.3

0.22

0.21

g/l

9.14

4146

20110

Benign neoplasm: Small intestine

304

1216

2.92

53.78

2.9

2.1

0.22

0.21

g/l

1.54

282

1129

Stroke, excluding SAH

3224

18044

1.37

53.57

2.2

0.20

0.21

g/l

4.87

2945

16682

Protein-energy malnutrition of moderate and mild degree

109

231

7.08

53.57

3.1

2.9

0.18

0.21

g/l

4.12

103

215

Dental caries 3, only avohilmo

4812

19348

1.30

53.56

2.2

2.3

0.21

g/l

0.12

4433

17973

Umbilical hernia

1407

9214

1.60

53.49

2.8

2.3

0.21

g/l

0.07

1308

8595

Statin medication

3846

16512

1.33

53.33

2.2

2.4

0.23

0.21

g/l

20.43

3572

15421

Other congenital malformations of the digestive system

324

1322

2.77

53.32

6.6

2.9

0.21

g/l

0.47

312

1248

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

410

1849

2.41

53.26

2.4

2.0

0.19

0.20

g/l

1.73

370

1658

Epilepsy

1635

11022

1.53

52.85

2.5

0.21

g/l

0.57

1510

10223

Schizophrenia or delusion

1592

10705

1.54

52.76

2.1

2.3

0.22

g/l

0.10

1429

9981

Schizophrenia, schizotypal and delusional disorders

1597

10747

1.54

52.72

2.1

2.3

0.22

g/l

0.10

1434

10021

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

394

1759

2.44

52.62

2.3

2.4

0.22

g/l

0.03

356

1641

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

490

2396

2.24

52.59

2.4

2.1

0.19

0.21

g/l

3.16

447

2219

Other disorders starting during childhood or adolecense, excluding more controls

244

824

3.08

52.52

3.5

4.0

0.22

g/l

0.41

229

787

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

184

560

3.86

52.49

1.8

1.9

0.20

0.21

g/l

1.00

163

519

Disorders of tooth development and eruption

317

1247

2.71

52.48

5.3

2.8

0.22

g/l

0.13

305

1178

Suppurative and necrotic conditions of lower respiratory tract

358

1548

2.60

52.47

2.7

2.2

0.19

0.21

g/l

5.54

325

1439

Dental caries 1, only avohilmo

4570

18307

1.30

52.43

2.2

2.3

0.21

g/l

0.32

4208

17002

Need for other prophylactic measures

372

1637

2.55

52.40

2.9

2.4

0.21

0.22

g/l

0.09

353

1539

Lung diseases due to external agents

754

4242

1.89

52.29

2.8

2.1

0.19

0.20

g/l

2.61

676

3914

Aortic aneurysm

1179

7330

1.66

52.07

2.1

2.2

0.20

g/l

0.49

1080

6748

Cytomegaloviral disease

194

621

3.79

51.85

5.1

2.3

0.22

g/l

0.06

181

580

Carcinoma in situ of other and unspecified digestive organs

217

748

3.57

51.76

2.7

2.2

0.22

0.21

g/l

2.13

204

694

Cerebral palsy and other paralytic syndromes

648

3500

1.98

51.48

2.7

2.3

0.21

g/l

0.62

600

3261

Stroke, including SAH

3395

19182

1.35

51.25

2.2

0.20

0.21

g/l

5.86

3107

17746

Other disorders of adrenal gland

306

1246

2.78

51.22

2.9

2.4

0.22

g/l

0.23

277

1179

Type of accident

1451

9663

1.56

50.81

2.6

2.3

0.20

0.21

g/l

7.17

1331

8985

Benign neoplasm: Transverse colon

603

3216

2.05

50.80

2.7

2.2

0.21

g/l

0.64

569

2986

Injuries to the ankle and foot

3446

24086

1.33

50.75

2.5

2.4

0.22

g/l

0.41

3165

22571

Psychotic depression

347

1486

2.53

50.63

2.5

2.3

0.22

0.21

g/l

0.35

318

1416

Preparatory care for dialysis

302

1237

2.81

50.48

2.7

2.3

0.23

0.21

g/l

2.79

292

1153

Calcific aortic valvular stenosis

1506

9935

1.55

49.93

2.2

2.1

0.19

0.20

g/l

4.25

1378

9102

Calcific aortic valvular stenosis, operated

1506

9935

1.55

49.93

2.2

2.1

0.19

0.20

g/l

4.25

1378

9102

Other disorders of kidney and ureter

721

4078

1.90

49.72

2.5

2.2

0.22

0.21

g/l

5.15

667

3793

Adrenocortical insufficiency

254

962

3.04

49.53

3.0

2.2

0.22

g/l

0.13

231

914

Myalgia

1165

7433

1.63

49.46

2.5

2.2

0.22

g/l

4.45

1083

6939

Erosion of teeth

138

362

4.64

49.41

5.7

2.7

0.22

g/l

0.00

128

348

Calcific aortic valvular stenosis, diagnosis (helper)

1501

9917

1.54

49.38

2.2

2.1

0.19

0.20

g/l

4.08

1373

9084

Operations 2 for CAVS

1501

9917

1.54

49.38

2.2

2.1

0.19

0.20

g/l

4.08

1373

9084

Other and unspecified mood [affective] disorders

359

1573

2.44

49.37

2.2

2.4

0.23

g/l

0.34

327

1490

Other diseases of arteries and capillaries

525

2690

2.11

49.17

2.4

2.2

0.20

0.21

g/l

0.69

475

2504

Assault by bodily force

412

1922

2.31

49.07

2.4

0.22

0.23

g/l

1.51

374

1797

Calcific aortic valvular stenosis, including rheumatic fever

1505

9956

1.54

48.99

2.2

2.1

0.19

0.20

g/l

4.07

1377

9121

Type 1 diabetes, wide definition, subgroup 1

1010

6225

1.69

48.98

2.4

0.19

0.22

g/l

34.81

914

5826

Malignant neoplasm of oropharynx

159

474

4.37

48.74

3.0

2.3

0.24

0.21

g/l

6.68

154

435

Kela-code for severe mental illness

1842

12937

1.47

48.66

2.2

2.3

0.22

g/l

0.99

1658

12057

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

881

5108

1.76

48.51

3.1

2.8

0.21

0.22

g/l

0.53

842

4794

Abscess of anal and rectal regions

469

2313

2.18

48.40

3.0

2.2

0.22

g/l

0.27

439

2155

Coronary atherosclerosis

3715

18605

1.32

48.35

2.1

2.3

0.21

g/l

4.61

3405

17271

Fissure and fistula of anal and rectal regions

1206

7794

1.61

48.30

2.5

2.2

0.22

0.21

g/l

1.28

1128

7248

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

250

938

2.93

48.24

2.1

1.8

0.18

0.19

g/l

2.33

225

839

Paralytic ileus

259

1006

2.91

47.70

2.9

2.0

0.21

g/l

0.01

245

923

Neuromuscular dysfunction of bladder

521

2694

2.09

47.51

2.4

2.3

0.21

g/l

0.44

478

2527

Special screening examination for infectious and parasitic diseases

1095

5112

1.65

47.45

2.5

2.1

0.24

0.23

g/l

3.04

1011

4779

Spinal stenosis

2754

16208

1.37

47.10

2.0

2.2

0.21

g/l

0.38

2525

15023

Disorders of magnesium metabolism

193

7.39

47.04

3.1

2.5

0.19

0.21

g/l

2.00

179

Gastrointestinal stromal tumor and sarcoma

125

328

5.29

46.68

2.1

0.23

0.21

g/l

2.07

120

303

Intentional self-harm by sharp object

174

547

3.63

46.67

2.7

2.5

0.22

0.23

g/l

1.32

164

513

Paracetamol of NSAID medication

1010

3065

1.71

46.42

2.4

2.9

0.22

0.21

g/l

2.41

942

2845

Neuroendocrine tumor and carcinoma of small intestine

134

367

4.78

46.40

2.6

2.2

0.23

0.21

g/l

1.59

126

343

Emotional disorders and disorders of social functioning with onset specific to childhood

291

1181

2.63

46.26

3.2

3.7

0.22

0.23

g/l

0.74

270

1111

Benign neoplasm: Caecum

598

3279

1.98

46.23

2.5

2.2

0.21

g/l

1.95

560

3044

Gonarthrosis [arthrosis of knee](FG)

4137

19210

1.29

46.23

2.1

2.3

0.21

g/l

0.23

3829

17869

Speech and linguistic disorders, excluding more controls

365

1548

2.35

46.20

3.7

3.2

0.22

g/l

0.14

340

1465

Family history of malignant neoplasm

545

2878

2.02

46.16

2.4

2.0

0.23

0.22

g/l

2.98

525

2704

Pruritus

590

3203

1.97

46.11

2.7

2.2

0.21

g/l

0.20

542

2997

Other/unspecified cytomegaloviral diseases

161

497

3.98

45.84

5.0

2.3

0.22

g/l

0.02

153

465

Heartburn

515

2674

2.05

45.67

2.4

2.0

0.22

g/l

0.63

478

2482

Other viral diseases, not elsewhere classified

954

5926

1.68

45.05

3.4

2.5

0.22

g/l

0.55

909

5546

Idiopathic gout

511

2682

2.07

44.96

2.2

0.21

0.20

g/l

0.90

469

2487

Non-allergic asthma (mode), excluding more controls

935

5732

1.68

44.74

2.4

2.2

0.22

g/l

0.47

877

5363

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

260

1042

2.77

44.48

2.3

1.9

0.19

0.20

g/l

1.29

229

934

Dentofacial anomalies [including malocclusion]

1299

8580

1.55

44.34

2.9

2.3

0.23

0.22

g/l

2.78

1224

8064

Other and unspecified effects of external causes

1324

8895

1.54

44.26

2.3

2.4

0.22

g/l

0.12

1222

8314

Arthropathies in other diseases classified elsewhere

248

981

2.86

44.14

2.5

2.3

0.21

g/l

0.84

225

927

Valvular operations

745

4387

1.79

43.97

2.1

2.4

0.19

0.21

g/l

10.20

687

4109

Diseases of salivary glands

966

6069

1.66

43.94

2.5

2.1

0.22

0.21

g/l

2.06

912

5643

UC patients in KELA-register (code 208), prior to 1994

304

1326

2.58

43.90

3.8

2.1

0.23

0.22

g/l

3.06

283

1241

Mental and behavioural disorders due to cannabinoids

182

608

3.33

43.67

2.3

2.6

0.21

0.24

g/l

6.03

155

564

All influenza (not pneumonia)

761

4508

1.77

43.61

2.7

2.4

0.22

g/l

0.05

717

4214

Procreative management

1597

9373

1.48

43.45

2.6

2.5

0.23

0.22

g/l

0.94

1521

8787

Allergic asthma (mode), excluding more controls

1060

6668

1.61

43.23

2.2

2.3

0.23

0.22

g/l

2.59

994

6250

Other noninfective disorders of lymphatic vessels and lymph nodes

233

903

2.92

43.15

2.9

2.0

0.21

0.22

g/l

1.21

217

856

Glomerulonephritis

571

3149

1.95

42.83

2.5

2.4

0.23

0.21

g/l

2.89

537

2939

Malignant neoplasm of floor of mouth

133

9.01

42.81

2.6

2.5

0.22

0.21

g/l

0.83

122

Fibromyalgia

467

2405

2.08

42.72

2.1

2.2

0.23

0.22

g/l

2.62

429

2270

ILD-related respiratory insufficiency

231

904

2.98

42.72

2.3

2.2

0.20

g/l

0.31

217

841

Injuries to the elbow and forearm

3521

25058

1.30

42.61

2.3

0.21

0.22

g/l

6.36

3219

23350

Sequelae of injuries, of poisoning and of other consequences of external causes

1191

7905

1.57

42.55

2.4

2.3

0.22

g/l

0.02

1105

7385

Pyothorax

276

1170

2.66

42.51

2.7

2.3

0.19

0.21

g/l

4.56

253

1087

Haemorrhage, not elsewhere classified

234

916

2.87

42.33

2.8

2.1

0.20

0.21

g/l

1.01

209

858

DVT of lower extremities

971

6175

1.65

42.28

2.3

2.1

0.21

g/l

0.79

895

5750

Dental operations, only avohilmo

3965

16074

1.29

42.06

2.2

2.3

0.21

g/l

0.10

3667

14838

Irregular menses

2145

12792

1.39

41.80

2.6

2.2

0.23

0.22

g/l

2.10

2005

11998

Vasculitis limited to skin, not elsewhere classified

193

697

3.24

41.57

2.6

2.3

0.20

0.21

g/l

0.45

181

652

Alcohol abuse counselling and surveillance

143

435

3.97

41.40

3.7

2.4

0.19

0.23

g/l

5.63

135

406

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

125

347

4.32

41.25

2.1

1.9

0.19

0.21

g/l

0.65

111

316

Other pulmonary heart/vessel disease

297

1318

2.52

41.14

2.6

2.2

0.19

0.20

g/l

3.59

279

1221

Erosion of teeth, including avohilmo

933

5691

1.65

41.12

2.8

2.2

0.23

0.22

g/l

1.20

871

5372

Inflammatory diseases of female pelvic organs

2876

16658

1.33

41.01

2.4

2.1

0.22

g/l

1.36

2676

15586

Haemolytic anaemias

233

929

2.85

40.95

3.1

2.3

0.21

g/l

0.12

219

865

Sciatica+with lumbago

2565

18519

1.35

40.92

2.2

2.3

0.22

0.21

g/l

4.79

2370

17302

Ischaemic Stroke, excluding all haemorrhages

2923

17063

1.33

40.85

2.1

2.2

0.20

0.21

g/l

4.38

2657

15758

Visual disturbances and blindness

2517

19129

1.35

40.84

2.3

0.22

0.21

g/l

1.38

2321

17807

Sleep disorders

1019

6592

1.61

40.79

2.3

0.23

0.22

g/l

3.48

936

6165

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

227

888

2.83

40.76

2.2

2.0

0.21

0.20

g/l

0.23

220

806

Malignant melanoma, excluding all cancers (controls excluding all cancers)

702

4142

1.77

40.67

2.1

2.0

0.22

0.21

g/l

3.10

655

3744

Zoster [herpes zoster]

914

5800

1.66

40.41

2.4

2.1

0.21

g/l

0.95

852

5375

Other headache syndromes

2084

15416

1.39

40.40

2.2

2.3

0.22

g/l

5.82

1946

14389

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2637

19768

1.34

40.25

2.3

0.22

0.21

g/l

6.49

2461

18447

Abdominal aortic aneurysm (AAA)

523

2823

1.95

40.22

1.8

2.1

0.20

0.19

g/l

2.08

477

2564

Disorders of parathyroid gland

1076

6998

1.59

40.15

2.6

2.0

0.22

0.21

g/l

4.74

1002

6467

Other disorders of bladder

632

3656

1.84

40.14

2.3

2.2

0.20

g/l

0.22

575

3407

Fall on and from stairs and steps

1265

8612

1.53

40.02

2.4

2.3

0.21

g/l

0.63

1162

8002

Somatoform disorder

809

4985

1.70

39.98

2.3

2.2

0.23

0.22

g/l

3.61

725

4678

Temporomandibular joint disorders

742

4459

1.73

39.92

2.5

2.1

0.23

0.22

g/l

1.70

691

4182

Disorder of lipoprotein metabolism, unspecified

704

4199

1.77

39.89

2.1

2.2

0.21

0.20

g/l

3.02

642

3895

Oral leukoplakia and related diseases, including avohilmo

513

2806

1.98

39.86

2.3

2.2

0.21

g/l

0.29

485

2636

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

240

977

2.72

39.83

1.9

2.0

0.21

0.20

g/l

0.93

228

884

Benign neoplasm: Ascending colon

714

4295

1.78

39.77

2.5

2.2

0.22

0.20

g/l

3.51

672

3988

Opening and dilatation of root channel of tooth

358

1725

2.25

39.72

3.1

2.3

0.22

g/l

0.17

338

1617

Disorders resulting from impaired renal tubular function

245

1020

2.75

39.60

3.0

2.4

0.24

0.21

g/l

4.51

229

952

Other diseases of upper respiratory tract

6146

26745

1.22

39.47

2.4

2.3

0.22

0.21

g/l

9.62

5705

24799

Gonarthrosis

3534

15992

1.29

39.43

2.1

2.3

0.21

g/l

0.95

3267

14911

Secondary right heart disease

267

1154

2.60

39.35

2.4

2.2

0.19

0.20

g/l

3.34

250

1069

Malignant neoplasm of corpus uteri

479

2581

2.02

39.25

1.7

2.0

0.22

0.21

g/l

3.66

457

2387

Chronic laryngitis and laryngotracheitis

758

4637

1.73

39.03

2.5

2.2

0.22

0.21

g/l

2.90

700

4319

Other diseases of jaws

377

1862

2.18

38.97

2.5

2.1

0.22

0.21

g/l

1.51

354

1752

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

119

7.76

38.96

2.6

1.9

0.22

0.21

g/l

0.14

108

Spondyloarthritis

877

5546

1.65

38.69

2.5

2.2

0.21

g/l

0.06

804

5142

Other postsurgical states

368

1814

2.21

38.68

2.7

2.2

0.20

0.21

g/l

2.62

350

1698

Obsessive-compulsive disorder

302

1364

2.35

38.65

3.2

2.6

0.23

g/l

0.31

282

1286

Superficial injury of lower leg

1192

8066

1.53

38.62

2.2

2.3

0.21

0.22

g/l

0.19

1094

7510

Hypersplenism

9.99

38.60

4.4

2.4

0.18

0.22

g/l

1.77

Polyuria

1104

7372

1.56

38.55

2.5

2.2

0.22

0.21

g/l

4.17

1017

6863

Poisoning by narcotics and psychodysleptics [hallucinogens]

121

343

4.13

38.46

2.4

0.22

0.24

g/l

1.56

105

318

Carcinoma in situ of colon

112

306

4.57

38.40

2.6

2.1

0.22

0.20

g/l

1.38

102

275

Other abnormalities of plasma proteins

131

399

4.08

38.35

2.7

2.1

0.19

0.21

g/l

1.82

119

371

Gingival hyperplasia

222

893

2.82

38.30

4.2

2.5

0.22

0.21

g/l

2.47

211

843

Allergic asthma (mode)

1060

6855

1.56

38.28

2.2

2.3

0.23

0.22

g/l

3.64

994

6429

Other immunodeficiencies

105

275

4.83

38.27

4.6

3.2

0.23

0.22

g/l

0.59

262

L04AC Interleukin inhibitors

289

1302

2.44

38.19

3.7

2.3

0.23

0.22

g/l

0.26

277

1222

Carcinoma in situ of endometrium

9.41

38.12

1.4

1.9

0.24

0.20

g/l

3.41

Other disorders of gingiva or/and edentulous alveolar ridge

304

1401

2.38

38.12

3.9

2.3

0.22

0.21

g/l

1.66

291

1317

Urticaria

1428

10026

1.47

38.06

2.5

2.4

0.22

g/l

1.01

1328

9373

COPD, hospital admissions 1, only main diagnosis

1748

10810

1.42

37.85

2.1

2.2

0.20

g/l

0.16

1591

9967

Emotional disorders starting during childhood or adolescence

270

1169

2.47

37.82

3.1

3.7

0.22

0.23

g/l

0.42

250

1096

Combinations of oral blood glucose lowering drugs

1411

9928

1.48

37.66

2.3

0.21

g/l

1.97

1320

9254

Major coronary heart disease event

3762

20144

1.27

37.64

2.1

2.3

0.20

0.21

g/l

6.62

3460

18673

Non-allergic asthma (mode)

935

5986

1.60

37.38

2.4

2.2

0.22

0.21

g/l

1.15

877

5588

Barrett oesophagus

300

1393

2.40

37.32

2.6

2.0

0.21

g/l

0.14

280

1308

Osteonecrosis

349

1717

2.24

37.23

2.2

0.21

g/l

0.64

330

1605

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

120

7.32

37.22

3.7

1.8

0.20

0.21

g/l

0.56

104

Idiopathic pulmonary fibrosis

427

2252

2.06

37.18

2.0

2.1

0.21

0.20

g/l

2.64

402

2079

Left hemicolectomy

182

679

3.16

37.14

2.7

2.2

0.20

g/l

0.52

167

633

Charcot foot

142

463

3.69

36.91

2.3

0.20

0.22

g/l

2.66

131

439

Intentional self-harm by unspecified means

230

4.88

36.75

2.9

2.5

0.22

0.23

g/l

0.65

212

Organic, including symptomatic, mental disorders

2434

13421

1.35

36.71

2.0

2.1

0.20

g/l

3.04

2146

12431

Disorders of lacrimal system

2052

15392

1.37

36.69

2.4

2.2

0.22

0.21

g/l

1.76

1868

14348

Myocardial infarction, without ST-elevation

1984

13648

1.38

36.69

2.0

2.2

0.20

g/l

2.37

1768

12570

Social phobias

372

1858

2.11

36.62

2.4

2.5

0.23

g/l

0.59

335

1745

Infections with a predominantly sexual mode of transmission

1318

9160

1.48

36.60

2.6

2.3

0.23

g/l

0.06

1226

8575

Sequelae of other external causes

314

1491

2.30

36.49

2.4

2.2

0.21

g/l

1.10

297

1394

Other disorders of lacrimal gland

1669

12143

1.42

36.46

2.4

2.2

0.22

0.21

g/l

1.78

1519

11328

Other and unspecified vasculitis limited to skin

171

622

3.20

36.34

2.6

2.3

0.20

0.21

g/l

0.47

161

579

Vascular diseases of the intestine

237

1005

2.64

36.32

2.9

2.2

0.20

g/l

0.43

216

932

Agoraphobia

173

622

3.05

36.31

2.8

2.3

0.22

0.23

g/l

1.57

153

589

Oral leukoplakia and related diseases

345

1709

2.23

36.26

2.2

0.21

g/l

0.31

333

1593

Carcinoid syndrome

101

272

4.99

36.21

2.3

0.23

0.21

g/l

1.19

254

Faecal incontinence

457

2476

1.97

36.08

2.0

1.8

0.21

g/l

0.34

407

2287

Follow-up examination after treatment for malignant neoplasms

550

3152

1.85

35.96

3.0

1.9

0.20

g/l

0.15

526

2920

Coxarthrosis

2655

13932

1.32

35.80

2.1

2.3

0.21

g/l

0.79

2468

12959

Open wound of forearm

478

2635

1.93

35.66

2.5

2.3

0.21

0.22

g/l

0.83

442

2457

Disturbances of skin sensation

1282

8936

1.48

35.63

2.3

0.23

0.22

g/l

13.04

1191

8331

Diabetic nephropathy, excluding more controls

841

4494

1.66

35.59

2.3

2.4

0.21

0.22

g/l

3.03

768

4126

Degeneration of nervous system due to alcohol

177

667

3.14

35.58

3.0

2.3

0.18

0.21

g/l

5.18

153

616

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1632

11889

1.42

35.35

2.3

0.22

0.21

g/l

1.30

1545

11090

Diseases of the ear and mastoid process

6365

27217

1.20

35.34

2.4

2.3

0.22

g/l

2.58

5947

25288

Nonorganic sleeping disorders

891

5782

1.60

35.30

2.4

2.3

0.23

0.22

g/l

3.27

817

5396

Enteropathic arthropathies

159

561

3.23

35.29

3.0

2.3

0.23

0.22

g/l

0.87

145

532

Degeneration of the brain due to alcohol

177

670

3.13

35.28

3.0

2.3

0.18

0.21

g/l

5.05

153

619

Type 1 diabetes, wide definition

1037

6936

1.54

35.20

2.4

0.19

0.22

g/l

29.39

938

6492

Ovarian cyst

1779

7505

1.40

34.62

2.2

2.1

0.22

g/l

3.94

1679

6971

Amputation of ankle bones

157

561

3.26

34.46

2.6

2.3

0.19

0.21

g/l

1.75

145

506

Rheumatism, unspecified

753

4743

1.67

34.44

2.1

0.22

0.21

g/l

1.90

706

4441

Postmenopausal osteoporosis with pathological fracture

356

1820

2.16

34.41

2.2

1.9

0.19

0.20

g/l

2.87

314

1681

Other and unspecified disorders of skin and subcutaneous tissue

369

1900

2.10

34.39

2.8

2.2

0.21

g/l

0.47

337

1770

Other general symptoms and signs

270

1217

2.37

34.28

2.2

2.5

0.22

g/l

0.06

255

1155

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

209

854

2.68

34.26

2.3

2.0

0.20

g/l

0.02

191

767

Ulcerative proctitis

326

1603

2.19

34.21

3.0

2.2

0.24

0.22

g/l

5.90

305

1497

Other and unspecified psoriasis

377

1961

2.08

34.17

2.7

2.2

0.21

0.22

g/l

1.03

352

1831

Postprocedural endocrine and metabolic disorders, not elsewhere classified

580

3418

1.78

34.16

2.3

2.1

0.22

g/l

1.39

551

3223

Other arthrosis

2736

15326

1.31

33.88

2.2

2.3

0.22

0.21

g/l

2.45

2525

14298

Insomnia

755

4767

1.65

33.84

2.3

0.23

0.22

g/l

3.24

700

4466

Familial hypercholesterolemia

787

5031

1.64

33.71

2.2

0.20

g/l

0.11

732

4670

Excessive, frequent and irregular menstruation

1902

7826

1.38

33.60

2.4

2.2

0.22

g/l

1.66

1777

7266

Myocardial infarction

2650

14875

1.31

33.57

2.1

2.3

0.20

0.21

g/l

6.16

2403

13772

Volvulus

175

668

2.97

33.54

3.0

2.0

0.20

0.21

g/l

1.10

162

616

Spondylosis

2738

18490

1.30

33.33

2.1

2.3

0.22

0.21

g/l

4.10

2516

17218

Injuries to unspecified part of trunk, limb or body region

513

2952

1.85

33.30

2.3

0.21

g/l

0.32

471

2756

Coxarthrosis [arthrosis of hip](FG)

2820

16072

1.30

33.29

2.1

2.2

0.21

g/l

0.85

2621

14899

Postmenopausal bleeding

1495

5874

1.45

33.17

2.0

2.1

0.21

g/l

0.98

1402

5438

Alcoholic gastritis

124

397

3.74

33.15

3.6

2.0

0.19

0.21

g/l

1.88

107

363

Unspecified acute lower respiratory infection

731

4606

1.66

33.13

2.6

2.3

0.21

g/l

0.48

678

4282

Serous carcinoma of ovary

235

1043

2.56

33.08

1.9

2.0

0.19

0.21

g/l

3.98

223

983

Other blood glucose lowering drugs, excl. Insulins

859

5633

1.60

32.95

2.4

2.2

0.20

0.21

g/l

0.54

793

5232

Disorders of psychological development

538

2889

1.80

32.94

3.4

3.2

0.22

g/l

0.31

499

2702

Open wound of ankle and foot

518

2999

1.83

32.77

2.2

2.4

0.20

0.22

g/l

4.25

480

2801

Benign lipomatous neoplasm

1120

7724

1.49

32.64

2.2

2.1

0.21

g/l

0.56

1061

7030

Visual disturbances

2287

17700

1.32

32.62

2.3

0.22

0.21

g/l

1.71

2110

16491

Follow-up care involving plastic surgery

233

1027

2.50

32.61

2.4

2.1

0.21

0.22

g/l

2.08

219

969

Diffuse large B-cell lymphoma, helper endpoint

225

975

2.53

32.57

2.4

1.9

0.19

0.20

g/l

1.64

206

878

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

225

975

2.53

32.57

2.4

1.9

0.19

0.20

g/l

1.64

206

878

Other and unspecified coagulation defects

267

1243

2.34

32.56

2.7

2.3

0.22

g/l

0.12

251

1167

Haemangioma and lymphangioma, any site

383

2020

2.00

32.51

2.5

2.3

0.22

0.21

g/l

1.43

364

1842

Coxibs

1484

5635

1.44

32.30

2.1

2.4

0.22

0.21

g/l

6.23

1371

5205

Carcinoma in situ of skin of other and unspecified parts of face

333

1682

2.11

32.29

2.1

1.8

0.20

0.19

g/l

2.32

309

1489

Other coagulation defects

376

1987

2.03

32.21

2.6

2.2

0.22

g/l

0.12

354

1856

Nephrotic syndrome

214

920

2.63

32.18

2.6

2.8

0.23

0.21

g/l

3.56

202

865

Other infectious diseases

421

2311

1.95

32.13

3.0

2.2

0.20

0.21

g/l

0.39

387

2149

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

422

2322

1.95

32.10

2.9

2.2

0.21

g/l

0.06

397

2170

Superficial injury of abdomen, lower back and pelvis

717

4529

1.65

32.10

2.2

2.3

0.22

g/l

0.09

642

4228

Benign neoplasm: Skin of eyelid, including canthus

607

3675

1.72

32.06

2.2

2.1

0.22

0.21

g/l

2.14

569

3336

Need for immunization against other single viral diseases

147

529

3.24

31.95

2.7

2.4

0.25

0.22

g/l

4.94

138

490

Sequelae of cerebrovascular disease

1694

11046

1.39

31.89

2.1

0.20

g/l

1.03

1517

10186

Sulfasalazine

1352

9700

1.43

31.86

2.6

2.1

0.22

0.21

g/l

1.07

1245

9033

Asthma and allergy, excluding more controls

557

3252

1.75

31.74

2.5

0.24

0.23

g/l

1.77

520

3056

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1276

5458

1.47

31.70

2.2

2.1

0.21

g/l

0.95

1176

4942

Benign neoplasm of other and unspecified endocrine glands

659

4112

1.69

31.58

2.3

0.22

0.21

g/l

1.47

620

3845

Disorders of oesophagus in diseases classified elsewhere

146

528

3.22

31.43

3.3

2.0

0.19

0.21

g/l

2.51

134

491

Colonic or urogenital fistula

1334

9594

1.44

31.38

2.6

2.3

0.22

0.21

g/l

0.81

1251

8938

Benign neoplasm of breast

477

2720

1.83

31.34

2.0

2.1

0.21

g/l

0.08

444

2492

Drug-induced osteoporosis with pathological fracture

125

420

3.62

31.20

3.8

2.1

0.21

g/l

0.15

117

397

Localized swelling, mass and lump of skin and subcutaneous tissue

1519

11164

1.40

31.20

2.4

2.3

0.22

0.21

g/l

3.35

1447

10375

Leisure time condition

859

5692

1.57

31.20

2.5

2.4

0.20

0.21

g/l

4.90

780

5303

Other degenerative diseases of the nervous system

1307

7054

1.45

31.06

2.0

2.2

0.20

0.21

g/l

2.84

1138

6554

Sicca syndrome [Sjögren]

471

2706

1.86

31.01

2.4

2.1

0.21

g/l

0.13

440

2541

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

359

1886

2.01

30.89

2.0

2.2

0.23

0.21

g/l

4.37

342

1716

Recurring oral aphthae, including avohilmo

680

4295

1.66

30.81

2.6

2.3

0.22

0.21

g/l

0.47

625

4025

Superficial injury of hip and thigh

697

4418

1.65

30.79

2.2

0.20

0.21

g/l

4.22

630

4085

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

597

3416

1.71

30.79

2.0

1.9

0.20

g/l

1.17

553

3068

Amputation of thigh

174

692

2.81

30.60

2.3

2.1

0.17

0.19

g/l

5.08

153

630

Psoriatic and enteropathic arthropathies

597

3657

1.71

30.53

2.5

2.3

0.22

g/l

0.20

556

3423

Chronic sinusitis

2084

16055

1.33

30.52

2.4

2.3

0.22

0.21

g/l

7.61

1940

14981

Dissocial personality disorder

117

378

3.59

30.45

2.1

2.6

0.21

0.23

g/l

1.11

100

350

Filling of root of tooth

199

848

2.64

30.42

3.5

2.3

0.22

g/l

0.07

188

799

Folate deficiency anaemia

204

5.03

30.42

2.6

2.3

0.19

0.21

g/l

1.60

188

Other specified/unspecified systemic involvement of connective tissue

327

1687

2.10

30.35

2.8

2.2

0.21

0.22

g/l

0.07

304

1581

Acquired haemolytic anaemia

164

641

2.94

30.34

3.3

2.3

0.21

g/l

0.02

155

599

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

287

3.96

30.32

2.7

1.9

0.18

0.20

g/l

1.54

254

Anosmia

255

3.92

30.21

2.3

1.9

0.22

g/l

0.18

244

Benign neoplasm: Rectosigmoid junction

202

863

2.57

30.19

2.5

1.9

0.22

0.20

g/l

2.49

190

781

Oesophageal obstruction

219

976

2.49

30.10

2.4

1.9

0.19

0.21

g/l

1.99

205

900

Disturbance of activity and attention

418

2286

1.88

30.05

2.9

3.2

0.23

g/l

0.02

381

2151

Acetic acid derivatives and related substances

1484

5580

1.42

30.05

2.1

2.4

0.22

0.21

g/l

5.69

1372

5154

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

182

742

2.69

30.04

2.2

2.0

0.19

g/l

0.02

158

661

Major coronary heart disease event excluding revascularizations

3373

18951

1.25

29.98

2.1

2.3

0.20

0.21

g/l

4.67

3081

17543

Benign neoplasm: Oesophagus

230

4.45

29.95

2.7

1.8

0.21

g/l

0.27

206

Shoulder lesions

4037

20427

1.23

29.90

2.2

2.3

0.22

0.21

g/l

5.54

3788

18992

Other disorders of white blood cells

316

1623

2.12

29.88

2.5

2.3

0.20

0.21

g/l

1.32

286

1518

Pericarditis

211

925

2.51

29.86

2.5

2.3

0.22

g/l

0.21

197

878

Superficial injury of thorax

720

4638

1.62

29.79

2.5

2.3

0.21

g/l

1.83

660

4328

Persons with potential health hazards related to communicable diseases

1645

12190

1.37

29.78

2.7

2.5

0.22

g/l

0.01

1541

11421

Appendectomy

3122

24371

1.26

29.70

2.3

0.22

g/l

1.30

2924

22765

Encephalopathy

254

4.46

29.69

5.3

2.2

0.16

0.21

g/l

7.88

236

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

817

4477

1.57

29.58

2.1

2.0

0.20

g/l

0.24

757

4021

Mixed connective tissue disease

354

1892

2.02

29.57

2.9

2.2

0.22

g/l

0.04

326

1778

Fitting and adjustment of other devices

1575

10894

1.38

29.54

2.4

2.1

0.20

0.21

g/l

5.96

1453

10019

Other and unspecified injuries of head

328

1711

2.06

29.37

2.6

2.3

0.20

0.21

g/l

1.15

295

1597

Asthma and allergy

556

3316

1.71

29.30

2.5

0.24

0.23

g/l

2.30

519

3115

Personal history of other diseases and conditions

511

3018

1.76

29.27

3.1

2.6

0.22

g/l

0.05

478

2849

Injuries to the neck

1035

7201

1.48

29.17

2.2

2.3

0.22

g/l

0.26

944

6715

Haemangioma, any site

353

1882

1.98

29.08

2.4

2.2

0.22

0.21

g/l

1.82

335

1715

Sub-endpoint used in defining T1D endpoints

1405

10125

1.40

29.06

2.4

0.19

0.21

g/l

26.70

1272

9386

Other dialysis

200

875

2.59

29.06

2.9

2.6

0.23

0.21

g/l

1.54

194

819

Other neurological diseases

3599

23827

1.24

28.98

2.3

2.2

0.21

g/l

1.20

3346

22030

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

284

4.00

28.90

2.2

1.8

0.22

0.20

g/l

1.76

265

Dissociative [conversion] disorders

190

802

2.55

28.83

2.4

2.2

0.23

0.22

g/l

0.43

171

757

Non-follicular lymphoma

503

3006

1.78

28.82

2.2

0.19

0.21

g/l

4.38

465

2803

Hidradenitis suppurativa

196

844

2.53

28.74

2.4

2.3

0.22

0.23

g/l

0.58

189

794

Oesophagitis

300

1532

2.12

28.67

2.4

2.1

0.20

0.21

g/l

1.01

276

1429

Other diseases of gallbladder

253

1215

2.27

28.66

2.7

1.8

0.22

0.21

g/l

0.60

241

1119

L02BA Anti-estrogens

811

5416

1.56

28.61

1.6

2.1

0.22

0.21

g/l

2.42

774

5054

Fall on same level involving ice and snow

2744

22066

1.27

28.46

2.4

2.3

0.21

g/l

1.56

2516

20552

Malignant neoplasm of rectosigmoid junction

124

437

3.38

28.33

2.5

2.2

0.20

0.21

g/l

0.82

118

405

Cardiac arrest

312

1375

2.07

28.31

2.4

2.3

0.20

0.21

g/l

2.51

283

1295

Benign neoplasm: Adrenal gland

410

2336

1.89

28.13

2.1

2.2

0.22

0.21

g/l

2.01

384

2195

Diseases of external ear

1589

11953

1.37

28.04

2.5

2.3

0.22

0.21

g/l

1.49

1462

11116

Melanocytic naevi of trunk

451

2613

1.80

28.04

2.7

2.2

0.23

0.21

g/l

3.67

428

2389

Benign neoplasm of major salivary glands

395

2206

1.88

28.03

2.5

2.1

0.22

0.21

g/l

1.71

369

2004

Dipeptidyl peptidase 4 (DPP-4) inhibitors

593

3718

1.68

27.96

2.7

2.2

0.20

0.21

g/l

0.40

557

3459

Myocarditis

231

1072

2.29

27.92

2.1

2.3

0.22

0.23

g/l

0.76

216

1010

Carcinoma in situ of skin of trunk

152

591

2.86

27.90

2.5

1.8

0.20

0.19

g/l

2.10

143

528

Malignant neoplasm of ovary

270

1349

2.20

27.85

1.9

2.0

0.19

0.21

g/l

3.88

253

1272

Traumatic subarachnoid haemorrhage

197

864

2.50

27.81

2.5

2.2

0.19

0.21

g/l

2.22

182

807

Infection of intervertebral disc (pyogenic)

104

335

3.77

27.80

3.3

2.1

0.19

0.20

g/l

0.56

309

Nonischemic cardiomyopathy

323

1713

2.04

27.80

2.3

2.4

0.20

0.21

g/l

2.11

296

1603

Acute gastritis

393

2207

1.89

27.76

2.6

2.0

0.20

0.21

g/l

2.17

363

2048

Artrosis, including avohilmo

4515

20794

1.21

27.74

2.2

2.3

0.22

0.21

g/l

0.83

4183

19347

Emphysema

369

2039

1.93

27.64

2.1

0.21

0.20

g/l

0.21

336

1888

Excessive attrition of teeth

1830

7531

1.35

27.50

2.4

2.2

0.23

0.22

g/l

3.96

1685

7070

Amiodarone users

528

3238

1.73

27.48

2.2

0.21

0.20

g/l

0.23

488

3010

Congenital malformations of the circulatory system

709

4491

1.60

27.45

3.1

2.8

0.21

0.22

g/l

1.99

679

4225

Maltreatment syndromes

251

1216

2.20

27.31

2.3

2.4

0.21

0.23

g/l

2.43

218

1142

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

552

3401

1.69

27.27

2.0

0.22

0.21

g/l

2.89

518

3090

Carcinoma in situ of endometrium

128

6.60

27.23

1.4

2.2

0.24

0.21

g/l

2.60

121

Other symptoms and signs involving general sensations and perceptions

223

1043

2.34

27.11

2.0

2.4

0.20

0.21

g/l

0.77

201

973

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1210

5182

1.44

27.05

2.2

2.1

0.21

0.20

g/l

0.99

1110

4687

Deforming dorsopathies

1353

9993

1.39

26.92

2.2

2.3

0.22

0.21

g/l

1.58

1252

9334

Acute suppurative otitis media

1085

7187

1.44

26.85

2.9

2.6

0.22

0.23

g/l

0.72

1019

6715

Other follicular disorders

349

1909

1.94

26.82

2.5

2.2

0.22

g/l

0.12

335

1796

Varicose veins

3108

19197

1.25

26.69

2.2

2.1

0.20

0.21

g/l

12.68

2872

17853

Hyperparathyroidism

894

6100

1.51

26.61

2.4

2.0

0.22

0.21

g/l

6.74

830

5633

Hypopituitarism

363

2026

1.91

26.30

2.8

2.7

0.22

g/l

0.58

342

1909

Mixed disorders of conduct and emotions, excluding more controls

299

3.48

26.30

2.5

3.7

0.23

g/l

0.33

286

Infective dermatitis

561

3516

1.67

26.28

2.3

2.2

0.20

0.21

g/l

1.54

514

3277

Other and unspecified aplastic anaemias

253

4.07

26.27

2.8

2.6

0.21

g/l

0.29

232

Acquired absence of limb

231

4.34

26.21

2.8

2.2

0.20

0.21

g/l

0.29

213

Burns and corrosions

654

4246

1.61

26.18

2.6

2.5

0.22

g/l

0.30

606

3971

Pneumonia due to other infectious organisms, not elsewhere classified

183

801

2.52

26.13

2.8

2.3

0.22

0.21

g/l

0.11

169

751

Bronchiectasis

426

2506

1.81

25.97

2.6

2.2

0.20

0.21

g/l

0.65

403

2331

Tobacco use

274

1405

2.10

25.91

2.3

0.21

0.22

g/l

0.41

243

1314

Disorders of continuity of bone

463

2778

1.76

25.84

2.4

2.3

0.22

g/l

0.35

421

2613

Cerebral cysts

285

1480

2.06

25.80

3.6

2.3

0.20

0.22

g/l

2.78

263

1377

Tubulo-interstitial nephritis, not specified as acute or chronic

344

1899

1.92

25.64

2.4

2.1

0.20

0.21

g/l

1.47

313

1762

Migraine

2152

14436

1.29

25.59

2.5

2.4

0.23

0.22

g/l

6.13

2022

13534

Drug-induced adrenocortical insufficiency

125

466

3.13

25.59

3.4

2.3

0.23

0.22

g/l

1.35

114

442

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

100

326

3.51

25.54

2.2

1.8

0.17

0.20

g/l

2.62

287

Dermatitis due to substances taken internally

291

1530

2.04

25.47

3.0

2.3

0.21

g/l

0.12

262

1436

Congenital malformations of the urinary system

312

1682

1.99

25.40

3.4

2.7

0.23

0.22

g/l

1.29

298

1581

Polyarthrosis

989

6722

1.46

25.37

2.1

0.21

g/l

0.01

903

6276

Disorders of breast

2204

16225

1.28

25.25

2.0

2.1

0.23

0.22

g/l

7.17

2064

15160

Sulfonylureas

1738

10686

1.33

25.14

2.3

2.1

0.19

0.20

g/l

2.60

1596

9814

Other and unspecified urticaria

903

6308

1.48

25.09

2.5

2.3

0.22

g/l

0.55

844

5916

Atopic dermatitis, strict definition with reimbursement

1275

9127

1.38

24.99

2.8

2.5

0.22

g/l

0.05

1189

8558

Recurring oral aphthae

262

1344

2.12

24.95

3.5

2.4

0.21

g/l

0.07

240

1265

Fracture of foot, except ankle

1084

7822

1.43

24.94

2.5

2.4

0.22

g/l

0.17

974

7314

Carcinoma in situ of colon

112

404

3.38

24.91

2.6

2.3

0.22

0.21

g/l

0.60

102

377

Hyperkinetic disorders

444

2615

1.74

24.77

2.9

3.2

0.23

g/l

0.19

404

2460

Secondary and unspecified malignant neoplasm of lymph nodes

428

2553

1.78

24.71

2.3

2.2

0.19

0.21

g/l

4.20

399

2373

Carcinoma in situ of breast, intraductal

438

2632

1.77

24.70

1.9

2.1

0.23

0.21

g/l

8.97

420

2480

Benign neoplasm: Parotid gland

321

1752

1.93

24.70

2.6

2.1

0.22

0.21

g/l

2.47

298

1575

Focal brain injury

327

1797

1.92

24.68

2.5

2.4

0.20

0.21

g/l

0.85

302

1677

Pneumocystosis

122

461

3.14

24.64

2.5

2.3

0.23

0.21

g/l

1.49

109

425

Childhood asthma (age<16), excluding more controls

480

2291

1.70

24.58

2.9

2.7

0.23

g/l

0.57

455

2130

Coeliac disease

583

3746

1.63

24.54

3.1

2.3

0.21

0.22

g/l

1.99

537

3515

therapeutic use

182

824

2.47

24.35

3.2

2.0

0.21

g/l

0.30

171

762

Lymphoid leukaemia

249

1258

2.12

24.34

2.3

2.4

0.20

g/l

0.17

225

1140

Other mental disorders due to brain damage and dysfunction and to physical disease

550

3502

1.65

24.33

2.2

2.1

0.20

g/l

0.28

493

3250

Viral pneumonia (unknown virus, not influenza)

331

1840

1.91

24.28

2.7

2.3

0.22

g/l

0.03

306

1728

Chronic rhinitis, nasopharyngitis and pharyngitis

1479

11244

1.35

24.19

2.4

2.3

0.23

0.21

g/l

13.88

1370

10484

Diabetic nephropathy

847

5853

1.50

24.11

2.3

2.4

0.21

g/l

0.31

773

5370

D07AA Corticosteroids, weak (group I)

707

4741

1.54

24.08

2.8

2.6

0.22

g/l

0.50

659

4439

Systemic sclerosis (FG)

148

617

2.68

23.77

2.7

2.0

0.20

0.22

g/l

1.98

136

586

Unspecified urinary incontinence

452

2762

1.73

23.77

2.7

2.1

0.20

0.21

g/l

2.94

412

2573

Use of pramipexole

1043

7562

1.43

23.72

2.2

0.21

g/l

1.15

949

7017

Injury of unspecified body region

381

2225

1.82

23.71

2.3

0.21

g/l

0.09

349

2078

Idiopathic thrombocytopenic purpura

179

812

2.44

23.68

3.9

2.3

0.20

0.21

g/l

1.37

173

764

Childhood asthma (age<16)

480

2317

1.68

23.61

2.9

2.7

0.23

g/l

0.50

455

2155

Cystic kidney disease

192

898

2.36

23.57

3.7

2.5

0.23

0.21

g/l

2.10

185

840

Open wound of abdomen, lower back and pelvis

173

773

2.45

23.53

2.7

2.4

0.22

g/l

0.37

158

721

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1579

12122

1.33

23.51

2.5

0.23

0.22

g/l

3.15

1472

11361

Other abnormal findings of blood chemistry

234

1179

2.15

23.42

2.5

2.2

0.21

g/l

0.72

218

1107

Benign neoplasm: Descending colon

362

2101

1.85

23.41

2.8

2.1

0.21

g/l

0.74

344

1951

Congenital malformations of heart and great arteries

627

4008

1.58

23.32

3.0

2.8

0.21

0.22

g/l

2.83

603

3772

Injury of intra-abdominal organs

150

635

2.62

23.19

3.0

2.4

0.21

0.22

g/l

0.40

144

596

Squamous cell neoplasms and carcinomas of the skin

587

3834

1.60

23.18

2.1

2.0

0.20

g/l

1.96

546

3492

Hypoparathyroidism

212

1040

2.24

23.08

3.1

2.0

0.20

0.21

g/l

0.85

199

975

Hodgkin lymphoma

146

609

2.62

23.08

2.7

2.4

0.19

0.21

g/l

2.39

131

555

Mental disorders, not otherwise specified

373

2173

1.80

23.05

2.2

2.3

0.23

0.22

g/l

1.97

346

2056

Burns and corrosions of external body surface, specified by site

514

3261

1.65

22.91

2.6

2.5

0.21

0.22

g/l

0.58

477

3051

Haemorrhoids and perianal venous thrombosis

1291

9696

1.36

22.87

2.2

2.1

0.21

g/l

1.45

1191

8942

Ulcer of oesophagus

351

2024

1.84

22.85

2.7

2.0

0.20

0.21

g/l

0.65

325

1883

Diabetic neuropathy

621

4118

1.59

22.85

2.7

2.4

0.19

0.21

g/l

6.69

572

3791

Shock, not elsewhere classified

202

4.17

22.74

4.1

2.2

0.18

0.21

g/l

1.96

191

Rheumatoid arthritis

1554

10888

1.33

22.74

2.2

0.21

g/l

2.34

1435

10171

Lumbar disc prolapse

3119

20615

1.22

22.62

2.2

2.3

0.22

0.21

g/l

8.94

2878

19258

Degeneration of macula and posterior pole

2215

14706

1.27

22.54

2.2

2.1

0.20

g/l

1.74

2004

13537

Monoamine oxidase A inhibitors

565

3677

1.60

22.48

2.3

2.2

0.22

0.21

g/l

0.75

519

3459

Blood alcohol or alcohol intoxication level

141

588

2.64

22.45

2.3

2.5

0.21

0.22

g/l

0.81

126

556

Laparoscopic left hemicolectomy

122

482

2.95

22.45

2.6

2.3

0.22

0.21

g/l

0.89

115

450

Other specified/unspecified bacterial intestinal infections

337

1934

1.86

22.43

2.9

2.2

0.21

g/l

0.15

318

1809

Scar conditions and fibrosis of skin

212

1046

2.19

22.37

2.8

2.2

0.23

0.22

g/l

1.54

202

984

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

265

1385

1.99

22.31

3.4

3.7

0.22

g/l

0.98

248

1316

Arterial embolism and thrombosis

287

1567

1.95

22.30

2.2

2.1

0.19

0.20

g/l

1.97

261

1446

Heart failure and hypertrophic cardiomyopathy

121

478

2.93

22.20

2.6

2.3

0.19

0.21

g/l

1.30

111

445

Other aneurysm

279

1518

1.97

22.15

3.0

2.2

0.20

0.21

g/l

0.43

258

1406

Carrier of infectious disease

140

589

2.64

21.99

2.6

2.3

0.20

0.22

g/l

1.54

131

558

Eosinophilic disease (BM)

100

357

3.19

21.93

2.1

2.3

0.21

g/l

0.33

334

Menorrhagia

1669

7143

1.32

21.86

2.3

2.1

0.22

0.21

g/l

1.16

1568

6635

Mental retardation, excluding more controls

191

895

2.25

21.84

3.0

3.3

0.22

g/l

0.10

181

854

Sequelae of injuries of head

272

1474

1.97

21.83

2.6

2.3

0.21

0.22

g/l

0.66

249

1372

Secondary malignant neoplasm of respiratory and digestive organs

351

3.31

21.83

1.9

2.1

0.16

0.20

g/l

6.71

326

Personal history of certain other diseases

327

3.19

21.79

2.7

2.2

0.21

0.23

g/l

1.67

300

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

301

1677

1.88

21.69

1.9

2.1

0.23

0.21

g/l

3.84

290

1524

Pain and other conditions associated with female genital organs and menstrual cycle

811

5458

1.46

21.59

2.4

2.2

0.23

0.22

g/l

2.98

756

5105

Complications following infusion, transfusion and therapeutic injection

101

367

3.16

21.56

3.2

2.2

0.22

0.21

g/l

0.50

344

Diffuse brain injury

184

869

2.26

21.53

2.6

2.5

0.22

g/l

0.27

169

819

1315

8857

1.35

21.44

2.1

2.0

0.20

g/l

0.86

1186

8119

Urolithiasis

1501

11650

1.32

21.28

2.5

2.3

0.21

g/l

3.17

1385

10787

Small fibre neuropathy

170

794

2.40

21.26

3.2

2.3

0.22

0.21

g/l

0.82

160

743

Secondary thrombocytopenia

317

3.39

21.25

3.8

2.4

0.18

0.21

g/l

3.26

297

Speech disturbances, not elsewhere classified

424

2623

1.70

21.24

2.4

2.1

0.21

g/l

0.04

381

2437

Methotrexate

671

4577

1.52

21.24

2.5

2.1

0.22

0.21

g/l

0.43

630

4257

Alcohol induced polyneuropathy

276

3.64

21.18

3.2

2.2

0.19

0.21

g/l

1.31

257

Disorders of porphyrin and bilirubin metabolism

279

3.51

21.12

3.6

2.7

0.24

0.22

g/l

0.95

262

Benign neoplasm of mouth and pharynx

539

3530

1.60

21.11

2.6

2.2

0.22

0.21

g/l

2.11

507

3285

SLE (Finngen)

185

887

2.26

21.10

2.4

2.0

0.20

0.22

g/l

3.59

170

844

Carcinoma in situ of oral cavity, oesophagus and stomach

109

5.58

21.09

2.8

2.1

0.21

0.20

g/l

0.52

Psoriasis (vulgaris), strict definition

180

857

2.30

21.08

3.3

2.3

0.22

g/l

0.54

169

805

Other abnormal uterine and vaginal bleeding

1107

5837

1.39

21.06

2.1

0.21

g/l

0.82

1013

5399

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

136

573

2.59

21.05

2.2

2.0

0.18

0.19

g/l

1.02

115

505

Oter anti-inflammatory and antirheumatic agents, non-steroids

1166

4782

1.39

21.05

2.2

0.21

0.20

g/l

3.45

1069

4415

Wide developmental disorders, excluding more controls

128

515

2.62

21.00

2.9

4.0

0.23

g/l

0.44

115

496

Thoracic aortic aneurysm

637

4325

1.54

20.99

2.1

2.3

0.21

g/l

0.01

585

4033

Myeloid leukaemia

129

532

2.66

20.98

2.8

2.1

0.20

g/l

0.05

116

478

Abnormal findings in nipple discharge synovial fluid wound secretions

104

391

3.05

20.87

3.5

2.3

0.22

g/l

0.07

366

Pyogenic arthritis

330

1918

1.82

20.82

2.3

0.21

g/l

0.43

300

1795

Subjective visual disturbances

1106

8256

1.38

20.79

2.2

0.22

0.21

g/l

2.03

1021

7698

Symptoms and signs involving speech and voice

1505

11721

1.32

20.79

2.3

2.2

0.22

0.21

g/l

2.24

1386

10912

Dermatophytosis

611

4120

1.55

20.78

2.3

0.21

g/l

0.67

556

3837

Other female pelvic inflammatory diseases

745

5211

1.48

20.78

2.3

2.1

0.21

0.22

g/l

0.25

693

4889

Thyroiditis, ILD-related definition

518

3368

1.60

20.71

2.6

2.1

0.22

g/l

0.02

489

3157

Vitamin D deficiency

106

402

2.95

20.64

3.6

2.3

0.20

0.22

g/l

3.17

100

374

Rash and other nonspecific skin eruption

482

3094

1.63

20.63

2.5

2.3

0.22

0.21

g/l

1.58

448

2895

Corns and callosities

342

2018

1.80

20.59

2.2

0.20

0.21

g/l

2.53

325

1892

Carcinoma in situ of skin

305

1740

1.84

20.42

2.3

1.9

0.21

0.20

g/l

2.32

282

1555

Inflammatory diseases of the central nervous system

398

2450

1.71

20.26

2.6

2.3

0.22

g/l

0.06

372

2293

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

259

1409

1.94

20.23

1.9

2.1

0.23

0.21

g/l

3.74

249

1283

Noninflammatory disorders of female genital tract

1995

7998

1.28

20.16

2.4

2.2

0.22

g/l

2.35

1871

7425

Other disorders of ear

4673

26988

1.17

20.14

2.2

2.3

0.21

g/l

1.20

4326

25071

Malignant neoplasm of skin

2989

18857

1.21

20.12

2.1

2.2

0.21

g/l

0.21

2747

17413

Other diseases of blood and blood-forming organs

343

2041

1.78

20.10

2.5

2.2

0.21

g/l

0.22

313

1913

Diabetic retinopathy, excluding more controls

1366

5897

1.35

20.07

2.5

2.4

0.20

0.22

g/l

16.72

1254

5432

Status epilepticus

201

1015

2.14

20.05

2.9

2.4

0.20

0.21

g/l

0.60

190

951

Disorders of conjunctiva

3900

27989

1.18

20.04

2.4

2.3

0.22

g/l

2.83

3601

26116

Fracture of forearm

2576

19991

1.23

19.97

2.3

0.21

0.22

g/l

6.25

2359

18612

Otitis externa

984

7260

1.39

19.96

2.4

0.22

0.21

g/l

0.64

910

6777

Striking against or struck by other objects

1437

11166

1.31

19.96

2.5

0.22

g/l

0.74

1324

10412

Left ventricular outflow tract obstruction (LVOTO), broad definition

498

3249

1.61

19.91

3.0

2.6

0.20

0.22

g/l

3.63

464

3056

Conjunctivitis

3498

25928

1.19

19.88

2.3

0.22

g/l

2.88

3230

24217

Personal history of malignant neoplasm

197

991

2.15

19.87

2.2

2.1

0.23

0.22

g/l

1.27

190

931

Systemic sclerosis

148

670

2.45

19.84

2.7

2.0

0.20

0.22

g/l

2.24

136

636

Malignant neoplasm of urinary organs

478

3096

1.62

19.80

2.0

2.2

0.21

0.20

g/l

2.59

446

2869

Paraplegia, diplegia of upper limbs

139

614

2.53

19.79

2.6

2.2

0.19

0.21

g/l

2.44

126

571

Systemic sclerosis, icd10

147

665

2.46

19.75

2.7

2.1

0.20

0.22

g/l

2.22

135

630

Other disorders starting during childhood or adolescence

247

1324

1.96

19.75

3.5

4.0

0.22

g/l

0.26

232

1255

Convalescence

258

1419

1.93

19.69

2.7

2.2

0.22

g/l

0.02

232

1338

Internal derangement of knee

1773

14127

1.28

19.64

2.4

2.3

0.22

g/l

1.74

1626

13193

Event of undetermined intent

296

1699

1.84

19.56

2.5

2.4

0.21

0.22

g/l

1.33

269

1586

Later onset COPD

1277

7680

1.34

19.54

2.0

2.1

0.19

0.20

g/l

3.34

1143

7043

Protozoal diseases

163

773

2.34

19.54

2.5

2.4

0.22

0.21

g/l

0.68

146

728

Adverse effects, not elsewhere classified

860

6231

1.42

19.50

2.4

0.22

g/l

0.66

807

5834

Benign neoplasm of meninges

368

2241

1.71

19.29

2.1

0.21

g/l

1.24

331

2026

Superficial injury of wrist and hand

849

6148

1.42

19.25

2.5

0.22

g/l

0.30

781

5774

Acute generalized exanthematous pustulosis

234

1262

1.99

19.22

3.1

2.3

0.21

g/l

0.17

210

1174

Polycythaemia vera

158

738

2.31

19.22

2.0

1.9

0.20

g/l

0.10

147

660

Generalized skin eruption due to drugs and medicaments

210

1094

2.07

19.19

3.2

2.3

0.21

g/l

0.40

188

1017

Other necrotizing vasculopathies (FG)

299

1736

1.83

19.14

2.3

2.1

0.23

0.21

g/l

2.71

278

1624

Carcinoma in situ of other and unspecified sites

156

727

2.32

19.14

1.9

2.0

0.21

0.19

g/l

2.55

142

647

Pain associated with micturition

532

3546

1.56

19.10

2.3

2.2

0.22

0.21

g/l

0.92

483

3306

Atopic dermatitis

2417

17023

1.23

19.08

2.5

2.4

0.23

0.22

g/l

3.13

2235

15939

Hypertrophy of breast in women and men

854

6208

1.42

19.01

2.3

2.2

0.23

0.22

g/l

3.95

794

5831

Benign neoplasm: Other and unspecified parts of small intestine

339

3.05

19.01

2.5

1.9

0.23

0.20

g/l

1.73

301

Calculus of kidney and ureter

1383

10786

1.31

18.98

2.5

2.3

0.22

0.21

g/l

3.61

1280

10006

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

152

704

2.34

18.98

2.6

0.20

g/l

0.23

139

641

Suppurative and unspecified otitis media

1489

10340

1.30

18.98

2.7

2.5

0.22

g/l

0.44

1395

9650

Spondylopathies (FG)

614

4208

1.51

18.97

2.4

2.3

0.22

g/l

0.60

565

3941

Other condition

625

4306

1.50

18.97

2.8

2.3

0.21

0.22

g/l

3.14

586

4030

Acute pharyngitis

623

4246

1.50

18.97

3.2

2.6

0.23

g/l

0.52

592

3958

Pneumonia derived septicemia

189

954

2.15

18.96

3.2

2.5

0.20

0.21

g/l

1.85

167

887

Soft tissue disorders related to use, overuse and pressure

1244

9572

1.33

18.90

2.1

2.2

0.22

0.21

g/l

5.98

1156

8926

Gonarthrosis,primary

4559

24925

1.17

18.88

2.1

2.3

0.21

g/l

0.10

4227

23117

Pneumothorax

335

2011

1.76

18.87

2.3

2.1

0.21

g/l

0.03

311

1866

Deficiency of other B group vitamins

120

505

2.63

18.87

3.1

2.1

0.19

0.21

g/l

1.88

115

467

Other and unspecified tonsillitis

1398

9216

1.31

18.86

2.8

2.5

0.23

g/l

0.18

1310

8622

Senility

170

3.92

18.82

1.6

2.0

0.18

0.19

g/l

0.56

154

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

262

1463

1.87

18.68

2.3

2.1

0.22

0.23

g/l

0.74

245

1383

Other noninflammatory disorders of vulva and perineum

404

2541

1.66

18.67

2.2

0.22

0.21

g/l

0.25

369

2361

Lichen simplex chronicus and prurigo

316

1877

1.78

18.64

2.4

2.2

0.21

g/l

0.39

289

1757

Abnormal findings on examination of urine, without diagnosis

230

1247

1.98

18.62

2.3

2.5

0.22

0.21

g/l

1.28

213

1166

Other obstructive and reflux uropathy

207

1079

2.04

18.59

2.4

2.2

0.21

0.22

g/l

1.22

196

1007

Sarcoidosis

630

4370

1.50

18.58

2.6

2.2

0.22

0.21

g/l

1.09

589

4094

Mixed hyperlipidaemia

213

1127

2.03

18.56

1.9

2.2

0.22

0.21

g/l

1.73

192

1059

Chronic tubulo-interstitial nephritis

199

1027

2.08

18.55

2.3

2.0

0.21

g/l

0.09

178

960

Other disorders involving the immune mechanism, not elsewhere classified

177

882

2.19

18.50

2.8

2.7

0.22

g/l

0.04

170

827

Polymyalgia rheumatica

612

4230

1.51

18.47

1.9

2.0

0.21

0.20

g/l

1.06

562

3895

Lung cancer and mesothelioma

828

5127

1.42

18.47

2.1

0.20

0.21

g/l

1.24

768

4768

Nail disorders

390

2446

1.67

18.46

2.3

0.23

0.22

g/l

1.56

369

2288

CR(E)ST syndrome

102

406

2.87

18.38

2.9

2.1

0.20

0.22

g/l

1.90

389

Benign lipomatous neoplasm of other sites/unspecified

333

2002

1.73

18.36

2.0

0.22

0.20

g/l

2.51

309

1801

Other misadventures during surgical and medical care

131

584

2.51

18.34

2.8

2.3

0.20

0.21

g/l

1.79

122

550

Herpesviral [herpes simplex] infections

524

3515

1.55

18.25

2.8

2.2

0.21

0.22

g/l

0.82

482

3295

Thiamine deficiency

142

4.65

18.15

3.2

2.5

0.16

0.23

g/l

5.00

127

Manic episode

153

722

2.28

18.15

2.3

2.2

0.23

0.22

g/l

0.22

139

686

Late syphilis

369

2.98

18.11

2.5

2.3

0.20

0.22

g/l

0.87

339

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

131

582

2.45

18.09

1.8

1.9

0.19

g/l

0.22

118

516

Chronic lymphocytic leukaemia, helper endpoint

131

582

2.45

18.09

1.8

1.9

0.19

g/l

0.22

118

516

Focal epilepsy

944

7027

1.38

18.08

2.5

0.21

g/l

0.36

874

6542

362

2244

1.70

18.05

3.3

2.2

0.13

0.20

g/l

44.85

295

2082

Benign neoplasm of middle ear and respiratory system

299

1755

1.78

18.04

2.7

2.1

0.21

g/l

0.61

283

1592

Car occupant injured in other and unspecified transport accidents

796

5767

1.42

18.02

2.4

2.3

0.22

g/l

0.18

737

5374

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2586

17076

1.22

17.98

2.2

2.1

0.20

g/l

0.06

2371

15731

Disorders of sclera, cornea, iris and ciliary body

2485

20756

1.22

17.93

2.4

2.3

0.22

g/l

0.01

2332

19335

Disease of hard tissues of teeth, NOS

240

3.44

17.93

2.8

2.3

0.24

0.22

g/l

1.37

228

Intracranial and intraspinal abscess and granuloma

297

3.23

17.89

2.9

2.5

0.19

0.21

g/l

1.48

276

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

194

3.77

17.88

1.8

0.24

0.20

g/l

3.86

170

Benign neoplasm of bone and articular cartilage

303

1788

1.76

17.86

2.5

2.2

0.23

0.22

g/l

1.69

287

1630

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

266

3.25

17.85

2.2

1.9

0.23

0.21

g/l

1.46

245

Speech and linguistic disorders

382

2296

1.66

17.84

3.8

3.2

0.22

g/l

0.43

357

2159

Schizoaffective disorder

345

2116

1.71

17.78

2.0

2.3

0.23

0.22

g/l

0.61

308

1992

Parodontitis, under 40 years, or operation codes

309

1831

1.74

17.70

2.6

0.23

0.24

g/l

0.64

293

1705

Parodontitis, under 40 years

308

1825

1.74

17.65

2.6

0.23

0.24

g/l

0.60

292

1699

Congenital malformations of cardiac septa

341

2027

1.72

17.57

3.0

3.1

0.21

g/l

1.38

333

1921

Arthropathy in ulcerative colitis

327

3.04

17.53

2.5

0.23

g/l

0.07

311

Malignant neoplasm of kidney, except renal pelvis

436

2848

1.61

17.48

2.1

2.2

0.22

0.20

g/l

2.70

409

2646

Benign neoplasm: Oesophagus

324

3.09

17.41

2.7

2.4

0.21

g/l

0.05

305

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

653

4602

1.46

17.34

2.5

2.2

0.22

g/l

0.90

610

4308

Somnolence, stupor and coma

216

1174

1.96

17.22

2.7

2.2

0.20

0.21

g/l

1.35

186

1087

Metabolic disorder, other/unspecified

6.32

17.21

4.9

3.5

0.20

0.22

g/l

0.94

Myocardial infarction, strict

2323

14090

1.23

17.18

2.1

2.3

0.20

0.21

g/l

3.24

2100

13020

Asthma and opportunity respiratory infection

246

1400

1.89

17.17

2.7

2.1

0.21

g/l

0.04

233

1304

Other and unspecified abdominal hernia

212

1151

1.98

17.17

2.8

2.1

0.21

g/l

0.04

203

1073

Discitis, unspecified

105

438

2.71

17.14

2.4

2.0

0.18

0.21

g/l

2.12

409

Anorexia

353

2.88

17.06

3.2

2.7

0.22

g/l

0.28

331

Scoliosis

385

2449

1.64

17.05

2.4

0.22

0.21

g/l

0.38

356

2292

Migraine without aura

771

5603

1.41

17.00

2.7

2.5

0.23

0.22

g/l

1.07

728

5281

Benign leiomyoma with endometriosis

562

3867

1.50

16.99

2.2

2.0

0.22

0.21

g/l

1.45

530

3522

Other and unspecified disorders of white blood cells

216

1185

1.96

16.97

2.7

2.3

0.20

0.21

g/l

1.72

192

1115

Foreign body in alimentary tract

275

1617

1.81

16.93

2.7

2.4

0.21

g/l

0.28

248

1503

Other symptoms and signs involving the nervous and musculoskeletal systems

1870

15283

1.25

16.93

2.3

0.22

0.21

g/l

1.47

1732

14232

Other maltreatment syndromes

157

770

2.19

16.88

2.8

2.4

0.22

0.23

g/l

1.16

142

724

Abnormal involuntary movements

599

4193

1.48

16.83

2.4

2.3

0.22

0.21

g/l

3.92

557

3918

Hypertrophy of breast

727

5255

1.42

16.83

2.0

2.2

0.23

0.22

g/l

4.46

674

4952

Syphilis

145

696

2.28

16.77

2.4

0.20

0.22

g/l

1.28

129

645

Other necrotizing vasculopathies

348

2185

1.68

16.63

2.4

2.2

0.23

0.21

g/l

3.96

325

2037

Lesion of lateral popliteal nerve

247

1418

1.85

16.56

2.4

2.2

0.21

0.22

g/l

0.41

227

1318

Atopic dermatitis, strict definition

1200

9148

1.31

16.55

2.8

2.6

0.22

g/l

0.08

1121

8577

Benign neoplasm: Ill-defined sites within the digestive system

117

4.63

16.50

2.9

1.9

0.22

0.20

g/l

0.48

104

Benign neoplasm: Cerebral meninges

329

2030

1.69

16.48

2.1

2.0

0.22

0.21

g/l

1.69

299

1837

Injuries to the wrist and hand

4831

30871

1.15

16.44

2.3

2.4

0.22

g/l

3.56

4465

28767

Injury of other and unspecified intrathoracic organs

302

1833

1.74

16.44

2.3

2.2

0.20

0.22

g/l

1.58

276

1710

Allergic urticaria

365

2316

1.64

16.41

2.5

2.4

0.22

g/l

0.28

335

2172

Symptoms and signs involving emotional state

144

692

2.23

16.34

2.2

2.5

0.23

0.22

g/l

1.11

132

651

Malignant neoplasm of vulva

257

3.35

16.33

2.3

2.0

0.22

0.21

g/l

0.53

236

Benign neoplasm of eye and adnexa

356

2245

1.65

16.28

2.5

2.1

0.21

g/l

1.00

331

2030

922

6582

1.36

16.22

2.1

2.0

0.19

0.20

g/l

1.10

826

6037

Autism spe, excluding more controls

340

2.75

16.15

3.2

3.6

0.24

g/l

0.20

326

Benign neoplasm: Pituitary gland, craniopharyngeal duct

198

1065

1.96

16.13

2.4

2.2

0.22

0.21

g/l

0.13

186

976

Systemic disorders of connective tissue in diseases classified elsewhere

5.53

16.11

5.4

2.0

0.23

0.21

g/l

0.58

Personal history of risk-factors, not elsewhere classified

288

3.03

16.08

2.6

2.7

0.21

0.22

g/l

0.58

270

Systemic lupus erythematosus

185

982

2.02

16.04

2.4

2.2

0.20

0.22

g/l

3.08

170

926

Other disorders of eye and adnexa

606

4289

1.46

15.97

2.5

2.3

0.22

g/l

0.76

569

4013

Sequelae of injuries of neck and trunk

158

797

2.15

15.93

2.6

2.3

0.20

0.22

g/l

1.24

147

745

Bullous disorders

282

1699

1.76

15.93

2.5

2.2

0.21

g/l

0.06

261

1588

Other benign neoplasms of connective and other soft tissue

353

2232

1.64

15.92

2.1

0.22

0.21

g/l

0.61

316

2035

Pneumococcal septicemia

176

923

2.06

15.90

3.1

2.6

0.20

0.21

g/l

1.94

156

859

Benign neoplasm: Tongue

124

569

2.35

15.85

2.9

2.0

0.23

0.21

g/l

1.77

115

513

Fistulae involving female genital tract

101

430

2.62

15.70

2.6

2.1

0.21

g/l

0.04

405

Atrophic disorders of skin

626

4472

1.45

15.69

2.5

2.2

0.22

0.21

g/l

1.57

580

4180

Certain conditions originating in the perinatal period

374

2125

1.62

15.69

3.9

3.5

0.22

g/l

1.35

350

1993

Malignant neoplasm of gallbladder

119

4.76

15.67

4.0

2.3

0.19

0.21

g/l

1.27

107

Carcinoma in situ, bladder

141

687

2.21

15.54

1.9

2.0

0.21

0.19

g/l

2.34

130

613

Malignant neoplasm of bladder

327

2054

1.67

15.47

2.4

2.1

0.20

g/l

1.45

303

1874

Artificial joint operation, meniscal resection

4556

26734

1.15

15.45

2.2

2.3

0.21

g/l

0.30

4230

24784

Seborrhoeic dermatitis

429

2864

1.56

15.43

2.9

2.3

0.22

0.21

g/l

0.65

394

2670

Diplopia

586

4155

1.46

15.41

2.4

2.3

0.22

0.21

g/l

0.73

534

3877

Carcinoma in situ of oral cavity, oesophagus and stomach

139

4.30

15.39

2.8

2.4

0.21

0.20

g/l

0.48

123

Other epidermal thickening

216

1221

1.89

15.33

2.9

2.3

0.21

g/l

0.16

196

1140

Arthropathy in Crohn disease

241

3.23

15.31

3.7

2.5

0.24

0.23

g/l

0.43

226

Acne

377

2439

1.59

15.27

2.4

2.8

0.23

g/l

0.63

349

2282

Vitreous haemorrhage

460

3126

1.53

15.25

2.4

2.2

0.20

0.21

g/l

0.97

428

2908

Acute and transient psychotic disorders

512

3543

1.49

15.24

2.1

2.3

0.22

g/l

0.55

466

3334

All dysplastic lesions of the vulva

208

1164

1.90

15.24

2.6

2.0

0.22

g/l

0.18

201

1101

Follicular lymphoma

174

919

2.01

15.17

1.8

2.0

0.20

g/l

0.45

162

827

Clear cell adenocarcinoma of kidney

240

1410

1.83

15.13

1.9

2.2

0.21

g/l

0.29

228

1320

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

333

2.81

15.11

1.8

0.19

0.20

g/l

0.97

294

Thyrotoxicosis, other and/or unspecified

855

6449

1.36

15.11

2.3

2.1

0.21

g/l

0.15

801

6034

Disorders of muscles

456

3095

1.53

15.07

2.4

2.3

0.21

g/l

0.13

423

2892

Lactose intolerance

149

748

2.13

15.07

2.6

2.4

0.24

0.22

g/l

2.52

137

706

Moderate visual impairment, binocular

154

785

2.11

15.06

2.3

2.1

0.20

g/l

0.12

143

725

Unspecified event, undetermined intent

134

650

2.24

15.05

2.9

2.5

0.22

g/l

0.08

119

609

Maternal care for other conditions predominantly related to pregnancy

753

5488

1.38

15.02

2.3

0.23

g/l

0.07

694

5197

Eosinophilia

101

440

2.58

15.01

2.1

2.4

0.21

g/l

0.38

411

Other symptoms and signs involving the circulatory and respiratory systems

297

1835

1.69

14.99

2.4

2.3

0.21

g/l

0.07

274

1732

Benign neoplasm: Anus and anal canal

125

589

2.28

14.98

2.3

1.9

0.21

0.20

g/l

0.67

112

537

Benign neoplasm of urinary organs

178

950

1.98

14.94

2.1

2.0

0.21

0.20

g/l

1.64

162

861

Other and unspecified diseases of blood and blood-forming organs

142

709

2.19

14.92

3.1

2.2

0.21

g/l

0.20

129

664

Systemic lupus erythematosus, unspecified

154

789

2.11

14.88

2.3

2.2

0.20

0.22

g/l

3.02

140

749

Hypertrophic cardiomyopathy

213

1214

1.89

14.88

2.3

0.20

0.21

g/l

0.71

196

1131

Amyloidosis

112

510

2.41

14.84

2.3

2.2

0.19

0.20

g/l

1.12

107

477

Hyperosmolality and hypernatraemia

332

2.82

14.81

1.9

2.2

0.19

0.20

g/l

0.12

305

Fracture of neck

277

1693

1.73

14.81

2.0

2.2

0.20

0.21

g/l

0.67

254

1568

Angina pectoris

2943

17066

1.18

14.79

2.0

2.3

0.21

g/l

0.01

2695

15827

Insulin, fast-acting (human)

591

4214

1.44

14.78

2.3

2.2

0.19

0.22

g/l

22.46

534

3931

Intrahepatic Cholestasis of Pregnancy (ICP)

262

1568

1.74

14.77

2.3

2.2

0.22

0.23

g/l

0.41

245

1490

Other disorders of the musculoskeletal system and connective tissue

652

4744

1.42

14.76

2.1

2.2

0.21

g/l

0.60

603

4433

Cardiomyopathy, Hypertrophic obstructive

107

480

2.46

14.71

2.3

2.5

0.20

0.21

g/l

1.30

456

Aortic valve malfunction, age under 60 years

435

2946

1.54

14.71

2.9

2.5

0.20

0.22

g/l

3.07

406

2765

Redundant prepuce, phimosis and paraphimosis

872

6585

1.35

14.71

2.4

2.6

0.21

0.22

g/l

0.94

814

6105

Abscess of lung

394

2.65

14.69

2.7

2.5

0.19

0.21

g/l

1.40

365

Carcinoma in situ of oropharynx, excluding all cancers

10.87

14.67

3.0

2.2

0.22

0.20

g/l

0.48

Other autoimmune haemolytic anaemias

337

2.84

14.57

2.6

2.3

0.21

g/l

0.25

317

Visual impairment including blindness (binocular or monocular)

314

1984

1.66

14.57

2.3

0.20

0.21

g/l

0.16

291

1836

Single spontaneous delivery

1326

8823

0.79

14.55

2.0

2.2

0.22

0.21

g/l

0.09

1244

8155

Focal epilepsy, strict definition

856

6496

1.35

14.53

2.5

2.4

0.21

g/l

0.34

788

6036

Malignant neoplasm of other and unspecified female genital organs

387

2.71

14.51

1.8

1.9

0.19

0.21

g/l

1.22

367

Other extrapyramidal and movement disorders in other diseases

983

7612

1.33

14.48

2.2

0.22

0.21

g/l

4.09

915

7071

Primary gonarthrosis, bilateral

2429

18058

1.20

14.46

2.0

2.2

0.21

g/l

0.18

2237

16718

Other disorders of eyelid

2036

16478

1.21

14.43

2.1

2.2

0.21

g/l

2.87

1881

15292

1825

14241

1.23

14.40

2.2

2.1

0.21

0.20

g/l

2.25

1687

13089

Follicular cysts of skin and subcutaneous tissue

794

5973

1.37

14.37

2.4

2.3

0.22

0.21

g/l

1.07

743

5561

Other peripheral vascular diseases

355

2312

1.60

14.37

2.3

2.2

0.21

g/l

0.08

332

2171

SLE, strict definition

174

940

1.98

14.36

2.3

2.2

0.20

0.22

g/l

2.18

159

890

SLE, ICD10

174

940

1.98

14.36

2.3

2.2

0.20

0.22

g/l

2.18

159

890

Reactive arthropathies

400

2672

1.55

14.32

2.6

2.3

0.22

0.21

g/l

0.52

366

2506

Other interventions on the root canals of the tooth

101

447

2.48

14.31

3.9

2.6

0.22

0.23

g/l

0.42

428

!Aliquae complicationes praecoces traumatis

201

1135

1.88

14.30

2.4

2.3

0.21

0.22

g/l

0.81

177

1059

Early complications of trauma

201

1135

1.88

14.30

2.4

2.3

0.21

0.22

g/l

0.81

177

1059

Other diseases of spinal cord

157

822

2.06

14.28

2.2

2.3

0.20

0.22

g/l

1.60

148

767

Presence of other devices

954

7358

1.33

14.27

2.4

2.0

0.20

g/l

0.43

902

6773

Other and unspecified types of non-Hodgkin lymphoma, hilmo

209

1198

1.87

14.26

2.3

2.2

0.20

0.21

g/l

0.40

191

1106

Toxic effects of substances chiefly nonmedicinal as to source

487

3384

1.49

14.25

2.3

0.21

0.22

g/l

1.29

457

3160

Cervicalgia

916

7037

1.33

14.22

2.1

2.2

0.22

0.21

g/l

4.31

849

6557

Disorders of ocular muscles, binocular movement, accommodation and refraction

2036

16931

1.21

14.13

2.5

2.4

0.22

g/l

0.30

1898

15829

Post-traumatic wound infection, not elsewhere classified

134

667

2.18

14.09

2.4

2.5

0.21

0.22

g/l

0.80

115

623

Left bundle-branch block

317

2022

1.64

14.09

2.1

2.2

0.21

g/l

1.05

289

1898

Rotator cuff syndrome

2987

19152

1.17

14.09

2.2

2.3

0.22

0.21

g/l

4.56

2790

17802

Prurigo nodularis

134

669

2.19

14.07

2.4

2.2

0.20

0.21

g/l

0.74

119

629

Ovarian dysfunction

256

1542

1.72

14.03

2.2

2.1

0.24

0.23

g/l

1.37

240

1453

Multiple myeloma, excluding all cancers (controls excluding all cancers)

181

993

1.92

14.01

2.4

2.0

0.19

g/l

0.15

170

886

Other skin changes

743

5564

1.38

13.99

2.6

2.2

0.21

g/l

1.28

686

5178

Lichen ruber planus, wide definition including periferal and oral lichen planus

940

7275

1.33

13.97

2.2

0.21

g/l

0.50

867

6791

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

156

823

2.05

13.96

2.9

2.8

0.22

g/l

0.15

149

771

Radiculopathy

748

5604

1.37

13.94

2.0

2.2

0.22

0.21

g/l

3.66

683

5189

Superficial injury of ankle and foot

490

3420

1.48

13.94

2.4

2.5

0.23

0.22

g/l

1.33

448

3232

Erythema intertrigo

125

610

2.24

13.94

2.5

2.1

0.21

g/l

0.04

112

566

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

8.39

13.92

2.9

1.3

0.20

0.23

g/l

0.68

Isolated proteinuria

150

781

2.07

13.90

2.2

2.5

0.22

0.21

g/l

0.80

139

733

Acute laryngitis and tracheitis

471

3206

1.48

13.87

3.1

2.6

0.22

0.23

g/l

0.34

444

2983

Parodontitis, operation under 40 years and operation codes

280

1727

1.66

13.87

2.6

2.5

0.23

0.24

g/l

0.51

265

1609

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

178

976

1.93

13.85

2.1

2.2

0.21

0.24

g/l

6.19

162

924

Migraine with aura

934

7210

1.32

13.79

2.4

0.23

0.22

g/l

2.61

881

6774

Diseases of male genital organs

2565

11027

1.19

13.79

2.4

2.6

0.22

0.21

g/l

1.35

2384

10208

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

261

1591

1.70

13.77

2.1

2.2

0.23

0.21

g/l

2.89

242

1444

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

153

3.73

13.72

2.4

0.22

0.20

g/l

0.49

140

Parodontitis, under 40 years and operation codes

279

1725

1.66

13.69

2.6

2.5

0.23

0.24

g/l

0.50

264

1607

Carcinoma in situ of lip, oral cavity and pharynx

6.84

13.69

2.8

2.1

0.20

0.19

g/l

0.33

132

663

2.18

13.68

2.6

2.2

0.19

0.20

g/l

0.68

123

614

Inflammatory disease of uterus

545

3889

1.44

13.64

2.3

2.1

0.23

0.22

g/l

1.14

510

3655

Coronary revascularization (ANGIO or CABG)

2239

13217

1.20

13.63

2.1

2.3

0.20

0.21

g/l

5.29

2063

12221

Diseases of tongue

291

1836

1.66

13.61

2.3

2.0

0.22

0.21

g/l

1.50

275

1720

Carcinoma in situ of skin of scalp and neck

103

469

2.39

13.59

2.3

1.8

0.20

0.19

g/l

0.74

419

Meniscus derangement

2735

16078

1.18

13.59

2.2

2.3

0.22

0.21

g/l

2.42

2545

15004

Hypertensive Renal Disease

162

868

1.98

13.57

2.0

2.1

0.22

0.20

g/l

2.69

147

814

Lesion of ulnar nerve

618

4518

1.41

13.57

2.4

2.3

0.21

g/l

0.03

567

4208

Single delivery by forceps and vacuum extractor

281

2711

0.62

13.55

2.1

2.4

0.24

0.23

g/l

1.47

266

2540

Injuries involving multiple body regions

178

985

1.92

13.54

2.3

0.21

0.22

g/l

0.35

159

918

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

325

2098

1.60

13.53

2.2

2.1

0.22

g/l

0.28

301

1981

Other hearing loss

1213

9542

1.28

13.53

2.2

2.1

0.20

g/l

0.24

1097

8755

Benign neoplasm: Skin of trunk

162

867

1.97

13.52

2.6

2.2

0.21

g/l

0.24

148

788

Fenamates

721

3604

1.38

13.49

2.1

2.3

0.22

0.21

g/l

8.22

638

3351

Other disorders of nervous system

312

2010

1.63

13.45

2.4

2.2

0.21

g/l

1.16

292

1882

Seropositive rheumatoid arthritis

1142

9063

1.28

13.44

2.2

2.1

0.20

0.21

g/l

1.86

1053

8442

Diffuse large B-cell lymphoma

225

1343

1.79

13.39

2.4

2.2

0.19

0.21

g/l

3.22

206

1250

Conductive and sensorineural hearing loss

3908

23885

1.15

13.29

2.2

2.3

0.21

g/l

2.39

3595

22138

Open wound of shoulder and upper arm

105

487

2.35

13.28

2.2

2.6

0.21

0.22

g/l

0.81

452

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2361

19821

1.19

13.20

2.3

0.22

g/l

2.84

2182

18563

Melanocytic naevi, other sites/unspecified

269

1671

1.67

13.17

2.5

2.2

0.23

0.21

g/l

1.71

257

1536

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

227

1353

1.75

13.16

2.1

2.0

0.20

0.19

g/l

0.29

206

1217

Benign neoplasm of other and unspecified sites

136

695

2.08

13.11

2.0

0.22

0.21

g/l

1.40

127

632

Migraine with aura and triptan purchases

578

4195

1.41

13.07

2.4

0.23

0.22

g/l

1.25

544

3954

Conjunctivitis (acute, non atopic)

1190

9509

1.27

13.06

2.4

0.22

g/l

0.79

1100

8893

Delivery

1359

8855

0.80

13.05

2.0

2.2

0.22

0.21

g/l

0.12

1275

8184

Neuralgia and neuritis, unspecified

241

1468

1.73

13.04

2.2

2.1

0.22

g/l

0.19

224

1370

Oral lichen ruber planus wide, hypothyreosis or thyroxin

261

1628

1.70

13.03

2.3

2.1

0.21

g/l

0.21

242

1534

Acne vulgaris

286

1805

1.63

13.03

2.3

2.9

0.23

g/l

0.19

264

1688

Other disorders of bone

839

6448

1.33

13.01

2.5

2.3

0.22

g/l

0.59

777

6035

Hyperhidrosis

126

627

2.12

13.00

2.6

2.0

0.23

0.22

g/l

0.39

117

588

Gastrojejunal ulcer

298

2.77

12.99

3.4

2.0

0.18

0.21

g/l

1.79

277

Special screening examination for neoplasms

201

1165

1.81

12.99

3.2

2.0

0.21

g/l

0.24

186

1070

Other infective otitis externa

275

1733

1.67

12.98

2.2

2.3

0.22

0.21

g/l

0.61

253

1615

Complications of other internal prosthetic devices, implants and grafts

179

1007

1.89

12.95

2.4

2.0

0.20

0.21

g/l

0.19

162

935

Open wound of hip and thigh

154

826

1.98

12.94

2.4

2.6

0.20

0.22

g/l

2.41

141

773

Propionic acid derivatives

1504

6148

1.25

12.87

2.3

2.7

0.21

g/l

3.72

1400

5695

Lactose intolerance, other/unspecified

131

668

2.09

12.77

2.7

2.3

0.24

0.22

g/l

2.19

121

629

Contact with sharp glass

173

965

1.89

12.77

2.2

2.5

0.22

0.23

g/l

0.20

158

902

Open wound of neck

192

3.27

12.76

2.4

2.5

0.19

0.23

g/l

2.39

178

Multiple myeloma and malignant plasma cell neoplasms

176

987

1.88

12.73

2.4

2.0

0.19

g/l

0.20

165

881

Malignant neoplasm of pyriform sinus, excluding all cancers (controls excluding all cancers)

10.79

12.71

2.4

2.0

0.20

0.19

g/l

0.11

Keratitis

1517

12515

1.23

12.71

2.3

0.22

0.21

g/l

0.78

1418

11641

Arthropathic psoriasis

501

3583

1.45

12.65

2.3

0.21

0.22

g/l

0.15

468

3356

Diseases of middle ear and mastoid

2453

17239

1.18

12.62

2.6

2.4

0.22

g/l

1.10

2294

16073

Cervical disc disorders

1691

14108

1.22

12.62

2.1

2.2

0.22

0.21

g/l

3.35

1578

13173

Gonarthrosis, primary, with knee surgery

2686

18988

1.17

12.62

2.0

2.2

0.21

g/l

0.03

2478

17560

Benign neoplasm: Other/unspecified site

313

2.65

12.58

2.1

2.0

0.22

0.21

g/l

0.78

281

Other shoulder lesions

402

2764

1.50

12.52

2.3

2.2

0.22

g/l

1.32

386

2594

Other or ill-defined heart diseases

222

1334

1.74

12.49

2.4

0.21

0.22

g/l

0.98

204

1251

Psoriatic arthropathies

452

3180

1.47

12.47

2.3

0.21

0.22

g/l

0.13

423

2986

Otitis media, unspecified

469

3046

1.46

12.46

3.5

3.0

0.22

g/l

0.41

447

2840

Assault by unspecified means

102

479

2.30

12.45

2.7

0.22

0.24

g/l

1.98

450

Congenital malformations of the musculoskeletal system, not elsewhere classified

315

2.64

12.45

4.5

2.7

0.22

0.23

g/l

0.62

299

Acute bronchiolitis

276

1571

1.64

12.45

4.7

3.7

0.22

g/l

0.18

266

1476

Malignant neoplasm, without specification of site

151

817

1.97

12.43

2.1

2.0

0.18

0.20

g/l

1.63

134

754

Benign neoplasm: Other and unspecified parts of mouth

138

723

2.02

12.39

2.8

2.0

0.22

0.21

g/l

1.50

128

659

Other noninflammatory disorders of uterus, except cervix

1041

5619

1.29

12.35

1.9

2.1

0.21

g/l

0.51

979

5196

Arterial embolism and thrombosis of lower extremity artery

165

919

1.91

12.33

2.0

2.2

0.18

0.20

g/l

3.08

152

848

Extrapyramidal and movement disorders

1612

13426

1.22

12.33

2.1

2.2

0.21

g/l

3.46

1487

12432

Hodgkin lymphoma, hilmo

146

786

1.99

12.27

2.7

2.5

0.19

0.22

g/l

2.93

131

729

Viral pneumonia (known virus, not influenza)

127

655

2.11

12.25

3.0

2.6

0.21

g/l

0.14

116

614

Other diseases of peritoneum

216

1303

1.75

12.24

2.6

2.1

0.21

g/l

0.04

200

1213

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

258

2.82

12.22

3.0

2.0

0.20

g/l

0.11

229

Carcinoma in situ of skin of trunk

152

833

1.97

12.22

2.5

2.0

0.20

g/l

0.55

143

767

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

441

3092

1.46

12.21

2.4

2.1

0.22

0.21

g/l

0.60

420

2817

Salpingitis and oophoritis

774

5944

1.34

12.21

2.4

2.1

0.22

g/l

0.03

711

5579

Drug-induced polyneuropathy

264

2.95

12.17

3.0

2.8

0.21

g/l

0.06

248

Bacterial, viral and other infectious agents

368

2503

1.52

12.14

3.1

2.5

0.22

g/l

0.68

343

2351

Focal epilepsy, mode (most common among epilepsy diagnosis)

794

6120

1.33

12.13

2.5

2.4

0.21

g/l

0.46

738

5690

Specific development disorders of scholastic skills

182

1032

1.82

12.13

3.6

3.7

0.22

0.23

g/l

0.87

170

976

Basal cell carcinoma

2568

17695

1.17

12.12

2.2

2.1

0.20

g/l

0.15

2352

16314

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

338

2.55

12.08

2.7

2.0

0.20

g/l

0.39

308

Drug-induced osteoporosis

317

2.68

12.07

3.6

2.1

0.21

0.22

g/l

0.26

297

Allergic conjunctivitis

2450

20819

1.17

11.96

2.3

0.22

g/l

2.94

2261

19495

Medical abortion

2829

13341

1.17

11.91

2.1

0.22

g/l

1.00

2651

12437

Fibroblastic disorders

1045

8355

1.28

11.87

2.3

2.2

0.21

g/l

0.31

965

7755

Chronic myeloproliferative disease

371

2.52

11.80

2.0

2.3

0.20

0.21

g/l

0.25

348

Benign neoplasm: Ill-defined sites within the digestive system

148

3.60

11.76

2.9

2.3

0.22

0.21

g/l

0.15

138

Myositis

133

705

2.03

11.75

2.7

2.3

0.21

g/l

0.09

123

657

Nummular dermatitis

361

2468

1.52

11.73

2.5

2.2

0.21

g/l

0.28

331

2296

Olecranon bursitis

285

1857

1.61

11.70

2.2

2.3

0.22

0.21

g/l

0.86

266

1721

Spontaneous rupture of synovium and tendon

374

2577

1.51

11.68

2.1

0.21

g/l

0.37

345

2402

Seronegative rheumatoid arthritis

519

3786

1.41

11.63

2.0

2.1

0.21

g/l

0.35

489

3533

Anti-inflammatory and antirheumatic products, non-steroids

1490

6152

1.23

11.63

2.3

2.7

0.21

g/l

3.22

1383

5699

347

2.44

11.63

2.6

2.2

0.23

g/l

0.34

329

Schizophrenia

674

5109

1.35

11.62

2.0

2.4

0.22

g/l

0.43

604

4804

Endometriosis

1496

7342

1.23

11.61

2.3

2.1

0.22

g/l

0.45

1415

6816

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

325

2174

1.54

11.58

2.2

0.22

g/l

0.18

301

2062

Complications of genitourinary prosthetic devices, implants and grafts

117

596

2.10

11.54

2.3

2.0

0.21

g/l

0.32

106

560

Cyst of kidney

318

2132

1.56

11.54

2.2

2.1

0.22

0.21

g/l

1.74

289

1989

Basal cell carcinoma, including avohilmo

2626

17980

1.17

11.52

2.2

2.1

0.20

g/l

0.05

2404

16590

Myeloproliferative diseases

381

2646

1.50

11.49

2.2

2.1

0.20

0.21

g/l

0.69

342

2452

Superficial injury of forearm

392

2728

1.48

11.46

2.2

2.4

0.22

g/l

0.04

351

2553

Polycystic ovarian syndrome

175

1006

1.80

11.45

2.1

2.2

0.24

0.23

g/l

0.85

162

947

Benign neoplasm of ovary

761

5890

1.33

11.42

2.1

0.22

0.21

g/l

0.83

728

5487

Oxicams

1120

5105

1.27

11.35

2.0

2.3

0.22

0.20

g/l

6.56

1040

4710

Oligomenorrhoea

147

808

1.91

11.34

2.5

2.2

0.22

g/l

0.02

139

765

Evidence of alcohol involvement determined by level of intoxication

239

2.82

11.30

2.8

2.5

0.20

0.23

g/l

2.40

222

Contusion of other and unspecified parts of foot

207

1257

1.72

11.30

2.5

2.6

0.23

0.22

g/l

0.42

199

1186

Other enthesopathies

1329

10956

1.23

11.29

2.1

2.3

0.22

g/l

3.52

1237

10239

Hemiplegia

231

1444

1.67

11.29

2.6

2.3

0.22

0.21

g/l

1.38

212

1343

Other predominantly sexually transmitted diseases, not elsewhere classified

626

4709

1.36

11.28

2.8

2.3

0.23

g/l

0.33

590

4417

Other and unspecified erythematous conditions

152

853

1.90

11.23

2.3

2.1

0.21

g/l

0.02

146

803

Other fall from one level to another

938

7460

1.28

11.13

2.5

2.6

0.21

g/l

0.48

866

6956

Sensorineural hearing loss

3677

22897

1.14

11.11

2.2

2.3

0.21

g/l

1.97

3386

21212

Disorders of synovium and tendon

2397

18705

1.17

11.11

2.2

2.3

0.22

0.21

g/l

1.72

2232

17438

Other benign neoplasms of uterus

196

1179

1.74

11.10

1.9

1.8

0.20

g/l

0.19

181

1062

Evidence of alcohol involvement determined by blood alcohol level

378

2.40

11.09

1.9

2.5

0.22

g/l

0.03

355

381

2.35

11.09

3.5

3.1

0.22

0.23

g/l

0.38

361

Ingrowing nail

237

1499

1.65

11.05

2.4

2.3

0.23

0.22

g/l

1.57

227

1402

Carcinoma in situ of lip, oral cavity and pharynx

5.55

11.01

2.8

2.4

0.20

0.21

g/l

0.13

Benign neoplasm: Long bones of lower limb

124

653

2.00

10.96

2.8

2.3

0.22

g/l

0.20

118

596

Postprocedural musculoskeletal disorders, not elsewhere classified

321

2180

1.54

10.95

2.0

2.2

0.21

g/l

0.13

296

2039

Left ventricular outflow tract obstruction, narrow definition

232

1467

1.66

10.95

3.0

2.9

0.20

0.22

g/l

2.45

218

1383

Chronic nephritic syndrome

191

1151

1.76

10.94

1.8

2.3

0.23

0.21

g/l

2.65

178

1075

Nonsuppurative otitis media

888

6055

1.29

10.94

3.1

2.6

0.22

g/l

0.33

822

5643

Carcinoma in situ of cervix uteri

258

1657

1.60

10.93

2.1

2.2

0.23

0.22

g/l

0.76

237

1543

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

137

3.48

10.93

2.2

1.8

0.22

0.20

g/l

0.55

116

Hallux valgus (acquired)

1574

9539

1.21

10.90

2.0

2.2

0.21

g/l

0.30

1453

8938

Strabismus

1113

9032

1.25

10.87

2.4

2.5

0.22

0.21

g/l

0.05

1035

8438

Lichen planus, including avohilmo

793

6213

1.31

10.86

2.2

0.21

g/l

0.23

734

5795

Kyphosis

331

2.51

10.86

2.1

2.2

0.21

g/l

0.02

315

Benign neoplasm: Other and unspecified parts of small intestine

443

2.29

10.82

2.5

2.0

0.23

0.21

g/l

1.34

415

Other and unspecified epidermal thickening

130

703

1.98

10.81

3.4

2.3

0.22

0.21

g/l

0.07

121

655

Other disorders of breast

512

3772

1.40

10.80

2.1

2.2

0.23

0.21

g/l

4.78

480

3555

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

272

1779

1.58

10.80

2.2

2.1

0.21

g/l

0.01

256

1620

Cauda equina syndrome

313

2.55

10.79

2.5

2.3

0.21

0.22

g/l

0.43

297

Special screening examination for other diseases and disorders

324

2196

1.52

10.77

2.4

2.0

0.22

0.21

g/l

0.32

297

2034

Other other unspecified disorders of the circulatory system

183

1098

1.77

10.74

3.0

2.2

0.21

g/l

0.20

167

1026

Ectropion of eyelid

177

1050

1.78

10.70

2.4

2.1

0.20

0.19

g/l

0.43

154

961

Benign neoplasm: Rectosigmoid junction

202

1246

1.73

10.70

2.5

2.1

0.22

0.21

g/l

1.02

190

1161

Other congenital malformations

366

2550

1.48

10.68

2.8

0.22

g/l

0.06

344

2409

Other encephalitis

133

728

1.95

10.67

2.9

2.5

0.23

0.21

g/l

1.18

119

688

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

199

2.92

10.62

1.7

1.8

0.21

0.19

g/l

1.11

170

Benign neoplasm: Skin of other and unspecified parts of face

357

2474

1.48

10.62

2.4

2.0

0.21

0.20

g/l

1.49

326

2229

Acute myeloid leukaemia, helper endpoint

194

2.97

10.62

1.9

2.1

0.22

0.20

g/l

0.59

170

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

194

2.97

10.62

1.9

2.1

0.22

0.20

g/l

0.59

170

Other (seronegative) rheumatoid arthritis, wide

837

6618

1.29

10.61

2.1

2.2

0.21

g/l

0.58

778

6152

Impetigo

189

1141

1.73

10.61

3.5

2.8

0.22

g/l

0.03

174

1072

Otitis externa, unspecified

453

3284

1.42

10.59

2.3

0.22

g/l

0.17

430

3074

Encephalitis

140

780

1.91

10.59

2.9

2.5

0.22

0.21

g/l

0.98

126

737

Thyrotoxicosis

1058

8587

1.26

10.57

2.2

0.21

g/l

0.07

985

8008

Perforation of oesophagus

126

3.71

10.57

3.5

2.2

0.18

0.21

g/l

1.97

117

Skin changes due to chronic exposure to nonionizing radiation

1678

13459

1.20

10.56

2.2

2.1

0.21

0.20

g/l

2.26

1553

12354

Leiomyoma of uterus

2780

13840

1.16

10.54

2.1

0.22

g/l

3.22

2607

12936

Ankylosing spondylitis

385

2717

1.46

10.51

2.4

2.3

0.22

g/l

0.55

353

2546

Endocrine disorders, other/unspecified

102

514

2.14

10.48

2.0

2.2

0.20

0.22

g/l

1.66

487

Myeloid leukaemia

129

705

1.96

10.46

2.8

2.4

0.20

0.21

g/l

0.39

116

657

Septal defects

295

1942

1.55

10.45

3.0

3.2

0.21

g/l

1.35

288

1843

Toxic effect of ethanol

179

1070

1.75

10.45

2.7

2.4

0.21

0.22

g/l

2.07

163

997

Carpal tunnel syndrome

2796

22209

1.15

10.44

2.1

2.2

0.22

0.21

g/l

0.44

2605

20702

Familial hypercholesterolemia, with ischemic heart disease

439

3184

1.43

10.41

2.1

2.2

0.20

g/l

0.21

405

2943

Postviral fatigue syndrome

152

3.23

10.34

2.3

2.8

0.24

g/l

0.18

147

Benign neoplasm: Skin of ear and external auricular canal

142

796

1.87

10.33

1.9

0.20

g/l

0.41

134

721

Superficial injuries involving multiple body regions

119

634

2.00

10.31

2.4

0.21

0.22

g/l

0.59

108

592

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

4.36

10.29

2.2

2.0

0.24

0.21

g/l

1.00

Reactive arthropathies, FINNGEN

303

2054

1.53

10.27

2.6

2.2

0.22

g/l

0.11

279

1927

Other benign neoplasms of skin

1629

13813

1.20

10.26

2.3

2.2

0.21

g/l

2.41

1521

12812

Other disorders of penis

423

3053

1.43

10.24

2.6

0.22

0.21

g/l

1.07

389

2820

Polyp of the female genital tract

1399

6764

1.22

10.20

2.0

2.1

0.22

0.21

g/l

5.54

1314

6291

Bell's palsy

499

3699

1.39

10.18

2.4

2.3

0.22

0.21

g/l

1.30

464

3443

Carcinoma in situ of skin of upper limb, including shoulder

451

2.19

10.15

2.3

1.8

0.23

0.19

g/l

4.59

400

Ocular pain

333

2307

1.49

10.12

2.4

0.22

g/l

0.32

316

2160

Pain in thoracic spine

625

4785

1.34

10.12

2.4

2.3

0.22

0.21

g/l

3.29

587

4476

Benign neoplasm: Appendix

211

2.83

10.11

2.3

2.0

0.22

0.21

g/l

0.90

191

Other arterial embolism and thrombosis

129

711

1.93

10.07

2.4

2.3

0.20

0.21

g/l

0.34

114

655

292

1963

1.52

10.07

2.1

2.2

0.23

g/l

0.24

279

1860

Cramp and spasm

204

1276

1.68

10.07

3.2

2.4

0.23

0.22

g/l

2.01

196

1200

Congenital malformations and deformations of the musculoskeletal system

360

2517

1.47

10.05

2.9

3.0

0.22

g/l

0.39

344

2383

Osteosarcoma, excluding all cancers (controls excluding all cancers)

4.71

10.04

2.9

3.4

0.21

g/l

0.08

Viral warts

409

2943

1.43

10.02

3.7

2.4

0.22

g/l

0.55

388

2762

Other erythematous conditions

164

973

1.79

10.01

2.3

2.2

0.21

g/l

0.01

157

913

Actinic keratosis

1623

13092

1.20

10.00

2.2

2.0

0.21

0.20

g/l

2.17

1503

12007

Drug-induced obesity

213

2.84

9.99

2.4

0.20

0.23

g/l

1.52

199

Migraine without aura and triptan purchases

582

4414

1.34

9.98

2.7

2.4

0.23

g/l

0.82

546

4156

Burns and corrosions of multiple and unspecified body regions

111

586

2.03

9.98

2.5

2.6

0.22

g/l

0.12

101

545

Mixed disorders of conduct and emotions

485

2.10

9.96

2.5

3.4

0.23

g/l

0.22

456

Allergic colitis

105

542

2.05

9.92

3.5

3.3

0.22

g/l

0.06

513

Other inflammation of eyelid

549

4146

1.36

9.92

2.4

2.2

0.22

0.21

g/l

3.05

514

3873

Pneumonia due to Streptococcus pneumoniae

178

1078

1.73

9.91

2.8

2.3

0.20

0.22

g/l

1.34

159

1009

Presbycusis

569

4294

1.35

9.90

1.9

0.19

g/l

1.08

494

3891

Orthopaedic devices associated with adverse incidents

509

2.15

9.87

3.1

2.1

0.20

0.21

g/l

0.26

477

Sequelae of injuries of lower limb

398

2860

1.44

9.87

2.1

2.3

0.22

g/l

0.05

367

2678

Injury of eye and orbit

554

4187

1.35

9.82

2.5

2.4

0.22

g/l

0.57

511

3933

Exposure to other and unspecified inanimate mechanical forces

289

1961

1.53

9.80

2.6

2.4

0.22

g/l

0.28

266

1838

Fall involving bed

141

808

1.86

9.79

2.2

2.3

0.19

0.20

g/l

1.33

129

748

Carcinoma in situ of skin of ear and external auricular canal

244

2.63

9.76

2.1

1.8

0.20

0.19

g/l

0.64

208

Dislocation, sprain and strain of joints and ligaments at neck level

579

4409

1.34

9.73

2.3

0.23

0.22

g/l

1.77

529

4134

Right bundle-branch block

160

949

1.78

9.71

2.6

2.3

0.21

g/l

0.38

150

893

Fracture at wrist and hand level

1438

12108

1.20

9.71

2.4

0.22

g/l

0.06

1325

11289

Pemphigoid

132

745

1.90

9.71

2.3

2.2

0.20

g/l

0.27

119

696

Rheumatoid arthritis, including avohilmo

1696

14500

1.19

9.70

2.2

0.21

g/l

1.39

1571

13485

Other crystal arthropathies

482

2.14

9.68

2.1

2.2

0.20

g/l

0.08

450

Benign neoplasm of other and unspecified female genital organs

155

910

1.78

9.65

1.9

2.1

0.22

0.21

g/l

0.75

142

838

Assault by blunt object

321

2.40

9.64

2.7

0.19

0.23

g/l

2.68

299

Prolonged pregnancy

253

3443

0.66

9.56

2.0

2.3

0.23

g/l

0.32

241

3247

Pure hyperglyceridaemia

109

581

2.01

9.55

2.7

2.3

0.22

0.21

g/l

0.72

103

544

Crystal arthropathies, rheuma endpoint

485

2.13

9.52

2.1

2.2

0.20

g/l

0.15

454

Morphin

402

2.23

9.50

2.2

1.9

0.20

0.21

g/l

0.30

373

Colorectal neuroendocrine tumor and carcinoma

365

2.32

9.45

2.2

2.1

0.23

0.21

g/l

1.16

349

Essential (haemorrhagic) thrombocythaemia

137

785

1.83

9.34

2.1

1.9

0.20

g/l

0.10

120

715

Mental retardation

191

1199

1.68

9.34

3.0

3.4

0.22

g/l

0.06

181

1135

Toxic effect of other and unspecified substances

287

2.46

9.33

2.1

2.7

0.22

0.23

g/l

0.90

266

Other hammer toe(s) (acquired)

779

5815

1.28

9.32

2.0

2.1

0.20

0.21

g/l

0.92

719

5428

Lichen planus

555

4241

1.35

9.32

2.1

2.2

0.21

g/l

0.21

515

3959

Benign neoplasm: Kidney

124

691

1.89

9.30

1.8

2.0

0.21

0.20

g/l

1.08

114

629

Anogenital herpesviral [herpes simplex] infection

223

1446

1.59

9.27

2.7

2.3

0.23

g/l

0.68

210

1360

Drug-induced hypoglycaemia without coma

408

2.20

9.20

2.5

2.4

0.18

0.21

g/l

2.34

379

Unspecified/other endometriosis

314

2184

1.47

9.19

2.3

2.2

0.23

0.22

g/l

2.05

297

2056

Other benign neoplasm of uterus: Other parts/unspecified

154

918

1.76

9.14

1.8

0.20

g/l

0.48

142

820

Benign neoplasm of brain and other parts of central nervous system

220

1428

1.59

9.14

2.3

2.2

0.22

0.21

g/l

0.38

205

1308

Open wound of wrist and hand

1834

15681

1.17

9.12

2.3

2.4

0.22

g/l

1.22

1691

14645

Ehlers-Danlos syndrome

198

2.77

9.11

3.2

2.5

0.22

0.23

g/l

0.27

189

Delivery, wide proxy

1145

7348

0.82

9.09

2.0

2.2

0.22

0.21

g/l

0.38

1072

6759

Viral infections of the central nervous system

299

2074

1.49

9.08

2.3

2.2

0.22

g/l

0.05

275

1944

Infectious mononucleosis

293

2019

1.49

9.03

2.7

2.5

0.23

g/l

0.05

273

1879

Voice disturbances

1114

9246

1.23

9.02

2.3

2.2

0.22

0.21

g/l

3.30

1035

8629

Trochanteric bursitis

584

4510

1.33

9.02

2.1

0.23

0.21

g/l

6.41

540

4198

Burn and corrosion of hip and lower limb, except ankle and foot

110

599

1.96

9.01

2.5

0.22

g/l

0.06

555

Haemangioma and lymphangioma, any site

383

2782

1.42

9.00

2.5

2.4

0.22

g/l

0.89

364

2613

Benign neoplasm: Skin, unspecified

141

823

1.79

8.99

2.1

0.20

0.21

g/l

0.62

136

744

Myeloproliferative diseases (CML excluded)

337

2401

1.46

8.96

2.1

0.20

0.21

g/l

0.58

302

2235

Carcinoma in situ of skin of other and unspecified parts of face

333

2369

1.46

8.94

2.1

2.0

0.20

g/l

0.83

309

2166

Other strabismus

893

7231

1.25

8.93

2.4

2.5

0.22

g/l

0.00

836

6760

Anxious personality disorder

411

2.15

8.88

2.8

2.3

0.22

0.24

g/l

1.14

386

Melanoma in situ

143

843

1.78

8.87

2.0

1.9

0.22

0.20

g/l

3.49

133

757

Malignant immunoproliferative diseases

202

2.75

8.83

3.0

1.9

0.16

0.20

g/l

2.93

176

Acute lymphadenitis

233

1545

1.56

8.82

2.6

2.5

0.22

g/l

0.75

222

1449

Superficial injury of shoulder and upper arm

456

3411

1.37

8.81

2.1

2.3

0.21

0.22

g/l

0.10

416

3180

Ascorbic acid deficiency

10.34

8.81

8.6

5.6

0.21

0.23

g/l

0.52

Ptosis of eyelid

472

3558

1.37

8.80

2.0

2.2

0.22

0.21

g/l

3.40

435

3314

Intracerebral haemorrhage

510

3879

1.35

8.78

2.5

2.0

0.20

g/l

0.06

474

3553

Alzheimer disease, excluding more controls

724

3818

1.29

8.77

1.6

2.1

0.19

0.20

g/l

0.96

606

3548

Rare circulating lymphoid malignancy

152

919

1.76

8.77

2.6

2.8

0.20

0.21

g/l

0.13

139

855

Erectile dysfunction, exclusion

3.95

8.69

2.8

2.9

0.19

0.22

g/l

1.13

Coxarthrosis, primary

2736

21133

1.14

8.67

2.1

2.2

0.21

g/l

0.15

2544

19496

Behavioural disorders, excluding more controls

326

2.24

8.61

2.4

2.8

0.22

0.24

g/l

0.88

311

Contact with heat and hot substances

225

1493

1.57

8.59

2.8

2.6

0.21

0.22

g/l

1.27

207

1394

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

140

827

1.77

8.57

2.5

2.1

0.23

0.21

g/l

2.82

133

751

Pyoderma

517

2.01

8.56

2.6

2.3

0.20

0.21

g/l

0.54

481

Osteonecrosis due to drugs

362

2.28

8.55

2.0

2.1

0.21

g/l

0.21

340

Other renal tubulo-interstitial diseases

107

587

1.93

8.54

2.4

2.0

0.20

0.22

g/l

1.59

550

Malignant neoplasm of parotid gland

207

2.74

8.53

1.9

2.4

0.24

0.21

g/l

2.48

192

Childhood allergy (age < 16)

476

2943

1.35

8.52

3.7

3.2

0.23

g/l

0.40

445

2749

Burn and corrosion of trunk

139

826

1.78

8.51

2.6

0.22

0.21

g/l

0.09

131

775

Somnolence

280

2.40

8.48

1.9

2.7

0.21

0.22

g/l

0.55

260

Nosocomial condition (hospital)

137

3.18

8.48

2.1

0.18

0.21

g/l

1.36

125

Abrasion of teeth

1081

6591

1.22

8.44

2.4

2.1

0.22

g/l

3.18

1001

6187

Varicella [chickenpox]

195

1259

1.61

8.43

3.3

2.8

0.22

0.23

g/l

0.20

177

1186

Other sleep disorders

450

3383

1.36

8.43

2.1

2.3

0.22

0.21

g/l

0.72

413

3140

Lesion of radial nerve

170

1066

1.68

8.41

2.3

2.2

0.21

g/l

0.42

159

984

Open wound of thorax

374

2.19

8.40

2.3

2.4

0.20

0.22

g/l

1.04

354

Spondylolisthesis/Spondylolysis

778

6275

1.26

8.39

2.1

2.2

0.22

0.21

g/l

1.18

719

5851

Other juvenile arthritis

159

977

1.69

8.37

4.3

2.9

0.23

0.22

g/l

0.92

152

922

Xerosis cutis

383

2.19

8.37

2.2

2.3

0.19

0.21

g/l

1.31

353

Melanocytic naevi

1183

9943

1.21

8.34

2.6

2.3

0.22

g/l

4.88

1123

9246

Malignant neoplasm of mesothelium and soft tissue

197

1283

1.61

8.33

2.2

0.20

g/l

0.25

189

1191

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1201

10109

1.21

8.32

2.4

2.3

0.22

g/l

0.30

1087

9409

Emergency coronary revascularization (for ACS)

2509

15978

1.14

8.32

2.0

2.2

0.20

g/l

4.86

2293

14701

Status post-ami

140

1884

0.59

8.31

1.6

2.1

0.19

g/l

0.43

122

1691

Benign neoplasm: Choroid

197

1278

1.60

8.29

2.4

2.0

0.21

0.20

g/l

0.49

183

1160

Other abnormal immunological findings in serum

473

2.03

8.26

2.4

2.6

0.22

g/l

0.03

444

Non-Hodgkin lymphoma, all

173

1096

1.66

8.22

1.9

2.2

0.17

0.20

g/l

4.06

155

1011

Sleep disorders, other/unspecified

134

793

1.77

8.22

2.5

2.4

0.23

g/l

0.51

116

745

Other overlap syndromes

483

2.02

8.16

2.8

2.1

0.22

g/l

0.01

455

Impacted cerumen

415

3105

1.38

8.16

2.5

2.2

0.21

g/l

0.98

372

2886

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

403

2.09

8.16

1.6

2.3

0.23

g/l

0.00

385

Lymphoid leukaemia

249

1710

1.52

8.15

2.3

2.4

0.20

g/l

0.81

225

1591

Other disorders of patella

704

5630

1.27

8.12

2.3

0.23

0.22

g/l

1.24

655

5298

Other and unspecified injuries of lower leg

285

2002

1.47

8.10

2.3

2.4

0.22

g/l

0.09

262

1890

Ankylosing spondylitis, ICD10

369

2711

1.40

8.10

2.4

2.3

0.22

g/l

0.10

339

2542

Campylobacter enteritis

123

717

1.82

8.08

2.9

2.4

0.22

g/l

0.41

115

678

Sequelae of injuries of upper limb

401

2986

1.38

8.07

2.4

2.3

0.22

g/l

0.18

375

2786

Restless leg syndrome

499

3837

1.34

8.06

2.1

2.2

0.22

0.21

g/l

2.19

469

3584

Heterophoria

317

2274

1.44

8.02

2.2

2.5

0.22

g/l

0.03

292

2140

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

151

929

1.69

7.99

3.8

3.0

0.22

g/l

0.03

145

878

Dissection of aorta

140

848

1.74

7.97

2.1

2.3

0.21

0.20

g/l

0.13

133

782

Other and unspecified haemorrhagic conditions

410

2.10

7.97

3.1

2.3

0.21

0.22

g/l

0.15

380

Oral lichen ruber planus, including avohilmo

260

1809

1.50

7.97

2.2

0.22

0.21

g/l

1.32

243

1705

Alzheimer’s disease (Atypical or mixed), excluding more controls

282

1707

1.47

7.97

1.5

2.0

0.19

g/l

0.05

241

1555

Mental retardation, wide definition

195

1279

1.59

7.94

3.0

3.4

0.22

0.21

g/l

0.11

184

1210

Other noninflammatory disorders of vagina

316

2270

1.43

7.93

2.6

2.1

0.22

0.21

g/l

1.29

299

2111

TMD related pain

139

840

1.73

7.92

2.2

2.3

0.23

g/l

0.33

128

794

Dermatographic urticaria

260

1805

1.49

7.91

2.1

2.2

0.23

0.22

g/l

1.41

240

1698

Enthesopathies of lower limb, excluding foot

916

7558

1.23

7.91

2.4

2.3

0.23

0.21

g/l

4.66

864

7073

Other salmonella infections

165

1043

1.66

7.90

3.8

2.1

0.21

0.22

g/l

0.21

153

978

Cysts of oral region, not elsewhere classified

182

1176

1.61

7.88

2.2

2.1

0.21

g/l

0.01

171

1101

Other and unspecified nail disorders

532

1.95

7.87

2.1

0.22

g/l

0.03

502

Hypertrophic disorders of skin

221

1488

1.54

7.85

3.2

2.3

0.22

g/l

0.02

207

1398

Perineal laceration during delivery

275

3466

0.70

7.85

2.2

2.3

0.23

g/l

0.15

261

3256

Congenital iodine-deficiency syndrome/hypothyroidism

139

845

1.73

7.83

2.8

2.2

0.20

0.21

g/l

0.35

125

802

Sequelae of infectious and parasitic diseases

314

2262

1.43

7.77

2.1

0.22

g/l

0.06

293

2107

Localized skin eruption due to drugs and medicaments

279

2.35

7.77

2.7

2.4

0.21

0.22

g/l

0.36

263

Haemangioma, any site

353

2596

1.40

7.77

2.4

2.3

0.22

g/l

1.12

335

2437

Other psoriatic arthropathies

428

3239

1.36

7.76

2.3

0.21

0.22

g/l

0.31

401

3038

Other factor of the environment

305

2.28

7.76

2.8

2.3

0.21

0.22

g/l

0.70

288

Correction of physiology of bite - demanding therapy visit

271

1903

1.47

7.76

2.3

0.23

0.22

g/l

0.88

251

1793

Other obstetric conditions, not elsewhere classified

977

5238

1.22

7.75

2.1

2.3

0.23

g/l

0.16

925

4935

Congenital malformations of aortic and mitral valves

184

1200

1.61

7.74

3.0

0.20

0.22

g/l

2.55

175

1129

Other enthesopathy of foot (+metatarsalgia)

415

3126

1.36

7.73

2.0

2.2

0.22

0.21

g/l

2.13

387

2943

Tongue abnormality

267

1878

1.48

7.72

2.3

2.1

0.22

0.21

g/l

0.87

251

1754

Unspecified lump in breast

633

5039

1.28

7.72

1.9

2.1

0.22

0.21

g/l

2.40

603

4703

Other superficial mycoses

520

1.94

7.72

2.4

2.5

0.21

0.22

g/l

0.68

491

Wet age-related macular degeneration

688

5429

1.27

7.71

2.0

0.20

g/l

0.62

626

4966

Human immunodeficiency virus [HIV] disease

492

1.97

7.71

1.9

2.5

0.25

0.23

g/l

1.50

458

Disorders of optic nerve and visual pathways

378

2811

1.38

7.69

2.4

2.3

0.22

g/l

0.63

359

2635

Benign neoplasm of thyroid gland

118

687

1.79

7.68

2.2

2.0

0.22

0.21

g/l

1.34

106

634

Other disorders of electrolyte and fluid balance, not elsewhere classified

204

2.60

7.66

2.5

2.4

0.21

g/l

0.25

188

Secondary polycythaemia

109

625

1.86

7.65

2.1

2.4

0.22

0.21

g/l

0.49

104

584

Peritonsillar abscess

812

6639

1.24

7.63

2.2

2.4

0.22

g/l

1.16

760

6194

Specific development disorders of speech and language

232

1526

1.51

7.62

3.9

3.3

0.22

g/l

0.06

216

1442

Supervision of normal pregnancy

545

3990

0.77

7.60

2.1

2.3

0.23

g/l

0.57

514

3752

Disorders of vestibular function (Vertigo)

2026

17754

1.15

7.57

2.1

2.2

0.22

0.21

g/l

4.71

1890

16472

Allergic purpura

131

791

1.74

7.54

3.1

2.3

0.20

0.22

g/l

2.34

124

740

Inguinal hernia

2680

16165

1.13

7.48

2.5

2.3

0.21

g/l

0.54

2476

14965

Pollen allergy

686

5464

1.26

7.45

2.9

2.7

0.23

0.22

g/l

2.19

638

5143

Psoriatic arthropathies, ICD10

439

3355

1.34

7.45

2.4

2.3

0.21

0.22

g/l

0.34

412

3146

Mixed specific developmental disorders

111

598

1.83

7.45

3.3

4.7

0.22

g/l

0.40

104

573

Pediculosis, acariasis and other infestations

233

1605

1.50

7.44

2.6

2.5

0.22

g/l

0.15

219

1510

Metatarsalgia

388

2912

1.37

7.44

2.0

2.2

0.22

0.21

g/l

1.73

362

2738

Scabies

180

1177

1.59

7.42

2.6

2.5

0.22

g/l

0.17

167

1110

Melanocytic naevi of other and unspecified parts of face

185

1213

1.57

7.40

2.1

2.2

0.22

0.21

g/l

0.67

171

1108

Transient ischemic attack

2323

17132

1.14

7.40

2.1

2.2

0.21

g/l

0.15

2149

15824

Other specified disorders of kidney and ureter

152

961

1.67

7.38

2.4

2.2

0.21

g/l

0.06

142

894

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

304

2.23

7.37

1.8

1.9

0.20

g/l

0.14

268

Orchitis and epididymitis

374

2796

1.37

7.36

2.5

2.4

0.21

g/l

0.09

345

2569

Bullous pemphigoid

103

590

1.87

7.34

2.0

2.1

0.20

g/l

0.03

549

Dislocation, sprain and strain of joints and ligaments of head

161

1029

1.62

7.31

2.2

2.7

0.21

0.22

g/l

0.91

148

967

Other bursopathies

549

4328

1.30

7.31

1.9

2.2

0.21

g/l

0.52

504

4037

Antenatal screening

581

4137

0.78

7.29

2.2

2.3

0.24

0.23

g/l

2.43

550

3888

Acute alcohol intoxication ICD-9

150

946

1.66

7.28

2.1

2.2

0.19

0.22

g/l

3.66

138

883

Benign neoplasm: Larynx

113

661

1.78

7.26

2.9

2.0

0.20

g/l

0.31

108

592

Polycystic ovarian syndrome, broad definition

316

2297

1.40

7.26

2.3

2.2

0.23

g/l

0.35

294

2164

Secondary parkinsonism, excluding more controls

103

588

1.84

7.25

1.7

2.2

0.21

g/l

0.45

556

Sequelae of other and unspecified infectious and parasitic diseases

224

1541

1.50

7.22

2.2

2.3

0.22

g/l

0.83

212

1455

Recurrent dislocation and subluxation of joint

265

1877

1.45

7.20

2.3

0.23

0.22

g/l

0.58

252

1768

Lifestyle-related condition

288

2.27

7.20

2.7

2.3

0.21

0.22

g/l

0.31

267

Impotence

232

1613

1.50

7.17

2.3

2.4

0.21

g/l

0.51

214

1481

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

310

2260

1.41

7.12

2.3

0.23

0.22

g/l

1.06

295

2129

Other disorders of optic [2nd] nerve and visual pathways

258

1829

1.46

7.12

2.4

0.22

0.21

g/l

0.71

244

1714

Vasomotor and allergic rhinitis

1555

13328

1.16

7.10

2.4

2.5

0.23

0.22

g/l

6.86

1453

12451

Vulvovaginal ulceration/inflammation in other diseases

203

1371

1.52

7.10

2.5

2.1

0.23

0.22

g/l

0.65

189

1297

Hypotension due to drugs

358

2.12

7.10

2.4

2.2

0.21

0.20

g/l

0.35

327

Ethmoidectomy

521

4096

1.30

7.10

2.4

2.3

0.22

g/l

0.12

493

3840

Autism

510

1.89

7.09

3.2

3.3

0.24

0.23

g/l

0.81

476

Nontraumatic intracranial haemmorrhage

804

6627

1.23

7.08

2.3

2.1

0.20

g/l

0.16

746

6091

Gonococcal infection

140

875

1.68

7.08

1.8

2.2

0.22

g/l

0.01

131

827

Wide developmental disorders

128

781

1.71

7.06

2.9

3.7

0.23

0.22

g/l

1.05

115

738

Generalized epilepsy

176

1159

1.58

7.03

2.0

2.8

0.23

0.22

g/l

0.24

169

1094

Granulomatous disorders of skin and subcutaneous tissue

109

639

1.79

7.03

2.0

2.2

0.22

g/l

0.26

599

Seborrhoeic keratosis

900

7514

1.22

7.00

2.7

2.1

0.22

0.21

g/l

4.07

836

6989

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

117

698

1.75

7.00

2.2

1.9

0.22

0.19

g/l

3.49

105

621

Cardiac murmurs and other cardiac sounds

375

2791

1.36

6.99

2.8

2.7

0.21

g/l

0.37

357

2635

Hyperplasia of prostate

1683

8372

1.16

6.99

2.2

2.5

0.21

g/l

0.49

1565

7713

Exposure to smoke, fire and flames

107

626

1.80

6.98

2.1

2.4

0.21

0.22

g/l

0.17

583

Benign neoplasm: Skin of lower limb, including hip

100

572

1.83

6.98

2.4

2.2

0.23

0.21

g/l

2.18

524

Other and unspecified intracranial injuries

130

801

1.70

6.97

2.6

2.4

0.20

0.21

g/l

0.84

115

749

Any dementia, excluding more controls

1382

8265

1.18

6.97

1.7

2.0

0.20

g/l

0.43

1183

7645

IgA nephropathy (IgA glomerulonephritis)

111

658

1.79

6.96

3.0

2.4

0.22

g/l

0.05

106

616

Other secondary coxarthrosis

151

967

1.64

6.95

2.0

2.2

0.20

0.21

g/l

0.96

142

913

Hypothermia

489

1.92

6.92

2.0

2.3

0.18

0.21

g/l

2.76

454

Intermittent heterotropia

227

1578

1.48

6.90

2.5

3.0

0.22

g/l

0.07

211

1500

Benign neoplasm: Conjunctiva

110

648

1.77

6.90

2.5

2.2

0.22

0.21

g/l

1.38

105

589

Temporomandibular joint disorders, including avohilmo

1617

14119

1.16

6.88

2.3

0.23

0.22

g/l

5.08

1516

13221

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

938

5068

1.21

6.88

2.2

2.3

0.23

g/l

0.23

891

4772

Monoarthritis, not elsewhere classified

179

1190

1.56

6.87

2.3

0.22

g/l

0.10

167

1122

Bruxism

461

1.93

6.81

2.6

2.4

0.22

0.23

g/l

0.43

436

Artificial joint re-operation

301

2213

1.41

6.81

1.9

2.1

0.20

0.21

g/l

1.09

277

2064

Inflammatory disorders of male genital organs, not elsewhere classified

385

2.05

6.80

2.3

2.6

0.21

0.22

g/l

0.43

352

Other localized connective tissue disorders

491

1.91

6.79

2.7

2.0

0.22

0.21

g/l

0.41

463

Other bacterial agents as the cause of diseases classified to other chapters

269

2.29

6.77

3.6

2.2

0.21

g/l

0.22

252

Iridocyclitis

921

7727

1.21

6.76

2.4

2.3

0.21

g/l

0.36

868

7203

Acute myeloid leukaemia and myelodysplastic syndromes

456

1.94

6.75

2.0

2.3

0.20

g/l

0.03

422

Contusion of toe(s) without damage to nail

100

579

1.81

6.74

2.4

2.5

0.22

0.23

g/l

0.02

544

Lichen simplex chronicus

150

966

1.63

6.73

2.3

2.2

0.22

0.21

g/l

0.14

140

909

Other nutritional anaemias

249

2.31

6.70

2.0

2.3

0.20

0.21

g/l

0.47

230

Personal history of medical treatment

211

2.44

6.66

4.6

2.2

0.23

0.22

g/l

0.28

193

Other/unspecified reactive arthropathies

268

1936

1.43

6.64

2.6

2.3

0.22

g/l

0.02

247

1811

Autonomic disorders

576

1.82

6.64

2.8

2.2

0.22

0.21

g/l

0.54

535

Other abnormal findings in urine

402

2.00

6.63

2.3

2.2

0.22

0.21

g/l

0.46

373

Other specified/unspecified inflammatory spondylopathies

184

1238

1.53

6.63

2.5

2.2

0.22

g/l

0.11

169

1166

Hydrocele

475

3725

1.30

6.61

2.7

2.4

0.20

g/l

1.17

438

3404

FESS (DNB20)

497

3922

1.30

6.61

2.4

2.3

0.22

g/l

0.06

469

3680

Erectile dysfunction

340

2557

1.37

6.59

2.6

2.3

0.21

0.20

g/l

1.16

313

2350

Anankastic personality disorder

144

921

1.62

6.57

2.3

0.23

g/l

0.34

126

877

TMD muscular pain linked with fibromyalgia

219

2.40

6.56

1.9

2.3

0.24

0.23

g/l

0.24

212

Viral encephalitis, not elsewhere classified/unspecified

534

1.85

6.55

2.3

2.5

0.22

0.21

g/l

0.27

502

Other/unspecified rheumatoid arthritis

525

4179

1.29

6.54

2.2

2.1

0.20

0.21

g/l

0.36

488

3877

Adult respiratory distress syndrome

342

2.09

6.48

2.5

2.3

0.21

g/l

0.31

318

Hypermobility syndrome

184

1244

1.52

6.45

2.4

2.2

0.23

g/l

0.01

165

1176

Generalized epilepsy, mode (most common among epilepsy diagnosis)

130

817

1.66

6.42

1.9

2.8

0.23

0.22

g/l

0.20

125

776

Human immunodeficiency virus [HIV] disease resulting in other conditions

449

1.92

6.41

1.8

2.5

0.25

0.23

g/l

1.67

418

Other specified/unspecified soft tissue disorders

207

1438

1.49

6.41

2.6

2.0

0.21

g/l

0.56

194

1330

Other and unspecified hereditary haemolytic anaemias

6.75

6.41

3.6

4.7

0.21

g/l

0.12

Hyperfunction of pituitary gland

181

1223

1.53

6.40

2.2

0.22

g/l

0.19

162

1146

Gout due to impairment of renal function

276

2.23

6.39

2.8

2.4

0.24

0.21

g/l

1.44

257

Coronary angioplasty

1702

11528

1.15

6.31

2.0

2.3

0.20

0.21

g/l

1.51

1553

10636

Examination and encounter for administrative purposes

162

1075

1.56

6.29

1.8

1.9

0.21

g/l

0.07

147

988

Erythema nodosum

126

792

1.67

6.28

2.6

2.1

0.22

0.21

g/l

0.55

114

745

Carcinoma in situ of oral cavity

4.83

6.27

1.3

1.7

0.23

0.19

g/l

0.94

Autoimmune hyperthyroidism

232

1650

1.45

6.27

2.2

2.0

0.21

0.22

g/l

0.64

217

1557

Burn and corrosion of wrist and hand

154

1013

1.58

6.27

2.5

2.6

0.22

g/l

0.24

141

951

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1104

9464

1.18

6.25

2.3

2.4

0.22

g/l

0.51

1019

8862

Other and unspecified paralytic syndromes

360

2.03

6.25

2.6

2.3

0.21

g/l

0.31

339

Labour and delivery complicated by fetal stress [distress]

494

4158

0.78

6.24

2.1

2.3

0.23

g/l

0.34

470

3919

Erythema multiforme

100

594

1.77

6.23

2.9

2.2

0.21

0.22

g/l

0.09

558

Dislocation, sprain and strain of joint and ligaments of hip

150

985

1.59

6.20

2.2

0.21

g/l

0.20

140

918

Cluster headache, strict

140

903

1.61

6.19

2.1

2.3

0.22

g/l

0.00

130

850

Carcinoma in situ of oesophagus

7.15

6.18

3.0

1.5

0.24

0.21

g/l

0.33

Astigmatism

245

1765

1.43

6.16

2.9

2.8

0.22

g/l

0.17

232

1671

Car occupant injured in noncollision transport accident

146

953

1.59

6.15

2.5

2.3

0.22

g/l

0.32

137

883

Chronic lymphocytic leukaemia

131

839

1.65

6.15

1.8

2.3

0.19

0.20

g/l

1.18

118

780

Otalgia

315

2366

1.37

6.13

2.4

2.5

0.22

0.21

g/l

1.41

291

2221

Hypertrophic scar

196

1358

1.49

6.13

2.7

2.3

0.22

g/l

0.29

182

1275

Female infertility, associated with anovulation

214

1500

1.45

6.13

2.3

2.2

0.24

0.23

g/l

0.90

200

1413

Other otitis externa (chronic)

262

1914

1.41

6.12

2.5

2.3

0.22

0.21

g/l

0.15

229

1782

Memory loss

377

2909

1.33

6.10

2.0

2.1

0.22

0.20

g/l

2.55

320

2696

Pathological resorption of teeth

117

727

1.68

6.08

3.4

2.3

0.21

g/l

0.05

111

684

Urethritis and urethral syndrome

583

1.77

6.07

2.5

2.2

0.22

g/l

0.15

552

Other specified/unspecified spondylopathies

116

723

1.69

6.05

2.4

2.0

0.20

g/l

0.01

105

676

Benign neoplasm: Endocrine gland, other/unspecified

3.92

6.02

1.8

2.0

0.20

0.21

g/l

0.21

Benign paroxysmal vertigo

1186

10267

1.17

6.02

2.0

2.2

0.22

0.21

g/l

2.86

1100

9525

Simple and mucopurulent chronic bronchitis

171

1159

1.53

6.01

2.4

2.3

0.20

g/l

0.09

155

1073

Other and unspecified injuries of shoulder and upper arm

124

785

1.65

6.01

2.3

2.4

0.23

0.22

g/l

0.79

115

725

Entropion and trichiasis of eyelid

338

2574

1.35

6.00

2.1

0.20

g/l

0.42

313

2362

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

194

2.39

5.99

2.7

2.6

0.20

0.21

g/l

0.59

175

Giant cell arteritis

176

1206

1.52

5.99

2.0

0.22

0.20

g/l

2.06

158

1123

Disorders of refraction and accommodation

1029

8773

1.18

5.98

2.6

2.5

0.22

g/l

0.69

964

8203

Injury of nerves and spinal cord at neck level

103

626

1.74

5.97

1.9

2.3

0.21

g/l

0.25

585

Other acute skin changes due to ultraviolet radiation

150

994

1.57

5.96

2.2

0.21

g/l

0.03

135

922

Other and unspecified glaucoma

284

2112

1.39

5.96

2.5

2.1

0.20

g/l

0.05

262

1950

Carbimazole or st.post thyroidectomy, condition for graves disease

814

6840

1.21

5.95

2.2

0.22

g/l

0.20

767

6392

Respiratory disorders in diseases classified elsewhere

360

2.00

5.94

2.1

2.3

0.21

g/l

0.21

337

Dental pulpitis 3

408

2276

1.31

5.89

2.8

3.5

0.23

g/l

0.12

377

2123

Cluster headache, wide

149

986

1.56

5.89

2.1

2.4

0.23

0.22

g/l

0.25

139

926

Seropositive rheumatoid arthritis, wide

1142

9878

1.17

5.87

2.2

0.20

0.21

g/l

1.61

1053

9188

Acute myeloid leukaemia

257

2.20

5.86

1.9

2.4

0.22

0.21

g/l

0.28

239

Panniculitis affecting regions of neck and back

160

1078

1.54

5.84

2.2

0.22

0.21

g/l

0.30

145

1008

Sudden idiopathic hearing loss

417

3278

1.30

5.84

2.5

2.2

0.21

g/l

0.21

385

3046

Benign neoplasm of breast

477

3808

1.28

5.83

2.0

2.1

0.21

g/l

0.01

444

3570

Carcinoma in situ of stomach

22.05

5.83

2.3

2.8

0.20

0.21

g/l

—

Other bullous disorders

119

754

1.66

5.81

2.7

2.3

0.21

g/l

0.46

114

707

Autism spe

513

1.79

5.81

3.2

3.0

0.24

0.23

g/l

0.81

479

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

155

1041

1.55

5.80

2.2

2.1

0.22

0.21

g/l

0.50

145

976

Pulmonary oedema

434

1.88

5.78

2.9

2.1

0.20

g/l

0.20

392

Benign neoplasm: Skin of scalp and neck

492

1.80

5.75

2.0

2.3

0.22

0.21

g/l

1.35

445

Infective bursitis

128

827

1.62

5.75

2.0

2.1

0.22

0.21

g/l

0.53

123

777

Malignant neoplasm of endocrine gland

292

2193

1.37

5.75

2.0

2.2

0.23

0.22

g/l

2.99

280

2051

Asthma mixed form (mode), excluding more controls

194

1358

1.46

5.72

2.5

2.2

0.21

0.22

g/l

0.77

183

1263

Carcinoma in situ of other and unspecified sites

156

1056

1.55

5.71

1.9

2.3

0.21

0.20

g/l

1.01

142

971

Phakomatoses, not elsewhere classified

294

2.09

5.69

2.8

0.21

0.23

g/l

0.70

275

Other and unspecified follicular disorders

153

1028

1.55

5.68

2.6

2.3

0.23

0.22

g/l

1.93

145

966

Embolic stroke with flimmer

100

608

1.72

5.68

1.6

2.1

0.18

0.20

g/l

2.55

556

Disorders of vitreous body and globe

2185

19231

1.12

5.66

2.2

0.21

g/l

1.61

2027

17882

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1108

9591

1.17

5.66

2.2

0.21

g/l

1.35

1020

8933

Paranoid personality disorder

467

1.83

5.64

2.3

2.4

0.22

g/l

0.22

439

Other and unspecified rosacea

334

2563

1.34

5.64

2.6

2.2

0.22

g/l

0.02

308

2407

Disorders of vitreous body

2123

18733

1.12

5.63

2.2

0.21

g/l

2.00

1969

17426

Benign neoplasm: Parotid gland

321

2452

1.35

5.63

2.6

2.1

0.22

0.21

g/l

1.24

298

2290

Oral leukoplakia, including avohilmo

123

793

1.63

5.63

2.1

2.2

0.21

g/l

0.21

115

745

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

145

963

1.55

5.62

1.8

2.2

0.21

g/l

0.10

121

876

Benign neoplasm: Appendix

276

2.12

5.58

2.3

0.22

g/l

0.30

254

Other and unspecified hypertrophic disorders of skin

131

2.67

5.58

6.1

2.5

0.19

0.22

g/l

1.21

124

Palmar fascial fibromatosis [Dupuytren]

639

5287

1.23

5.57

2.3

2.2

0.20

g/l

0.03

585

4873

Nonspecific lymphadenitis

228

1653

1.42

5.57

2.5

2.2

0.22

0.23

g/l

0.51

217

1563

Effects of foreign body entering through natural orifice

968

8300

1.18

5.57

2.6

2.5

0.22

g/l

0.61

891

7749

Other/unspecified seropositive rheumatoid arthritis

1127

9780

1.17

5.57

2.2

0.20

0.21

g/l

1.59

1039

9099

Benign neoplasm: Anus and anal canal

125

810

1.62

5.57

2.3

2.1

0.21

g/l

0.08

112

756

Alzheimer’s disease (Early onset)

1145

0.54

5.55

1.8

1.9

0.19

0.20

g/l

0.51

1054

Sacroiliitis, not elsewhere classified

166

1136

1.50

5.54

2.1

2.2

0.23

0.22

g/l

0.24

155

1078

Golimumab

125

808

1.61

5.53

2.0

2.3

0.24

0.23

g/l

0.52

119

760

Benign neoplasm of male genital organs

417

1.86

5.53

3.1

2.1

0.21

0.20

g/l

0.14

366

Benign neoplasm: Lower jaw bone

3.32

5.53

2.3

2.2

0.24

0.22

g/l

0.67

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

142

945

1.56

5.52

2.4

2.5

0.23

0.22

g/l

0.68

135

891

Marginal zone B-cell lymphoma

237

2.23

5.51

2.1

2.2

0.20

0.21

g/l

0.26

221

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

151

2.54

5.48

2.5

2.0

0.15

0.20

g/l

2.50

132

Juvenile arthritis (FINNGEN)

169

1164

1.49

5.47

4.2

2.8

0.23

0.22

g/l

0.71

162

1102

Disorders of ornithine metabolism

23.14

5.45

3.4

3.8

0.24

0.20

g/l

—

Benign neoplasm: Tongue

124

807

1.61

5.45

2.9

2.2

0.23

0.21

g/l

1.30

115

752

Acute nephritic syndrome

587

1.72

5.44

2.3

2.7

0.23

0.21

g/l

1.24

548

Melanocytic naevi of trunk

451

3609

1.28

5.42

2.7

2.3

0.23

0.22

g/l

2.51

428

3375

Benign neoplasm: salivary glands, exclude unknown (D119)

355

2764

1.32

5.41

2.5

2.2

0.22

0.21

g/l

1.20

331

2577

Mature T/NK-cell lymphomas, hilmo

365

1.94

5.40

3.0

2.3

0.20

0.21

g/l

0.27

338

Diseases of inner ear

2353

20929

1.11

5.35

2.1

2.2

0.22

0.21

g/l

2.86

2201

19415

Diabetic retinopathy

1629

9151

1.14

5.34

2.4

0.20

0.21

g/l

10.52

1485

8428

Other and unspecified diseases of spleen

2.98

5.34

2.5

0.23

0.21

g/l

0.40

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

4.28

5.33

3.1

1.7

0.19

0.20

g/l

0.04

Haemolytic-uraemic syndrome

4.11

5.33

4.0

3.0

0.23

0.22

g/l

0.13

All dysplastic lesions of the cervix uteri, vagina or vulva

960

8195

1.18

5.32

2.4

2.2

0.23

0.22

g/l

1.05

904

7728

Benign neoplasm: Other/unspecified site

440

1.84

5.32

2.1

0.22

0.21

g/l

0.44

410

Deviated nasal septum

1413

12478

1.14

5.31

2.3

2.4

0.22

0.21

g/l

5.77

1301

11615

Other and unspecified mononeuropathies, also in other diseases

130

859

1.58

5.30

2.3

2.1

0.21

g/l

0.50

122

794

Other/unspecified enthesopathies, not elsewhere classified

355

2769

1.31

5.30

2.1

2.2

0.22

0.21

g/l

1.82

333

2583

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

138

921

1.56

5.29

3.0

3.6

0.22

g/l

0.60

132

877

Other keratitis

416

3307

1.28

5.29

2.2

2.3

0.22

g/l

0.11

391

3106

Other specified and unspecified disorders of eye and adnexa

159

1095

1.51

5.27

2.6

2.2

0.23

0.21

g/l

1.54

147

1029

L01XX Other antineoplastic agents

234

1727

1.40

5.26

1.9

2.1

0.20

g/l

0.89

211

1610

Crushed, pushed or stepped on by crowd or human stampede

257

1916

1.37

5.26

2.9

2.7

0.22

0.23

g/l

0.06

233

1793

Polyarthritis, unspecified

151

1030

1.52

5.25

2.5

2.3

0.22

0.21

g/l

0.04

141

970

Dislocation of lens

352

1.93

5.25

2.1

0.19

0.20

g/l

0.46

321

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

165

2.36

5.25

1.9

2.1

0.24

0.23

g/l

0.31

160

Benign neoplasm of major salivary glands

395

3131

1.29

5.22

2.5

2.2

0.22

0.21

g/l

0.80

369

2911

Other and unspecified bullous disorders

255

2.13

5.22

3.0

2.3

0.21

g/l

0.19

242

Dislocation, sprain and strain of joints and ligaments of knee

2545

21564

1.10

5.21

2.3

2.4

0.23

0.22

g/l

4.46

2377

20187

Inflammatory disorders of breast

213

1546

1.41

5.18

2.0

2.2

0.22

g/l

0.04

200

1467

Carcinoma in situ of skin of scalp and neck

103

652

1.67

5.17

2.3

2.2

0.20

g/l

0.12

596

Respiratory tuberculosis, confirmed

495

1.76

5.17

2.4

2.1

0.20

g/l

0.24

453

Temporal arteritis

156

1078

1.51

5.16

2.0

0.22

0.20

g/l

1.74

138

1003

Rosacea

433

3471

1.27

5.16

2.6

2.2

0.22

0.21

g/l

0.78

400

3256

Postpartum haemorrhage

589

6190

0.82

5.15

2.1

2.2

0.23

g/l

0.41

563

5851

Suggestive for eosinophilic asthma

364

2863

1.30

5.12

2.2

0.22

0.21

g/l

0.55

345

2673

Recurrent dislocation of patella

166

1154

1.47

5.11

2.1

2.3

0.23

g/l

0.37

159

1088

Other complications of labour and delivery, not elsewhere classified

173

2352

0.70

5.09

2.1

2.3

0.23

g/l

0.24

165

2208

Pustulosis palmaris et plantaris

173

1220

1.47

5.08

2.0

2.2

0.23

0.22

g/l

1.12

159

1153

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

3.13

5.07

3.1

2.2

0.24

0.21

g/l

1.28

Postpartum care and examination

302

2511

0.76

5.07

2.1

2.3

0.23

g/l

0.27

278

2346

Embolic stroke

183

1301

1.45

5.06

1.7

2.1

0.20

g/l

0.12

165

1196

Persistent delusional disorders

297

2279

1.34

5.05

2.0

2.2

0.22

0.21

g/l

0.63

267

2131

All dysplastic lesions of the vagina

103

653

1.65

5.04

3.1

2.0

0.23

0.22

g/l

0.23

620

Abnormal blood-pressure reading, without diagnosis

180

1279

1.45

5.03

2.3

0.22

g/l

0.57

163

1215

Benign neoplasm: Skin of upper limb, including shoulder

385

1.85

5.03

2.9

2.0

0.22

0.21

g/l

0.33

352

Adhesive capsulitis of shoulder

703

5932

1.20

5.01

2.2

0.22

0.21

g/l

1.18

653

5526

Benign neoplasm: Floor of mouth

3.51

4.98

1.7

2.6

0.21

g/l

0.09

Other congenital malformations, not elsewhere classified

211

2.21

4.98

3.7

3.8

0.21

0.22

g/l

0.35

204

Abnormal findings on diagnostic imaging of central nervous system

170

1199

1.46

4.96

2.7

2.3

0.22

g/l

0.65

157

1123

Giant cell arteritis with polymyalgia rheumatica

156

1087

1.50

4.96

2.0

0.22

0.20

g/l

1.87

138

1011

Other orthopaedic follow-up care

205

1492

1.41

4.95

2.3

2.2

0.21

0.22

g/l

0.21

187

1398

Other disorders of the genitourinary system

514

4221

1.24

4.95

2.1

0.22

0.21

g/l

1.59

470

3941

Exposure to unspecified smoke, fire and flames

232

2.13

4.93

2.0

2.6

0.19

0.22

g/l

1.60

216

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

2.98

4.92

1.5

1.6

0.21

0.19

g/l

0.60

HSIL lesion of the cervix uteri, vagina or vulva

627

5238

1.21

4.91

2.4

2.2

0.23

0.22

g/l

1.54

587

4959

Habit and impulse disorders

360

1.86

4.86

2.4

2.6

0.24

0.23

g/l

0.24

340

Corneal ulcer

696

5881

1.20

4.86

2.1

2.3

0.22

g/l

0.22

658

5507

Dementia in other diseases classified elsewhere

175

1247

1.45

4.86

2.1

0.20

g/l

0.45

156

1159

Complications following abortion and ectopic and molar pregnancy

150

1041

1.50

4.85

2.4

2.1

0.22

g/l

0.11

142

985

Correction of physiology of bite - very demanding therapy visit

110

715

1.60

4.83

2.8

2.2

0.22

g/l

0.30

101

673

Benign neoplasm: Spinal meninges

199

2.20

4.83

2.0

1.8

0.20

g/l

0.16

181

Universal erythroderma, KELA reimbursement

385

1.85

4.83

2.7

2.2

0.20

0.21

g/l

0.53

357

Anterior Iridocyclitis

800

6844

1.19

4.83

2.4

2.3

0.21

g/l

0.48

752

6383

Visual field defects

334

2622

1.30

4.81

1.9

2.2

0.21

g/l

0.16

307

2445

Chondropathies

594

4955

1.22

4.80

2.6

2.4

0.22

g/l

1.00

541

4644

Personal history of allergy to drugs, medicaments and biological substances

248

2.06

4.79

2.1

2.3

0.23

0.22

g/l

0.32

234

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

155

1080

1.47

4.77

1.8

2.2

0.24

0.21

g/l

4.80

147

983

TMD related operations

619

5186

1.21

4.77

2.7

2.3

0.23

0.22

g/l

1.49

574

4879

Carcinoma in situ of skin of ear and external auricular canal

328

1.92

4.76

2.1

0.20

0.19

g/l

0.17

300

Background retinopathy and retinal vascular changes

554

1.69

4.75

3.2

2.1

0.21

g/l

0.14

512

Endometriosis of ovary

636

5327

1.21

4.75

2.5

2.1

0.22

g/l

0.20

608

4978

Other sexually transmitted chlamydial diseases

187

1346

1.42

4.75

2.3

2.5

0.24

0.23

g/l

0.20

168

1253

Carcinoma in situ, bladder

141

974

1.52

4.74

1.9

2.3

0.21

0.20

g/l

0.93

130

899

Tooth eruption problems

446

3578

1.25

4.74

3.4

2.9

0.23

g/l

0.03

421

3354

Congenital malformations of the nervous system

561

1.67

4.73

2.5

3.3

0.22

g/l

0.22

534

Other and unspecified acute skin changes due to ultraviolet radiation

114

753

1.58

4.72

2.2

0.21

g/l

0.11

101

691

Testicular hypofunction

127

857

1.54

4.72

2.5

0.23

0.22

g/l

0.30

121

794

Other/unspecified enthesopathies of lower limb, excluding foot

275

2111

1.33

4.68

2.6

2.2

0.23

0.22

g/l

1.74

255

1987

Chronic conjunctivitis

123

827

1.55

4.66

2.1

2.5

0.22

0.21

g/l

0.68

111

782

Respiratory tuberculosis, bacteriologically and histologically confirmed

510

1.70

4.65

2.4

2.1

0.20

g/l

0.28

466

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

106

690

1.59

4.62

2.6

2.3

0.22

g/l

0.27

655

Acute appendicitis

3058

26682

1.09

4.62

2.3

0.22

g/l

3.94

2850

24881

Papillary adenocarcinoma of thyroid gland

204

1505

1.40

4.62

1.9

2.1

0.23

0.22

g/l

2.59

197

1413

Pustular psoriasis

189

1378

1.42

4.62

2.0

2.2

0.23

0.22

g/l

1.20

175

1299

Other symptoms and signs involving the urinary system

390

3133

1.27

4.62

2.4

2.2

0.22

0.21

g/l

1.50

359

2918

Asthma mixed form (mode)

194

1415

1.40

4.61

2.5

2.1

0.21

g/l

0.44

183

1313

Toxic effect of corrosive substances

100

2.73

4.60

3.2

2.5

0.19

0.23

g/l

2.04

Malignant immunoproliferative diseases

268

2.03

4.60

3.0

2.2

0.16

0.21

g/l

4.10

246

Retinal vascular disorders

474

3892

1.24

4.59

2.4

2.1

0.20

g/l

0.10

439

3592

Convergent concomitant strabismus

208

1537

1.39

4.58

3.1

2.6

0.22

g/l

0.46

197

1450

Hyperaldosteronism

118

791

1.56

4.58

2.1

2.2

0.23

0.21

g/l

1.16

106

739

Hyperkinetic disorders (excl. ADHD)

446

1.74

4.57

3.3

3.8

0.22

0.23

g/l

0.30

424

Other lack of coordination

476

1.74

4.56

2.3

2.5

0.20

0.21

g/l

0.44

444

Benign neoplasm: Pituitary gland, craniopharyngeal duct

198

1457

1.40

4.55

2.4

2.3

0.22

g/l

0.01

186

1362

Benign neoplasm of other and unspecified sites

136

939

1.51

4.54

2.0

2.2

0.22

0.21

g/l

0.43

127

880

Respiratory conditions due to other external agents

571

1.66

4.50

2.3

2.1

0.22

0.21

g/l

0.71

534

Guttate psoriasis

348

1.85

4.50

1.9

2.2

0.22

g/l

0.30

326

Hordeolum and other deep inflammation of eyelid

211

1571

1.38

4.49

2.4

0.21

0.22

g/l

0.19

202

1480

Hirsprung

5.16

4.48

10.9

5.2

0.22

0.20

g/l

0.59

Malignant melanoma

582

4888

1.21

4.47

2.1

2.2

0.22

0.21

g/l

2.49

541

4542

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1499

0.64

4.46

1.8

2.2

0.22

g/l

0.57

1417

Pregnancy, childbirth and the puerperium

1050

6275

0.87

4.45

1.9

2.2

0.21

g/l

0.07

993

5750

Unspecified contracted kidney

147

2.40

4.44

2.8

2.3

0.24

0.22

g/l

0.68

140

Other and unspecified injuries of ankle and foot

152

1073

1.46

4.44

3.7

2.4

0.21

0.22

g/l

1.05

141

1012

Dental caries 2 and operation codes, only avohilmo

2842

19095

0.92

4.41

2.5

0.23

0.22

g/l

6.37

2658

17860

Dental caries 2 and operation codes

3261

24054

1.08

4.38

2.8

2.3

0.23

0.22

g/l

4.40

3057

22507

Disorders of speech understanding and production

162

1139

1.44

4.37

3.9

3.4

0.21

g/l

0.10

148

1079

Other disorders of pigmentation

172

1247

1.42

4.37

2.3

0.20

0.21

g/l

1.30

158

1176

Meningitis

189

1390

1.40

4.36

2.4

2.3

0.22

g/l

0.34

179

1308

Other ill-defined and unspecified causes of mortality

225

1700

1.36

4.36

2.3

2.1

0.17

0.20

g/l

5.40

199

1568

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

240

1825

1.34

4.35

2.6

2.2

0.23

g/l

0.11

233

1732

Spirochaetal infections, other/unspecified

330

2625

1.29

4.33

2.7

2.2

0.22

0.21

g/l

1.17

309

2458

Tuberculosis, IBD comorbidity

281

2189

1.31

4.32

2.4

2.0

0.20

g/l

0.34

259

2015

Other secondary gonarthrosis

216

1627

1.37

4.32

1.9

2.1

0.21

g/l

0.22

202

1524

Herpesviral keratitis and keratoconjunctivitis

170

1233

1.42

4.31

2.2

0.21

g/l

0.85

156

1153

Dental caries 2

3335

24369

1.08

4.30

2.8

2.3

0.23

0.22

g/l

4.93

3126

22803

Injury of urinary and pelvic organs

537

1.66

4.30

2.7

2.4

0.21

g/l

0.09

501

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

195

1442

1.38

4.29

2.1

0.21

g/l

0.02

183

1305

Diseases of appendix

3302

27995

1.08

4.27

2.4

2.3

0.22

g/l

4.83

3085

26079

Long labour

587

6075

0.84

4.27

2.1

2.2

0.23

g/l

1.19

561

5736

Schizotypal disorder

560

1.63

4.26

1.9

2.4

0.23

g/l

0.21

527

Retinal vascular occlusion

464

3834

1.23

4.26

2.3

2.1

0.20

g/l

0.02

432

3541

Dysplasia of cervi uteri

836

5589

1.17

4.26

2.4

2.1

0.23

0.22

g/l

3.21

785

5214

Systemic atrophies primarily affecting the central nervous system

166

1204

1.43

4.24

2.4

0.21

g/l

0.16

157

1119

Vascular dementia

290

2194

1.30

4.23

1.6

1.9

0.20

0.19

g/l

2.48

246

1981

Renal tubulo-interstitial disorders in diseases classified elsewhere

261

1.98

4.22

2.5

2.1

0.23

0.22

g/l

0.57

237

Glaucoma secondary to other eye disorders

160

1153

1.43

4.21

1.9

2.3

0.20

0.21

g/l

0.64

147

1074

Acute and subacute iridocyclitis

746

6424

1.18

4.20

2.4

2.3

0.21

g/l

0.48

700

5999

Benign neoplasm: Vulva

430

1.72

4.20

2.3

2.1

0.22

0.21

g/l

0.86

404

Pre-eclampsia or poor fetal growth

1019

8936

1.15

4.20

2.3

2.2

0.22

0.23

g/l

1.02

956

8430

Other osteochondropathies

269

2093

1.31

4.19

2.7

2.3

0.23

0.22

g/l

0.59

246

1968

Bronchitis, not specified as acute or chronic

330

2631

1.28

4.19

2.4

2.2

0.21

g/l

0.12

314

2444

Monocytic leukaemia

3.16

4.19

1.3

2.1

0.21

g/l

0.01

Benign neoplasm: Vagina

260

1.95

4.18

1.5

2.1

0.22

0.20

g/l

1.06

245

Pilonidal cyst

290

2276

1.30

4.16

2.8

2.4

0.22

0.23

g/l

2.93

274

2121

Other contact dermatitis

299

2358

1.29

4.16

2.3

2.2

0.22

g/l

0.31

280

2216

Malignant neoplasm of bone and articular cartilage

227

2.04

4.13

2.5

0.19

0.21

g/l

0.82

214

Benign neoplasm: Long bones of lower limb

124

858

1.49

4.09

2.8

2.4

0.22

g/l

0.18

118

801

Symptoms and signs involving appearance and behaviour

192

2.11

4.08

2.1

2.2

0.20

0.22

g/l

1.15

183

Postzoster neuralgia

398

1.76

4.08

2.2

0.20

0.21

g/l

0.09

369

Retinal detachments and breaks

1449

13055

1.12

4.05

2.3

2.2

0.21

g/l

0.16

1358

12122

Allergic rhinitis

1160

10213

1.13

4.03

2.5

0.23

0.22

g/l

4.71

1083

9592

Other infective spondylopathies

3.42

4.02

3.6

1.8

0.19

0.22

g/l

0.88

Neovascular glaucoma

159

1156

1.42

4.00

1.9

2.3

0.20

0.21

g/l

0.77

146

1076

Overexertion and strenuous or repetitive movements

372

3025

1.25

4.00

2.4

2.3

0.22

g/l

0.50

330

2822

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.63

3.99

3.3

1.7

0.22

g/l

0.05

Perforation of tympanic membrane

377

3071

1.25

3.99

2.1

2.3

0.21

g/l

0.07

347

2861

Appendicitis, broad definition

3265

27843

1.08

3.99

2.3

0.22

g/l

4.70

3049

25937

Varicose veins of other sites

248

1924

1.32

3.99

3.7

2.1

0.20

0.22

g/l

4.35

222

1800

Optic atrophy

517

1.65

3.98

2.6

0.21

0.22

g/l

0.36

488

Obstructed labour due to malposition and malpresentation of fetus

536

5988

0.84

3.98

2.2

0.23

g/l

1.22

507

5663

Viral meningitis

130

912

1.47

3.97

2.6

2.3

0.22

0.23

g/l

0.19

119

858

Benign neoplasm: Skin of eyelid, including canthus

607

5173

1.19

3.97

2.2

0.22

0.21

g/l

1.81

569

4811

Crowding of teeth, including avohilmo

311

2038

1.28

3.97

4.0

3.3

0.22

0.23

g/l

0.26

292

1910

Cerebral aneurysm, nonruptured

334

2689

1.27

3.97

2.2

0.22

g/l

0.28

308

2515

Benign neoplasm: Other and unspecified parts of mouth

138

982

1.46

3.97

2.8

2.2

0.22

0.21

g/l

0.54

128

917

Other and unspecified disorders of autonomic nervous system

2.72

3.96

2.4

2.2

0.23

g/l

0.02

Trigger finger

558

4728

1.20

3.89

2.2

0.22

0.21

g/l

0.65

524

4423

Pre-eclampsia or eclampsia

762

6613

1.16

3.87

2.2

0.22

g/l

0.43

722

6230

Pre-eclampsia

697

6009

1.17

3.87

2.2

0.22

g/l

0.54

660

5660

Contact with other hot metals

404

1.72

3.84

2.9

2.6

0.20

0.21

g/l

0.90

377

Dependent personality disorder

561

1.60

3.84

2.2

0.23

0.22

g/l

0.48

532

Routine general health check-up of defined subpopulation

456

1.65

3.83

2.1

1.8

0.22

0.23

g/l

0.29

430

Enteropathogenic Escherichia coli infection

2.86

3.83

3.3

2.8

0.20

0.22

g/l

0.66

Complications of labour and delivery

2213

13418

0.91

3.81

2.2

0.22

g/l

0.80

2085

12587

Thyrotoxicosis with diffuse goitre

512

4315

1.20

3.80

2.2

0.22

g/l

0.13

475

4051

Corneal scars and opacities

109

750

1.51

3.78

2.6

2.3

0.21

g/l

0.11

103

708

Tuberculosis, wide

288

2292

1.28

3.78

2.4

2.0

0.20

g/l

0.31

266

2102

Pleural plaque

363

2966

1.25

3.78

2.2

2.1

0.19

0.20

g/l

1.13

320

2717

Mild or no visual impairment, binocular

111

2.47

3.77

1.9

2.2

0.21

0.22

g/l

0.31

106

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1386

9060

0.89

3.75

2.2

0.23

g/l

0.86

1311

8521

Atypical facial pain

191

1445

1.36

3.73

2.0

2.1

0.23

0.22

g/l

1.97

176

1355

Phantom limb syndrome

3.07

3.73

2.5

2.8

0.23

g/l

0.04

Other congenital malformations of nervous system

220

1.97

3.72

2.1

3.0

0.22

0.23

g/l

0.58

214

Inguinal or femoral hernia, bilateral

407

3369

1.23

3.72

2.4

2.3

0.21

0.20

g/l

0.48

373

3138

Non-small cell lung cancer

597

5109

1.19

3.72

2.0

2.1

0.20

g/l

0.91

553

4695

Mild mental retardation

103

703

1.52

3.71

2.9

3.1

0.23

0.22

g/l

0.27

665

Chronic iridocyclitis

194

1475

1.35

3.67

2.5

2.3

0.21

0.22

g/l

0.53

186

1378

Primary coxarthrosis, bilateral

1168

10469

1.13

3.66

2.0

2.1

0.21

0.20

g/l

0.18

1089

9659

Residual foreign body in soft tissue

182

1370

1.36

3.66

2.2

0.22

g/l

0.20

173

1283

Thyroiditis

263

2082

1.29

3.64

2.1

2.3

0.22

g/l

0.38

254

1958

Single delivery by caesarean section

492

3382

0.83

3.63

2.4

0.23

g/l

0.76

462

3175

Testicular dysfunction

133

956

1.43

3.62

2.5

0.23

0.22

g/l

0.39

127

886

Carcinoma in situ of breast, other/unspecified

281

1.83

3.60

2.0

1.8

0.23

0.20

g/l

1.52

264

Pedestrian injured in collision with car, pick-up truck or van

642

1.53

3.59

2.0

2.2

0.23

0.22

g/l

1.07

602

Henoch-Schönlein purpura nephritis (HSPN)

2.70

3.59

2.1

2.9

0.19

0.23

g/l

1.32

Other/unspecified synovitis and tenosynovitis

443

3708

1.21

3.58

2.4

2.2

0.21

g/l

0.33

417

3462

Pedal cyclist injured in other and unspecified transport accidents

409

3399

1.22

3.58

2.3

2.4

0.21

0.22

g/l

0.36

367

3177

Helminthiases

475

1.63

3.57

3.2

2.3

0.19

0.22

g/l

2.86

448

Coxarthrosis, primary, with hip surgery

1994

17402

1.09

3.57

2.1

0.21

g/l

0.07

1852

16049

Hyperprolactinaemia

115

806

1.47

3.56

2.1

2.2

0.22

g/l

0.11

103

760

Parkinson's disease, strict definition, excluding more controls

445

3654

1.21

3.56

2.0

2.2

0.20

g/l

0.32

404

3405

Diabetic retinopathy, strict definition

812

6270

1.16

3.56

2.4

0.19

0.21

g/l

13.86

729

5789

Other neurotic disorders

192

1465

1.34

3.55

2.5

2.1

0.22

0.21

g/l

0.29

176

1368

Inguinal hernia, bilateral

398

3304

1.23

3.55

2.4

2.3

0.21

0.20

g/l

0.34

366

3077

False labour

774

5569

0.87

3.54

2.1

2.3

0.23

g/l

1.15

731

5255

Demyelinating diseases of the central nervous system

295

2373

1.26

3.53

2.5

2.3

0.22

g/l

0.29

280

2236

Other specified and unspecified retinal disorders

136

987

1.42

3.53

2.8

2.2

0.21

g/l

0.17

128

921

Viral agents as the cause of diseases classified to other chapters

606

1.55

3.51

3.4

2.6

0.22

g/l

0.01

574

Eustachian salpingitis and obstruction

252

1992

1.29

3.49

2.9

2.4

0.23

g/l

0.61

242

1866

Dronedarone medication

118

840

1.46

3.45

2.5

2.2

0.21

g/l

0.15

105

794

Macular pucker

577

4964

1.18

3.45

2.4

2.1

0.20

g/l

0.56

526

4610

Cholera

170

1283

1.36

3.44

2.4

2.1

0.22

0.21

g/l

0.46

165

1209

Benign neoplasm: Brain, supratentorial

307

1.76

3.44

3.4

2.4

0.23

0.22

g/l

0.57

284

Benign neoplasm: Skin of trunk

162

1214

1.37

3.43

2.6

2.3

0.21

g/l

0.07

148

1139

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

494

1.59

3.43

2.1

1.9

0.22

0.21

g/l

0.41

454

Allergic contact dermatitis

485

4109

1.20

3.42

2.4

2.2

0.22

g/l

1.18

450

3866

Disorder of external ear, unspecified

121

866

1.44

3.41

2.7

2.2

0.21

0.22

g/l

0.04

111

809

Pregnancy hypertension

1485

12174

1.11

3.41

2.2

0.22

g/l

0.09

1406

11449

Cluster headache, strict, including avohilmo

170

1282

1.36

3.41

2.3

0.22

g/l

0.03

160

1206

Ankylosing spondylitis, strict definition

157

1170

1.38

3.41

2.5

2.3

0.23

g/l

0.58

147

1104

Alzheimer’s disease (Early onset), excluding more controls

934

0.62

3.40

1.8

2.0

0.19

0.20

g/l

0.60

860

Malignant neoplasm of thyroid gland

257

2050

1.28

3.39

1.9

2.2

0.23

0.22

g/l

2.49

249

1918

Other specified/unspecified dorsopathies

136

993

1.41

3.38

2.6

2.1

0.22

0.21

g/l

0.49

119

933

Immunodeficiency associated with other specified major defects, or unspecified

6.80

3.38

4.3

3.3

0.19

0.24

g/l

—

Optic neuritis

145

1070

1.39

3.36

2.5

2.3

0.22

g/l

0.03

139

1014

Poisoning by medicine, drug-induced

357

1.71

3.35

1.8

2.4

0.20

0.23

g/l

1.50

334

Calculus of lower urinary tract

203

1576

1.32

3.35

2.2

0.20

g/l

0.47

178

1457

Disorders of puberty

348

1.70

3.34

3.7

0.23

g/l

0.15

332

Guillain-Barre syndrome

436

1.63

3.34

1.7

2.2

0.21

g/l

0.03

412

Burns and corrosions confined to eye and internal organs

102

711

1.48

3.32

2.4

0.23

0.22

g/l

0.03

663

Other demyelinating diseases of the central nervous system

126

911

1.42

3.31

2.3

0.23

g/l

0.01

120

858

Benign neoplasm of bone and articular cartilage

303

2466

1.25

3.31

2.5

2.3

0.23

0.22

g/l

1.18

287

2308

Other disorders of iris and ciliary body

101

704

1.49

3.31

2.1

2.3

0.20

0.21

g/l

1.06

653

Benign neoplasm: Penis

3.52

3.27

2.1

2.5

0.22

0.23

g/l

0.20

Dental pulpitis 3, only avohilmo

356

2139

1.23

3.27

2.6

3.6

0.23

g/l

0.57

327

1995

Generalized epilepsy, strict definition

598

1.52

3.26

2.3

2.9

0.24

0.22

g/l

1.15

568

Vascular dementia (subcortical)

103

722

1.47

3.26

1.6

1.9

0.19

g/l

0.08

661

Other specified/unspecified disorders of bone/cartilage

105

739

1.47

3.26

2.1

2.3

0.21

0.22

g/l

0.66

706

Multiple delivery

206

2622

0.77

3.24

2.0

2.3

0.23

0.22

g/l

0.34

195

2454

Contact with other hot fluids

114

815

1.44

3.24

3.0

2.6

0.22

g/l

0.01

105

765

Follicular lymphoma, hilmo

174

1332

1.35

3.24

1.8

2.2

0.20

0.21

g/l

1.29

162

1234

Personality and behavioural disorders due to brain disease, damage and dysfunction

415

1.64

3.24

2.1

2.5

0.21

g/l

0.03

386

Exposure to controlled fire, not in building or structure

2.78

3.23

2.5

2.8

0.23

0.22

g/l

0.20

Epidural haemorrhage

224

1.88

3.22

2.5

3.0

0.20

0.22

g/l

1.08

210

Anomalies of dental arch relationship, including avohilmo

700

5499

1.15

3.22

3.0

2.6

0.23

0.22

g/l

1.00

658

5167

Parkinson's disease, excluding more controls

479

3973

1.19

3.22

2.0

2.2

0.20

g/l

0.31

437

3700

Unspecified chronic bronchitis

134

984

1.40

3.22

2.8

2.1

0.20

0.21

g/l

0.22

119

907

Carcinoma in situ of skin

305

2498

1.25

3.21

2.3

2.0

0.21

0.20

g/l

0.95

282

2311

Benign neoplasm: Connective and other soft tissue of thorax

2.62

3.18

2.9

1.9

0.22

0.21

g/l

0.17

Other and unspecified visual disturbances

356

2960

1.22

3.18

2.4

2.2

0.22

0.21

g/l

0.67

329

2777

Other and unspecified nerve root and plexus disorders, also in other diseases

703

6169

1.15

3.16

2.1

2.3

0.23

0.22

g/l

2.68

635

5752

Tonsillectomy and adenotomy

2212

14288

1.08

3.15

2.4

2.5

0.23

0.22

g/l

2.24

2085

13427

Phantom limb syndrome with pain

2.95

3.15

1.9

1.8

0.22

g/l

0.01

Idiopathic peripheral autonomic neuropathy

2.52

3.14

2.4

0.20

g/l

0.05

Pregnancy with abortive outcome

2768

13520

1.08

3.13

2.1

0.22

g/l

0.06

2602

12596

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

101

711

1.46

3.13

2.2

2.4

0.23

0.22

g/l

0.21

673

302

1.74

3.12

2.2

2.5

0.20

0.22

g/l

0.41

277

Cluster headache, wide,, including avohilmo

179

1379

1.33

3.12

2.3

0.23

0.22

g/l

0.15

169

1296

Other and unspecified vascular occlusions

352

2930

1.22

3.12

2.3

2.1

0.20

g/l

0.03

321

2698

Myocardial infarction, with ST-elevation

671

5877

1.16

3.12

2.2

0.20

g/l

0.27

616

5393

Benign neoplasm of middle ear and respiratory system

299

2450

1.24

3.11

2.7

2.2

0.21

g/l

0.15

283

2285

Flat foot [pes planus] (acquired)

356

2966

1.22

3.11

2.3

2.2

0.22

g/l

0.68

328

2789

Other protozoal intestinal diseases

349

1.68

3.09

3.1

2.4

0.23

0.22

g/l

0.34

331

Urethral stricture

211

1664

1.30

3.09

2.1

2.3

0.21

0.20

g/l

0.86

184

1543

Endometriosis of pelvic peritoneum

547

4658

1.17

3.08

2.3

2.2

0.23

0.22

g/l

3.09

524

4370

Sacrococcygeal disorders, not elsewhere classified

112

806

1.43

3.07

2.0

2.2

0.22

g/l

0.13

105

772

Burn and corrosion of shoulder and upper limb, except wrist and hand

558

1.52

3.07

2.6

2.5

0.21

0.22

g/l

0.69

521

Gluteal tendinitis

140

1046

1.38

3.06

2.2

2.1

0.23

0.21

g/l

3.30

132

990

Pedal cyclist injured in transport accident

821

7292

1.14

3.05

2.3

2.4

0.21

0.22

g/l

0.36

749

6806

Benign neoplasm: Skin of lip

265

1.77

3.05

2.1

1.8

0.21

g/l

0.19

239

Other and unspecified injuries of wrist and hand

132

977

1.39

3.05

2.4

2.5

0.22

g/l

0.20

121

916

Horner syndrome

329

1.70

3.01

2.8

2.5

0.23

0.22

g/l

0.93

308

Carcinoma in situ of skin of upper limb, including shoulder

645

1.49

3.01

2.3

2.0

0.23

0.20

g/l

3.83

597

Benign neoplasm: Lower jaw bone

103

2.33

2.99

2.3

2.7

0.24

0.22

g/l

0.82

Hallux rigidus

561

4872

1.17

2.98

2.1

2.2

0.22

0.21

g/l

1.21

514

4577

Abscess of spleen

6.56

2.98

2.9

2.6

0.26

0.20

g/l

—

Adenomyosis (Endometriosis of uterus)

513

4425

1.17

2.98

2.1

0.22

0.21

g/l

0.49

484

4111

Vascular dementia (mixed)

329

1.68

2.97

1.3

2.0

0.21

0.19

g/l

1.37

299

Bitten or struck by other mammals

375

3152

1.21

2.97

2.3

0.22

g/l

0.46

341

2966

Conduct disorder

463

1.55

2.95

2.4

2.8

0.22

0.23

g/l

0.42

434

Dislocation, sprain and strain of joints and ligaments of thorax

114

830

1.41

2.94

2.2

2.3

0.22

g/l

0.10

784

Radial styloid tenosynovitis [de Quervain]

196

1541

1.30

2.94

2.3

2.2

0.22

g/l

0.44

183

1461

Other and unspecified injuries of abdomen, lower back and pelvis

330

1.67

2.93

2.2

2.4

0.21

0.22

g/l

0.69

311

Other specified disorders of muscle

106

763

1.43

2.93

2.1

2.2

0.21

g/l

0.20

713

Other disorders originating in the perinatal period

349

1.68

2.93

3.4

5.0

0.21

0.20

g/l

0.37

336

Spinal instabilities

113

823

1.42

2.93

3.2

2.3

0.23

0.22

g/l

1.44

105

779

Ill-defined and unknown causes of mortality

243

1962

1.26

2.92

2.3

2.1

0.17

0.20

g/l

4.97

214

1808

Disorders of puberty, all

425

1.58

2.92

3.9

0.23

0.22

g/l

0.62

406

Embedded teeth, including avohilmo

269

2190

1.24

2.92

3.2

2.6

0.22

0.23

g/l

0.79

253

2039

Superficial injury of neck

450

1.56

2.89

2.3

2.6

0.22

0.23

g/l

0.45

420

Postpartum hemorraghe, all women as controls

589

6713

0.87

2.89

2.1

2.2

0.23

g/l

0.38

563

6337

Retinal detachment with retinal break

489

4216

1.18

2.89

2.4

2.2

0.21

g/l

0.32

447

3913

Hypermetropia

258

2099

1.25

2.88

2.7

2.8

0.21

0.22

g/l

0.12

243

1962

Chronic mastoiditis

106

767

1.43

2.88

1.9

2.2

0.21

0.20

g/l

0.04

706

Frostbite

271

1.75

2.87

3.1

2.3

0.21

0.22

g/l

0.46

249

Congenital malformations of genital organs

308

2535

1.22

2.86

2.6

2.7

0.23

0.22

g/l

0.32

294

2402

Use of biperiden

196

1549

1.29

2.85

2.0

2.2

0.22

g/l

0.14

173

1456

Family history of certain disabilities and chronic diseases leading to disablement

136

1021

1.36

2.85

2.2

0.23

g/l

0.01

129

959

Aneurysms, operations, SAH

626

5498

1.15

2.84

2.1

2.2

0.21

g/l

0.13

581

5113

Burn and corrosion of head and neck

576

1.49

2.83

2.5

2.6

0.21

0.22

g/l

0.19

539

Schizoid personality disorder

470

1.55

2.82

2.4

0.22

0.23

g/l

0.12

438

Causalgia

430

1.57

2.81

2.4

2.2

0.20

0.23

g/l

1.97

407

conjunctival haemorrhage

280

2308

1.24

2.81

2.6

2.2

0.21

g/l

0.41

258

2142

Problems related to social environment

701

1.44

2.80

2.6

2.2

0.21

g/l

0.10

652

Lichen sclerosus et atrophicus

364

3073

1.20

2.80

2.2

2.1

0.21

g/l

0.02

332

2871

Adenocarcinomas of cervix

106

2.26

2.80

3.1

2.4

0.24

0.21

g/l

1.42

100

Benign neoplasm: Cranial nerves

593

1.47

2.79

2.2

2.0

0.22

0.20

g/l

1.25

539

Abscess of Bartholin gland

610

1.47

2.78

2.6

2.1

0.22

g/l

0.08

573

Malignant neoplasm of respiratory system and intrathoracic organs

802

6587

1.13

2.77

2.1

0.20

g/l

0.32

753

6013

Postprocedural disorders of nervous system

228

1839

1.26

2.75

2.3

0.23

g/l

0.85

216

1734

Other disorders of binocular movement

529

1.50

2.75

2.0

2.7

0.22

g/l

0.07

502

Malignant neoplasm of lip

184

1.90

2.75

1.7

2.1

0.20

g/l

0.14

166

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

124

923

1.37

2.74

1.7

1.9

0.20

0.18

g/l

1.15

116

810

Mental and behavioural disorders associated with the puerperium

213

1.81

2.73

1.9

2.3

0.24

0.23

g/l

0.48

207

Benign neoplasm of urinary organs

178

1400

1.30

2.73

2.1

2.2

0.21

g/l

0.69

162

1308

Acute appendicitis, no complications

2289

21363

1.07

2.73

2.3

0.23

0.22

g/l

3.52

2143

19959

Other specified/unspecified deforming dorsopathies

465

1.53

2.73

2.1

0.21

0.22

g/l

0.94

445

Biomechanical lesions, not elsewhere classified

179

1409

1.30

2.73

2.4

2.1

0.23

0.21

g/l

1.97

165

1319

Other deformities of toe(s)

134

1015

1.36

2.72

2.3

2.1

0.21

g/l

0.03

123

963

Carcinoma in situ of cervix uteri

258

2111

1.24

2.71

2.1

0.23

0.22

g/l

0.45

237

1988

Dyshidrosis [pompholyx]

369

1.60

2.71

2.3

0.22

g/l

0.18

351

Motorcycle rider injured in other and unspecified transport accidents

195

1549

1.28

2.71

2.2

2.5

0.23

g/l

0.07

187

1447

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1676

13565

1.09

2.70

2.1

2.2

0.22

g/l

0.26

1588

12733

Dementia, including avohilmo

1772

11327

1.09

2.70

1.7

2.1

0.20

g/l

1.00

1545

10457

Outcome of delivery

414

3004

0.85

2.69

2.0

2.2

0.24

0.23

g/l

3.13

395

2816

Unspecified visual impairment (binocular)

387

1.59

2.68

2.2

2.5

0.21

g/l

0.24

367

Adult-onset Still disease

2.39

2.66

2.4

2.3

0.20

0.23

g/l

0.42

Benign neoplasm: Extrahepatic bile ducts

2.97

2.65

2.5

1.8

0.27

0.20

g/l

2.58

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

102

2.26

2.65

2.0

2.3

0.17

0.20

g/l

0.94

Chondrocostal junction syndrome [Tietze]

134

1019

1.35

2.65

2.4

2.1

0.23

0.22

g/l

0.89

119

954

Alzheimer’s disease (Late onset), excluding more controls

536

3110

1.16

2.65

1.6

2.0

0.20

g/l

0.05

446

2882

Overjet

716

1.42

2.64

4.2

4.5

0.22

g/l

0.01

690

Other congenital malformations of circulatory system

703

1.43

2.64

2.6

2.5

0.22

g/l

0.03

663

Epiphora

594

1.46

2.63

1.9

2.1

0.19

0.21

g/l

1.30

557

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

2.31

2.63

1.6

2.2

0.19

0.21

g/l

0.92

Acute appendicitis, with complications

769

6876

1.13

2.63

2.3

0.21

g/l

0.44

707

6401

Scissor bite

108

794

1.40

2.62

4.2

4.4

0.23

0.22

g/l

0.49

101

760

Mouth breathing

1697

15735

1.08

2.62

2.2

2.5

0.22

g/l

2.20

1561

14722

Etanercept

219

1773

1.26

2.61

3.0

2.4

0.22

g/l

0.16

199

1665

Retinal haemorrhage

654

1.44

2.61

2.5

2.1

0.21

0.20

g/l

0.27

608

Burns and corrosions of multiple body regions

241

1.75

2.59

2.1

2.6

0.21

0.22

g/l

0.50

221

Acné excoriée

4.98

2.59

1.4

2.1

0.25

0.22

g/l

—

Injury of nerves at hip and thigh level

103

2.23

2.58

2.0

2.5

0.23

0.22

g/l

0.39

Acute nasopharyngitis (common cold)

427

3654

1.17

2.58

2.6

2.4

0.22

g/l

0.75

396

3425

Other congenital malformations of upper alimentary tract

212

1.82

2.57

2.6

2.5

0.21

g/l

0.05

200

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

280

1.68

2.56

1.9

2.2

0.21

0.23

g/l

0.76

262

Unstable angina pectoris

1620

12443

1.09

2.56

1.9

2.2

0.21

0.20

g/l

0.39

1495

11457

Secondary parkinsonism+Parkinsonism in other disease

107

793

1.39

2.55

1.7

2.3

0.21

g/l

0.34

101

733

Pterygium

871

0.66

2.54

2.1

2.3

0.20

0.21

g/l

0.07

815

Behavioural disorders

480

1.50

2.54

2.4

2.9

0.22

0.23

g/l

0.44

448

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

174

1.87

2.54

2.8

2.0

0.21

g/l

0.11

154

Disorders of visual cortex

7.97

2.53

1.2

1.6

0.23

0.22

g/l

—

Lordosis

2.58

2.53

2.7

2.1

0.24

0.22

g/l

0.32

Dementia due to Parkinsons disease, excluding more controls

506

1.49

2.53

1.6

2.1

0.19

g/l

0.01

469

Chronic diseases of tonsils and adenoids

3603

21651

1.06

2.53

2.4

0.23

0.22

g/l

13.39

3399

20237

Benign neoplasm: Skin of ear and external auricular canal

142

1097

1.33

2.52

1.9

2.2

0.20

0.21

g/l

0.27

134

1017

Other/unspecified soft tissue disorders related to use, overuse and pressure

102

750

1.40

2.52

2.2

0.22

g/l

0.34

710

Paralytic strabismus

259

2144

1.23

2.52

2.3

2.2

0.21

g/l

0.07

235

1995

Dementia

1636

10469

1.09

2.51

1.7

2.1

0.20

g/l

0.39

1424

9658

Foreign body entering into or through eye or natural orifice

291

2435

1.21

2.51

2.2

2.4

0.22

g/l

0.46

270

2277

Amoebiasis

139

2.00

2.50

2.5

2.4

0.22

g/l

0.10

130

Benign neoplasm: Endocrine gland, other/unspecified

2.29

2.49

1.8

2.1

0.20

0.21

g/l

0.36

Abnormal findings in cerebrospinal fluid

2.48

2.49

2.8

2.5

0.21

0.22

g/l

0.10

Mixed conductive and sensorineural hearing loss

469

4084

1.16

2.48

2.2

0.21

g/l

0.10

430

3787

Other menopausal disorders

927

5907

0.90

2.48

1.9

2.1

0.23

0.22

g/l

10.97

868

5511

Brain meningioma, excluding all cancers (controls excluding all cancers)

145

1124

1.31

2.48

2.1

0.23

0.21

g/l

2.37

132

1018

Other spirochaetal diseases

996

9063

1.11

2.48

2.5

2.3

0.22

0.21

g/l

6.28

921

8449

Spinal enthesopathy

715

1.39

2.48

2.3

1.8

0.19

g/l

0.29

642

Coronary artery bypass grafting

1167

8131

1.10

2.47

2.0

2.3

0.19

0.20

g/l

5.44

1069

7498

Crossbite

255

1955

1.23

2.46

4.6

3.4

0.22

g/l

0.09

237

1854

Disorder of the sleep-wake schedule

460

1.51

2.46

2.8

0.23

0.22

g/l

0.16

430

Burn and corrosion of other internal organs

2.38

2.45

4.4

2.3

0.21

0.23

g/l

0.40

Contusion of ankle

130

996

1.33

2.44

2.4

0.23

0.22

g/l

1.23

121

946

Stenosis and insufficiency of lacrimal passages

352

3004

1.19

2.44

2.2

0.21

g/l

0.11

316

2796

Exposure to other and unspecified animate mechanical forces

712

1.40

2.44

2.2

2.6

0.23

g/l

0.06

668

Disorders of optic chiasm

4.77

2.43

2.7

2.9

0.26

0.21

g/l

—

Benign neoplasm: Penis

2.89

2.42

2.1

0.22

0.23

g/l

0.11

Other/unspecified disorders of vestibular function

142

1105

1.32

2.42

2.0

2.1

0.22

0.21

g/l

1.00

134

1022

Benign lipomatous neoplasm of other sites/unspecified

333

2832

1.19

2.41

2.0

2.1

0.22

0.21

g/l

1.56

309

2634

Alzheimer’s disease, wide definition

678

6348

0.89

2.41

1.6

1.9

0.19

g/l

0.17

572

5757

Pedestrian injured in transport accident

245

2026

1.23

2.41

1.9

2.2

0.22

g/l

0.41

226

1886

Aphakia

347

1.57

2.41

1.9

2.1

0.21

g/l

0.10

325

Blepharochalasis

1177

10813

1.10

2.40

2.0

2.2

0.22

0.21

g/l

3.79

1091

10080

Enterobiasis

2.22

2.39

2.3

3.1

0.20

0.23

g/l

1.01

Gestational diabetes (for exclusion)

1110

7174

1.10

2.38

2.1

2.2

0.23

g/l

0.59

1046

6781

Iridocyclitis in diseases classified elsewhere

497

1.48

2.38

2.1

2.4

0.21

0.22

g/l

0.16

464

Other specified disorders of external ear

141

1100

1.32

2.37

2.3

0.20

0.21

g/l

0.39

129

1023

Other secondary gout

2.48

2.37

2.0

1.9

0.21

g/l

0.11

Secondary parkinsonism

103

769

1.38

2.37

1.7

2.2

0.21

g/l

0.46

710

Flatback syndrome

4.69

2.35

1.9

1.8

0.20

0.22

g/l

—

Tuberculosis of other organs

600

1.43

2.33

2.9

2.1

0.19

0.20

g/l

0.96

557

Severe visual impairment, binocular

114

2.06

2.33

2.5

0.21

g/l

0.01

106

Monocytic leukaemia

2.28

2.32

1.3

2.6

0.21

0.20

g/l

0.03

Female infertility

1066

6006

1.10

2.32

2.4

2.2

0.23

0.22

g/l

2.15

1010

5619

Calcification and ossification of muscle

2.65

2.32

1.5

2.0

0.21

0.23

g/l

0.43

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

129

2.01

2.32

1.8

2.6

0.20

0.21

g/l

0.28

119

Lumbosacral plexus disorders

2.26

2.31

2.1

2.2

0.20

0.22

g/l

0.73

Any dementia

1438

9382

1.09

2.31

1.7

2.0

0.20

g/l

0.22

1228

8626

Anomalies of pupillary function

500

1.46

2.29

2.2

2.5

0.21

0.22

g/l

0.62

476

Lyme disease

980

8950

1.10

2.29

2.5

2.3

0.22

0.21

g/l

6.28

905

8344

Blindness, monocular

211

1.74

2.28

1.8

2.0

0.23

0.22

g/l

0.38

202

Contracture of joint

297

1.61

2.27

2.3

2.2

0.22

0.21

g/l

0.15

280

Transient retinal artery occlusion

2.64

2.26

1.9

2.1

0.21

0.20

g/l

0.20

Degenerative macular diseases

454

3975

1.16

2.26

2.3

2.1

0.21

0.20

g/l

0.52

413

3671

Degenerative diseases of the nervous system

1240

8606

1.09

2.24

1.8

2.0

0.19

0.20

g/l

1.29

1057

7882

Acute inflammation of orbit

152

1.87

2.23

2.7

2.4

0.21

0.22

g/l

0.45

143

Peroneal tendinitis

404

1.51

2.23

2.8

2.1

0.25

0.22

g/l

3.17

385

Cerebral atherosclerosis

290

1.61

2.21

1.8

2.1

0.21

0.20

g/l

0.37

261

Thyrotoxicosis with toxic multinodular goitre

224

1857

1.23

2.21

2.1

0.21

g/l

0.22

209

1734

Alzheimer’s disease (undefined)

199

0.39

2.21

1.5

1.8

0.18

g/l

—

172

Ulcer of vagina/vulva

606

1.41

2.20

2.1

0.23

0.22

g/l

1.39

568

Macular hole

213

1760

1.24

2.20

2.1

0.21

0.20

g/l

0.43

190

1634

Multiple myeloma and malignant plasma cell neoplasms

176

1426

1.26

2.18

2.4

2.2

0.19

0.20

g/l

1.07

165

1320

Hereditary nephropathy, not elsewhere classified

2.33

2.17

3.4

2.6

0.20

0.21

g/l

0.20

Inflammatory diseases of prostate (prostatitis)

480

4231

1.15

2.17

2.3

2.4

0.22

0.21

g/l

2.69

442

3916

Melanocytic naevi of lip

153

1.84

2.16

1.3

2.1

0.23

0.21

g/l

0.54

138

Brain glioblastoma

365

0.53

2.13

1.8

2.3

0.29

0.21

g/l

2.76

343

Disorders of orbit

155

1240

1.28

2.13

2.4

2.2

0.21

0.22

g/l

0.17

142

1165

Alport

3.22

2.13

2.4

4.2

0.31

0.22

g/l

—

Unknown and unspecified causes of morbidity

227

1887

1.22

2.13

2.4

2.1

0.21

0.22

g/l

1.24

213

1780

Malignant neoplasm of bone and articular cartilage of limbs

2.11

2.12

3.4

2.6

0.19

0.22

g/l

1.25

Other and unspecified injuries of forearm

162

1.81

2.12

2.7

2.8

0.19

0.23

g/l

1.75

154

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2237

17224

1.06

2.10

2.2

0.22

g/l

4.02

2098

16101

Mental and behavioural disorders of puerperium, not classified elsewhere

231

1.66

2.10

1.9

2.3

0.24

0.23

g/l

0.46

225

Preparation and fitting of bite rail to mouth

475

4192

1.14

2.10

2.7

2.3

0.23

0.22

g/l

1.34

440

3948

Excessive vomiting in pregnancy

244

2046

1.21

2.09

2.0

2.3

0.22

g/l

0.26

223

1946

Eclampsia

2.83

2.08

1.7

2.3

0.23

0.24

g/l

—

Open bite

162

1305

1.26

2.08

3.5

3.2

0.22

g/l

0.14

151

1236

Glaucoma

2377

19749

1.06

2.06

2.0

2.2

0.21

g/l

0.28

2166

18250

Diabetes mellitus in pregnancy

973

5771

1.10

2.06

2.1

2.3

0.23

g/l

0.92

915

5445

Tuberculosis of other organs, strict

683

1.37

2.05

2.9

2.1

0.19

0.20

g/l

0.79

629

Synovial cyst of popliteal space [Baker]

268

2274

1.20

2.05

1.9

2.1

0.21

g/l

0.19

247

2121

Chalazion

406

3555

1.15

2.04

2.2

2.3

0.22

0.21

g/l

1.83

372

3325

Benign neoplasm: Spinal meninges

266

1.61

2.04

2.0

0.20

0.21

g/l

0.30

250

Covid-19 suspected case

711

6433

1.11

2.03

2.5

2.4

0.22

g/l

0.67

649

6011

Contusion of toe(s) with damage to nail

274

1.59

2.02

1.9

2.6

0.22

0.23

g/l

0.36

252

Normal-pressure hydrocephalus

117

1490

0.77

2.02

1.7

2.0

0.20

g/l

0.18

101

1375

Disorders of eyelid in diseases classified elsewhere

114

885

1.32

2.02

2.0

2.2

0.21

g/l

0.00

108

830

Premature rupture of membranes

522

4314

0.88

2.01

2.1

2.3

0.23

g/l

0.27

497

4069

Effects of other external causes

693

1.36

2.01

1.9

2.5

0.24

0.23

g/l

0.59

652

Other degenerative diseases of the basal ganglia

466

1.45

2.00

2.1

2.0

0.20

0.21

g/l

0.11

434

Alzheimer’s disease (Atypical or mixed)

288

2456

1.18

2.00

1.5

1.9

0.19

g/l

0.66

246

2216

Other dermatomyositis

136

1.89

1.99

3.0

2.3

0.20

0.22

g/l

0.70

126

Alzheimer’s disease, wide definition, excluding more controls

565

3429

1.13

1.98

1.6

2.1

0.20

g/l

0.71

471

3183

Contact with other sharp object(s)

207

1721

1.22

1.98

2.0

2.4

0.23

g/l

0.60

193

1610

Postpartum hemorraghe, parous women as controls

589

5746

0.89

1.97

2.1

0.23

g/l

0.27

563

5458

Tuberculosis

224

1878

1.21

1.97

2.2

2.0

0.20

g/l

0.10

210

1724

Other and unspecified disease of Bartholin gland

108

837

1.32

1.97

2.1

0.22

0.21

g/l

0.46

102

795

Melanocytic naevi, other sites/unspecified

269

2292

1.19

1.97

2.5

2.2

0.23

0.22

g/l

1.10

257

2150

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

129

1.90

1.97

3.3

2.2

0.22

0.21

g/l

0.12

120

Deep bite

406

3116

1.15

1.96

3.5

3.0

0.23

0.22

g/l

0.96

390

2933

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

284

1.57

1.96

2.0

2.2

0.22

0.23

g/l

0.03

272

Pedal cyclist injured in noncollision transport accidents

388

3399

1.15

1.95

2.5

2.4

0.21

0.22

g/l

0.86

359

3188

Other and unspecified degenerative diseases of nervous system

629

1.37

1.95

2.1

2.2

0.19

0.20

g/l

0.20

583

Diphtheria

3.16

1.95

3.4

2.4

0.23

g/l

—

Abscess of external ear

325

1.52

1.94

2.2

2.4

0.22

g/l

0.17

305

Benign mammary dysplasia

529

4733

1.13

1.92

1.9

2.1

0.22

0.21

g/l

3.66

499

4410

Respiratory tuberculosis, confirmed and not-confirmed

196

1628

1.22

1.92

2.2

2.1

0.20

g/l

0.00

184

1500

Respiratory tuberculosis

196

1628

1.22

1.92

2.2

2.1

0.20

g/l

0.00

184

1500

Pseudosarcomatous fibromatosis

4.81

1.91

1.2

2.1

0.26

0.23

g/l

—

Respiratory and cardiovascular disorders specific to the perinatal period

113

790

1.31

1.91

4.4

5.1

0.20

0.21

g/l

0.65

106

763

Gestational [pregnancy-induced] hypertension

809

7375

1.10

1.90

2.1

2.2

0.23

0.22

g/l

0.51

763

6947

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

109

1.97

1.89

1.4

2.3

0.25

0.23

g/l

0.31

Motorcycle rider injured in noncollision transport accidents

762

1.33

1.88

2.7

2.6

0.22

0.23

g/l

0.66

707

Plantar fascial fibromatosis

354

3093

1.16

1.87

2.2

0.23

0.22

g/l

2.25

330

2903

Other acquired deformities of musculoskeletal system and connective tissue

167

1371

1.24

1.86

2.0

2.3

0.21

0.22

g/l

0.70

156

1290

Ankle and foot

208

1.66

1.86

4.7

2.3

0.21

0.22

g/l

0.66

194

Other inflammation of vagina/vulva

102

789

1.31

1.86

2.2

0.23

0.22

g/l

0.85

751

Benign neoplasm: Skin of lower limb, including hip

100

774

1.32

1.85

2.4

2.3

0.23

0.22

g/l

1.22

731

Alzheimer’s disease (undefined), excluding more controls

178

0.43

1.85

1.5

1.9

0.18

g/l

—

160

Meralgia paraesthetica

121

960

1.29

1.85

2.3

2.2

0.23

0.22

g/l

1.14

111

896

Type 1 diabetes, definitions combined

312

2694

1.17

1.85

2.8

2.9

0.19

0.23

g/l

16.52

282

2545

LSIL lesion of the cervix uteri, vagina or vulva

424

3750

1.14

1.84

2.6

2.2

0.23

0.22

g/l

0.33

405

3547

Other bursitis of elbow

217

1.65

1.84

2.2

2.4

0.21

g/l

0.17

204

Benign neoplasm: Central nervous system, other parts/unspecified

2.22

1.84

1.9

0.22

0.21

g/l

0.16

Benign neoplasm of meninges

368

3232

1.15

1.83

2.1

0.21

g/l

0.71

331

3015

Triptan medication for migraine, min. 3 purchases

2088

15591

1.06

1.83

2.3

0.23

0.22

g/l

3.72

1968

14635

Bicuspidal aortic valve syndrome

129

1033

1.28

1.82

2.7

2.6

0.21

0.22

g/l

0.96

124

969

Early lumbar disc prolapse, operated

292

2518

1.17

1.82

2.3

2.4

0.24

0.23

g/l

2.18

279

2384

Syndrome of inappropriate secretion of antidiuretic hormone

110

1.92

1.82

1.6

2.5

0.18

0.20

g/l

0.57

103

662

1.34

1.81

2.1

2.3

0.20

0.23

g/l

1.93

625

Carcinoma in situ of bronchus and lung

3.69

1.81

3.2

2.5

0.19

0.17

g/l

—

Felty syndrome

148

1.79

1.81

3.0

2.2

0.21

g/l

0.03

135

Other disorders of conjunctiva

516

4631

1.13

1.80

2.7

2.2

0.21

g/l

0.79

473

4309

Benign neoplasm: Kidney

124

991

1.28

1.80

1.8

2.2

0.21

g/l

0.40

114

936

Convergence insufficiency and excess

282

1.53

1.78

2.2

2.7

0.23

g/l

0.03

268

Dermatitis herpetiformis

510

1.39

1.77

2.4

2.2

0.21

g/l

0.41

475

Early syphilis

308

1.51

1.77

2.0

2.5

0.22

g/l

0.22

285

Injury of nerves at wrist and hand level

130

1046

1.27

1.76

2.2

2.4

0.23

0.22

g/l

0.50

125

989

Non-small cell lung cancer, adenocarcinoma, helper endpoint

227

1931

1.19

1.75

2.1

0.20

g/l

0.31

206

1787

Non-small cell lung cancer, adenocarcinoma

227

1931

1.19

1.75

2.1

0.20

g/l

0.31

206

1787

Trichomoniasis

228

1.61

1.75

3.1

1.9

0.20

0.21

g/l

0.81

215

Impingement syndrome of shoulder

997

9237

1.09

1.75

2.5

2.3

0.22

0.21

g/l

2.52

937

8630

Drug-induced headache, not elsewhere classified

104

1.92

1.74

2.1

2.2

0.20

0.22

g/l

0.74

Myelodysplastic syndrome

212

1.63

1.74

2.1

0.18

0.20

g/l

0.61

192

Speech therapy

1051

9762

1.08

1.73

2.3

2.2

0.22

0.21

g/l

5.05

961

9088

Achilles tendinitis

377

3329

1.14

1.73

2.3

0.22

0.21

g/l

0.52

359

3119

Disorders of pituitary gland, other and/or unspecified

135

1.79

1.71

2.7

2.6

0.24

0.22

g/l

0.68

124

Amblyopia ex anopsia

143

1168

1.25

1.70

2.6

3.0

0.22

g/l

0.09

134

1096

Anisometropia and aniseikonia

108

855

1.29

1.70

2.5

0.20

0.21

g/l

0.60

100

805

Malignant melanoma of skin

409

3638

1.14

1.69

1.9

2.2

0.22

0.21

g/l

1.86

382

3377

Other congenital malformations of brain

136

1.79

1.69

3.3

4.0

0.22

0.21

g/l

0.20

129

Benign neoplasm: Skin, unspecified

141

1152

1.25

1.68

2.1

2.2

0.20

0.22

g/l

1.32

136

1074

HSIL lesion of the cervix uteri

520

4683

1.12

1.68

2.3

2.2

0.23

g/l

2.17

484

4438

Contact with machinery

386

3426

1.14

1.65

2.5

2.4

0.21

g/l

0.13

359

3167

Sixth [abducent] nerve palsy

119

959

1.27

1.63

2.3

0.21

g/l

0.35

104

894

Other peripheral vertigo

335

2952

1.15

1.63

1.9

2.2

0.22

0.21

g/l

1.79

313

2755

Malignant neoplasm of heart, mediastinum and pleura

335

0.58

1.62

1.8

2.4

0.17

0.20

g/l

1.31

307

Female infertility, cervigal, vaginal, other or unspecified origin

943

5841

1.09

1.62

2.3

2.2

0.23

0.22

g/l

1.92

895

5467

Other congenital malformations of skin

137

1121

1.24

1.62

2.3

2.6

0.22

g/l

0.51

128

1056

Toxic effect of alcohol

579

1.34

1.61

2.7

2.3

0.20

0.22

g/l

1.67

542

malignant neoplasm of male genital organs

1670

10012

1.06

1.61

2.1

2.4

0.20

g/l

0.45

1528

9206

Muscle strain

104

825

1.28

1.61

2.1

2.3

0.22

g/l

0.12

775

Other abnormal products of conception

865

6242

0.92

1.61

2.2

0.23

g/l

0.66

816

5902

Spontaneous abortion

1517

10953

0.94

1.61

2.3

2.2

0.22

g/l

0.27

1432

10279

Benign neoplasm of other and unspecified female genital organs

155

1286

1.23

1.61

1.9

2.1

0.22

0.21

g/l

0.34

142

1218

Benign neoplasm of thyroid gland

118

952

1.27

1.60

2.2

2.1

0.22

0.21

g/l

0.74

106

901

Collapsed vertebra, not elsewhere classified

201

1.61

1.60

3.2

1.8

0.21

0.20

g/l

0.11

190

Left side

127

0.37

1.59

1.6

2.4

0.24

0.22

g/l

—

117

Parapsoriasis

494

1.37

1.59

2.4

2.2

0.21

0.22

g/l

0.28

464

Other bursitis, not elsewhere classified

250

1.53

1.58

2.1

2.2

0.21

g/l

0.02

234

Type 1 diabetes, strict (exclude DM2)

308

2694

1.15

1.57

2.8

2.9

0.19

0.23

g/l

16.88

278

2547

Chronic suppurative otitis media, including avohilmo

282

2462

1.16

1.57

2.0

2.4

0.22

0.21

g/l

0.59

267

2302

All dysplastic lesions of the cervix uteri

755

6934

1.09

1.57

2.4

2.2

0.23

g/l

1.76

708

6548

Localized scleroderma [morphea]

350

1.44

1.56

2.1

0.23

0.22

g/l

0.55

327

Chronic suppurative otitis media

237

2044

1.17

1.56

2.0

2.4

0.22

0.21

g/l

0.47

223

1906

Delayed puberty

170

1.64

1.55

3.5

3.3

0.22

0.24

g/l

0.52

158

Injury of muscle and tendon at wrist and hand level

481

4343

1.12

1.54

2.1

2.4

0.23

0.22

g/l

3.74

453

4069

Other benign neoplasms of connective and other soft tissue

353

3133

1.14

1.54

2.1

2.2

0.22

0.21

g/l

0.30

316

2938

Other disorders of bone density and structure

663

1.31

1.53

2.3

2.2

0.22

g/l

0.13

625

Benign neoplasm of eye and adnexa

356

3166

1.14

1.51

2.5

2.1

0.21

g/l

0.25

331

2950

Third [oculomotor] nerve palsy

499

1.36

1.51

2.7

2.2

0.22

0.21

g/l

0.42

467

Other specified and unspecified disorders of choroid

1.94

1.50

1.6

2.5

0.21

0.22

g/l

0.20

Severe visual impairment, monocular

229

1.55

1.49

2.2

0.21

0.22

g/l

0.26

216

Congenital malformations of trachea and bronchus

254

1.52

1.49

3.0

2.6

0.22

0.21

g/l

0.20

242

Torticollis

413

1.39

1.49

2.0

2.5

0.24

0.22

g/l

0.84

391

Benign neoplasm: Vagina

347

1.43

1.46

1.5

2.1

0.22

g/l

0.34

331

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

2.16

1.46

1.3

2.2

0.19

0.24

g/l

0.93

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

140

1164

1.22

1.45

2.5

2.2

0.23

0.21

g/l

2.12

133

1092

Benign neoplasm: Connective and other soft tissue of thorax

104

1.83

1.44

2.9

2.4

0.22

g/l

0.07

Cervicocranial syndrome

379

3393

1.13

1.44

2.2

0.22

0.21

g/l

1.84

358

3163

Tooth agenesis EXCLUDE clefts and syndromes

119

973

1.24

1.43

3.7

3.5

0.23

g/l

0.07

110

917

Undescended testicle

331

1.44

1.43

4.1

3.9

0.20

0.21

g/l

0.27

311

Hypersomnia

357

1.41

1.42

1.5

2.6

0.22

g/l

0.04

334

Other and/or unspecified nontoxic goitre

296

2618

1.14

1.40

2.1

0.22

0.21

g/l

0.89

283

2460

Liveborn infants according to place of birth

261

1.47

1.40

3.7

5.0

0.20

0.21

g/l

1.37

251

Benign neoplasm: Vertebral column

2.27

1.39

3.2

2.1

0.19

0.22

g/l

—

Other chromosome abnormalities, not elsewhere classified

153

1.68

1.39

3.2

4.5

0.21

0.19

g/l

0.63

146

Need for immunization against single bacterial diseases

1.97

1.39

4.3

5.0

0.22

0.21

g/l

0.31

Benign neoplasm: Connective and other soft tissue of abdomen

2.16

1.38

2.5

2.0

0.21

0.22

g/l

0.19

Lateral epicondylitis

482

4381

1.11

1.38

2.2

2.3

0.23

0.22

g/l

1.76

444

4105

Nontoxic multinodular goitre

759

7043

1.09

1.37

1.9

2.1

0.22

0.21

g/l

2.39

711

6567

Melanoma in situ

143

1201

1.21

1.36

2.0

2.1

0.22

0.20

g/l

2.25

133

1114

Birth injury to scalp

3.28

1.36

5.6

5.8

0.21

0.19

g/l

—

Malignant neoplasm of eye, brain and central nervous system

145

1218

1.21

1.36

2.3

0.23

0.21

g/l

1.29

138

1131

Other vitreous opacities

137

1147

1.22

1.35

2.1

2.2

0.20

0.21

g/l

0.82

122

1074

Graves disease, strict definition

323

2879

1.13

1.34

2.2

0.21

0.22

g/l

0.80

301

2712

Benign neoplasm: Larynx

113

929

1.24

1.34

2.9

2.3

0.20

0.21

g/l

0.82

108

863

Rheumatic fever incl heart disease

107

874

1.24

1.34

2.5

2.1

0.20

g/l

0.01

798

Maternal care for other known or suspected fetal problems

586

4098

0.91

1.33

2.3

0.23

g/l

0.53

548

3862

Benign neoplasm: Cerebral meninges

329

2941

1.13

1.33

2.1

0.22

0.21

g/l

1.06

299

2744

Calcific tendinitis of shoulder

206

1785

1.17

1.33

2.0

2.2

0.22

g/l

0.70

199

1682

Other disorders of Eustachian tube

767

1.26

1.33

3.4

2.2

0.21

0.22

g/l

0.96

725

Fourth [trochlear] nerve palsy

643

1.29

1.32

2.2

0.20

0.21

g/l

0.60

604

Dystonia

188

1619

1.18

1.32

2.2

2.3

0.22

g/l

0.07

170

1520

Other conjunctival vascular disorders and cysts

661

1.28

1.32

3.2

2.2

0.22

0.21

g/l

0.35

618

Use of riluzole

100

1.81

1.31

2.7

2.2

0.25

0.22

g/l

1.42

Infections of genitourinary tract in pregnancy

292

2591

1.14

1.31

1.9

2.2

0.21

0.22

g/l

0.95

278

2446

Brain glioblastoma and astrocytoma

446

0.68

1.31

1.6

2.4

0.28

0.21

g/l

3.60

414

Glucosamine medication

2140

16352

1.05

1.30

2.0

2.1

0.21

g/l

1.64

1959

15123

Use of selegiline

117

1407

0.82

1.30

1.8

2.1

0.20

g/l

0.47

110

1306

Postmenopausal atrophic vaginitis

1036

5851

1.07

1.29

2.0

2.1

0.23

0.21

g/l

9.89

987

5432

Viral infections of central nervous system, not elsewhere classified/unspecified

287

1.44

1.29

1.5

2.3

0.22

g/l

0.02

270

Secondary lactase deficiency

2.60

1.29

2.5

2.4

0.24

g/l

—

Disturbances of smell and taste

144

1218

1.20

1.27

2.2

0.23

0.22

g/l

1.01

134

1145

Contact with other specified venomous animals

164

1.59

1.26

2.9

2.8

0.24

0.22

g/l

1.59

153

Progressive vascular leukoencephalopathy

110

909

1.23

1.26

2.0

1.8

0.20

0.19

g/l

0.42

828

Benign neoplasm: Skin of scalp and neck

683

1.27

1.26

2.0

2.4

0.22

g/l

0.52

643

Tinnitus

892

8356

1.07

1.26

2.1

2.3

0.22

0.21

g/l

6.82

832

7779

Caught, crushed, jammed or pinched in or between objects

159

1358

1.19

1.25

2.7

2.6

0.22

g/l

0.20

149

1271

Hereditary corneal dystrophies

115

957

1.23

1.24

2.3

2.0

0.21

g/l

0.32

108

907

Endometriosis diagnosis and infertility diagnosis occurring together

308

2753

1.13

1.24

2.2

0.23

0.22

g/l

0.49

297

2617

Other and unspecified syphilis

1.99

1.24

2.2

2.8

0.25

0.23

g/l

0.37

Mastocytosis

133

1.65

1.23

2.6

3.1

0.21

0.23

g/l

0.45

127

Benign neoplasm: Conjunctiva

110

911

1.23

2.5

2.3

0.22

0.21

g/l

0.67

105

856

Nasal polyp

725

6755

1.08

1.21

2.2

2.3

0.22

0.21

g/l

2.15

688

6289

Contact with sharp object, undetermined intent

572

1.28

1.19

2.3

2.5

0.21

0.22

g/l

0.63

527

Uterine polyps

341

3077

1.12

1.18

2.1

2.2

0.22

0.21

g/l

1.32

320

2865

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1710

12829

1.05

1.18

2.2

0.23

0.22

g/l

3.10

1616

12040

Burn and corrosion confined to eye and adnexa

626

1.27

1.18

1.9

2.3

0.24

0.23

g/l

0.84

584

Foreign body in respiratory tract

175

1515

1.17

1.18

2.7

2.4

0.22

g/l

1.00

159

1414

Benign neoplasm: Lymph nodes

2.01

1.17

2.0

1.9

0.23

0.19

g/l

1.08

Myopia

394

3582

1.11

1.17

2.6

2.5

0.23

0.22

g/l

0.28

368

3366

Benign neoplasm: Skin of upper limb, including shoulder

538

1.29

1.17

2.9

2.1

0.22

0.21

g/l

0.33

502

Sequelae of inflammatory diseases of the central nervous system

1.89

1.16

3.0

2.5

0.20

0.23

g/l

0.79

Bacterial meningitis

115

964

1.21

1.15

2.1

2.3

0.22

g/l

0.34

106

910

Use of galantamine

170

1958

0.86

1.14

1.5

1.9

0.19

g/l

0.36

156

1765

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

224

1973

1.14

2.1

2.0

0.20

g/l

0.06

201

1821

Undefined dementia

293

3000

0.89

1.13

1.8

0.19

g/l

0.21

243

2688

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

1.86

1.13

1.6

2.5

0.21

g/l

0.07

Maternal care for known or suspected malpresentation of fetus

427

3483

0.91

1.12

2.4

2.3

0.23

g/l

0.23

404

3290

Endometriosis ASRM stages 3,4

798

7482

1.07

1.12

2.5

2.1

0.22

g/l

0.19

760

7000

Multiple superficial injuries of ankle and foot

2.55

1.12

2.2

2.6

0.18

0.24

g/l

—

MS-disease / Multiple Sclerosis

222

1962

1.14

1.11

2.3

0.23

0.22

g/l

0.69

212

1853

Other acute disseminated demyelination

236

1.44

1.11

3.5

2.3

0.23

g/l

0.19

224

Medial epicondylitis

126

1069

1.19

1.11

2.1

2.2

0.23

0.22

g/l

0.94

120

1011

Congenital malformation of optic disc

2.14

1.10

3.2

4.4

0.21

0.20

g/l

—

Vitreous prolapse

1.86

1.10

2.8

2.1

0.21

g/l

0.07

Alzheimer disease, including avohilmo

1119

8523

0.94

1.09

1.6

2.0

0.20

g/l

0.08

961

7784

Cervicobrachial syndrome

807

7579

1.07

1.09

2.0

2.2

0.23

0.22

g/l

6.40

751

7087

Congenital malformations of ovaries, fallopian tubes and broad ligaments

155

1339

1.17

1.08

2.0

2.2

0.23

g/l

0.77

150

1272

Disorders of synovium and tendon in diseases classified elsewhere

562

1.27

1.08

1.9

2.3

0.22

0.21

g/l

0.20

529

Sickle-cell disorders

2.06

1.07

1.6

2.6

0.23

0.21

g/l

—

Other endophthalmitis

106

1.67

1.07

2.2

0.22

0.21

g/l

0.20

Alzheimer’s disease (Late onset)

633

5818

0.93

1.07

1.6

1.9

0.19

g/l

0.60

532

5261

Atopic conjunctivitis

138

1184

1.18

1.06

2.3

2.4

0.22

g/l

0.05

125

1108

Maternal care for known or suspected abnormality of pelvic organs

678

5010

0.93

1.06

2.3

2.2

0.23

g/l

0.44

656

4729

Renal cell carcinoma of kidney

117

992

1.20

1.05

2.2

2.1

0.22

0.20

g/l

2.02

105

921

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

290

2615

1.12

1.05

2.1

2.2

0.22

g/l

0.41

276

2464

Female genital prolapse

1180

6463

1.06

1.05

2.0

2.1

0.22

0.21

g/l

2.54

1104

6001

Polypectomy (DHB20)

186

2113

0.87

1.05

2.1

2.3

0.22

0.21

g/l

1.08

176

1968

Lipoprotein deficiency

1.95

1.05

1.9

2.6

0.18

0.22

g/l

0.66

Use of donepezil

573

5919

0.93

1.03

1.6

1.9

0.20

0.19

g/l

0.50

501

5354

Anoxic brain damage

353

1.34

1.02

3.1

2.5

0.21

0.20

g/l

0.28

327

Vasomotor rhinitis (mode)

247

2214

1.13

1.02

2.0

2.2

0.22

g/l

1.24

230

2072

Type1 diabetes, definitions combined, early onset

157

1794

0.86

1.01

2.9

3.3

0.20

0.23

g/l

8.23

144

1703

Other puerperal infections

181

1591

1.15

1.00

1.9

2.2

0.24

0.23

g/l

1.27

170

1504

Prepatellar bursitis

155

1351

1.16

1.00

2.2

2.3

0.22

0.21

g/l

0.45

143

1269

Benign neoplasm of brain and other parts of central nervous system

220

1962

1.13

1.00

2.3

2.2

0.22

0.21

g/l

0.18

205

1836

Other disorders affecting eyelid function

222

0.61

0.99

1.5

2.0

0.21

g/l

0.12

211

Benign neoplasm of mesothelial tissue

2.42

0.98

2.7

2.0

0.25

0.21

g/l

—

Benign neoplasm of male genital organs

607

1.24

0.97

3.1

2.5

0.21

g/l

0.01

554

Benign neoplasm: Brain, supratentorial

409

1.30

0.97

3.4

2.5

0.23

0.22

g/l

0.26

385

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

1.84

0.97

1.4

2.6

0.27

0.23

g/l

0.80

Other disorders of cornea

321

2928

1.11

0.96

2.6

2.2

0.22

0.21

g/l

0.69

300

2742

Congenital malformations of eye, ear, face and neck

205

1825

1.13

0.95

2.3

2.8

0.23

0.22

g/l

0.69

200

1719

Other benign neoplasms of uterus

196

1743

1.14

0.95

1.9

0.20

g/l

0.02

181

1615

Noonan syndrome

2.25

0.94

2.0

3.5

0.17

0.22

g/l

—

Benign neoplasm: Extrahepatic bile ducts

1.79

0.94

2.5

2.4

0.27

0.21

g/l

2.23

Vertigo of central origin

430

1.28

0.93

2.5

2.1

0.21

g/l

0.07

402

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

359

1.31

0.93

1.8

2.1

0.19

0.20

g/l

0.16

330

Other congenital malformations of limb(s)

168

1.47

0.93

3.1

4.7

0.22

g/l

0.02

161

Findings of drugs and other substances, not normally found in blood

119

1.58

0.93

2.9

2.3

0.20

0.21

g/l

0.18

112

Photocontact dermatitis [berloque dermatitis]

2.01

0.92

2.9

2.1

0.19

0.21

g/l

—

Other specified/unspecified disorders of middle ear and mastoid

1.89

0.92

1.9

2.8

0.20

0.21

g/l

—

Explosion of other materials

1.70

0.89

2.5

2.0

0.22

0.24

g/l

0.32

Erosion and ectropion of cervix uteri

100

853

1.19

0.88

2.4

2.1

0.22

0.21

g/l

1.21

800

Balanced rearrangements and structural markers, not elsewhere classified

1.73

0.88

2.2

3.1

0.24

0.22

g/l

0.40

Carcinoma in situ of breast, other/unspecified

389

1.29

0.88

2.0

1.9

0.23

0.21

g/l

0.97

370

Pedestrian injured in collision with pedal cycle

103

881

1.18

0.88

1.8

2.1

0.21

0.22

g/l

0.37

823

Rheumatic valve diseases

605

1.22

0.88

2.7

2.1

0.19

0.20

g/l

0.52

548

Other intracranial haemorrhages

101

863

1.19

0.87

2.9

2.1

0.20

g/l

0.16

800

Sequelae of other and unspecified effects of external causes

129

1.53

0.87

5.8

2.6

0.26

0.23

g/l

0.56

122

N06DA Anticholinesterases

1043

8850

0.95

0.87

1.6

2.0

0.20

g/l

0.30

920

8065

Use of anticholinesterases

1043

8850

0.95

0.87

1.6

2.0

0.20

g/l

0.30

920

8065

Mandibular prognathia AND surgery (LeFortI or BSSRO)

111

0.53

0.86

2.7

2.8

0.18

0.23

g/l

—

104

Maternal care for known or suspected disproportion

1060

0.84

0.86

3.4

2.2

0.21

0.23

g/l

1.95

1007

Endometriosis ASRM stages 1,2

563

5278

1.07

0.86

2.3

2.2

0.23

0.22

g/l

2.41

540

4966

Other inherited muscular atrophy

1.80

0.84

1.7

2.7

0.20

0.21

g/l

—

Malignant neoplasm of prostate

1606

9761

1.04

0.84

2.1

2.4

0.20

g/l

0.50

1467

8972

Benign neoplasm: Vulva

591

1.22

0.84

2.3

2.0

0.22

0.21

g/l

0.34

567

Early lumbar disc prolapse operation

306

2807

1.10

0.83

2.3

2.4

0.24

0.23

g/l

2.00

291

2647

Endometriosis of rectovaginal septum and vagina

257

2340

1.11

0.83

2.2

2.1

0.22

0.21

g/l

1.20

242

2170

Benign neoplasm: Skin of lip

358

1.28

0.81

2.1

0.21

0.22

g/l

0.72

333

Hypertrophy of bone

1.71

0.78

1.5

2.3

0.23

0.22

g/l

0.07

Injury of muscle and tendon at forearm level

495

1.23

0.78

2.6

2.5

0.21

0.22

g/l

0.09

465

Melanocytic naevi of other and unspecified parts of face

185

1663

1.12

0.78

2.1

2.2

0.22

g/l

0.43

171

1562

Disorders of sphingolipid metabolism and other lipid storage disorders

1.66

0.78

2.0

2.5

0.21

g/l

0.14

Unequal limb length (acquired)

166

1.41

0.78

2.7

2.8

0.23

g/l

0.10

153

Melanocytic naevi of eyelid, including canthus

175

1.40

0.77

2.0

0.22

g/l

0.04

161

Cyst of Bartholin Gland

111

967

1.16

0.77

2.0

2.1

0.22

g/l

0.15

104

915

Brachial plexus disorders

288

2648

1.09

0.77

2.2

0.23

0.22

g/l

0.45

271

2493

Use of antiglaucoma preparations and miotics

273

2507

1.10

0.76

1.9

2.0

0.20

g/l

0.13

253

2305

Placental disorders

184

0.64

0.76

3.4

2.1

0.24

0.23

g/l

0.23

177

Other noninflammatory disorders of cervix uteri

173

1554

1.12

0.75

2.2

2.1

0.22

0.21

g/l

1.11

160

1439

Injury of muscle and tendon at hip and thigh level

315

2912

1.09

0.75

2.2

2.3

0.23

0.22

g/l

1.16

297

2738

Femoral hernia

143

1271

1.14

0.75

2.2

2.0

0.21

g/l

0.10

128

1180

Vascular syndromes of brain in cerebrovascular disorders

146

1302

1.13

0.73

2.1

0.21

0.20

g/l

0.60

137

1212

Tick-borne viral encephalitis

1.57

0.73

1.9

2.7

0.24

0.22

g/l

0.26

Drug-induced interstitial lung disorders, unspecified

1.80

0.73

1.0

2.2

0.25

0.22

g/l

—

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

1.78

0.72

2.7

2.1

0.21

0.19

g/l

—

Family history of other specific disorders

265

1.30

0.72

2.7

0.23

0.22

g/l

0.19

248

Other specified/unspecified disorders of ear

1.67

0.71

2.4

2.2

0.20

0.23

g/l

0.53

Supervision of high-risk pregnancy

673

3857

1.06

0.71

2.1

2.2

0.23

g/l

0.05

633

3626

Vascular dementia (other)

144

1.43

0.71

1.8

2.0

0.21

0.19

g/l

0.55

134

Poor fetal growth

295

2726

1.09

0.70

2.5

2.2

0.23

g/l

0.41

270

2581

Otosclerosis

231

2519

0.91

0.70

2.4

2.2

0.21

g/l

0.14

219

2364

Congenital malformations of larynx

103

1.53

0.69

2.4

4.6

0.18

0.20

g/l

0.58

Mesothelioma, excluding all cancers (controls excluding all cancers)

267

1.30

0.69

2.0

1.9

0.18

0.20

g/l

0.65

236

Scleritis and episcleritis

191

1735

1.11

0.69

2.4

2.2

0.23

0.22

g/l

1.34

181

1638

Pneumoconiosis due to asbestos and other mineral fibres

549

1.20

0.68

2.1

0.17

0.19

g/l

1.44

498

Deep endometriosis

299

2776

1.08

0.66

2.2

2.1

0.22

0.21

g/l

0.72

283

2606

Other and unspecified hydrocephalus

487

1.21

0.66

2.0

2.4

0.20

0.21

g/l

0.47

457

Injury of muscle and tendon at lower leg level

510

4821

1.06

0.66

2.3

0.23

0.21

g/l

3.16

470

4511

Other benign neoplasm of uterus: Other parts/unspecified

154

1389

1.12

0.66

1.8

0.20

g/l

0.15

142

1273

Melanocytic naevi of lip

207

1.33

0.66

1.3

2.4

0.23

0.22

g/l

0.19

193

Transient global amnesia

284

3058

0.92

0.65

2.0

2.1

0.21

g/l

0.01

257

2858

Abnormalities of forces of labour

265

2864

0.92

0.65

2.2

0.23

g/l

0.19

260

2710

Benign lipomatous neoplasm

1120

10792

1.04

0.65

2.2

0.21

g/l

0.81

1061

10035

Noise effects on inner ear

108

1220

0.88

0.65

2.1

2.3

0.20

0.22

g/l

2.00

103

1132

Rubella [German measles]

109

965

1.14

0.64

2.6

0.21

0.23

g/l

1.15

103

907

Foreign body in ear

499

1.20

0.63

2.0

2.7

0.23

0.22

g/l

0.26

462

Unspecified dementia

290

2812

0.93

0.63

1.8

1.9

0.19

g/l

0.33

241

2562

Contact with nonpowered hand tool

137

1231

1.12

0.63

1.9

2.3

0.22

g/l

0.13

127

1150

Nondiabetic hypoglycaemic coma

1.55

0.62

2.8

3.0

0.19

0.22

g/l

0.60

Other lesions of median nerve

808

1.15

0.62

1.8

2.1

0.20

0.21

g/l

0.78

749

Injury of blood vessels at forearm level

1.59

0.61

1.7

2.8

0.20

0.23

g/l

0.53

Vascular dementia (undefined)

855

1.14

0.61

1.7

1.8

0.20

0.18

g/l

1.77

776

Loose body in joint

649

1.17

0.61

1.6

2.3

0.21

0.22

g/l

0.20

609

L02BX Other hormone antagonists and related agents

178

1626

1.11

0.61

1.9

2.3

0.19

0.20

g/l

0.36

164

1490

Other specified transport accidents

114

1.44

0.61

4.0

3.0

0.23

g/l

0.09

108

Hair colour and hair shaft abnormalities

106

1.46

0.60

2.5

2.3

0.19

0.22

g/l

0.80

Trigeminal neuralgia

187

1713

1.10

0.60

2.2

2.1

0.23

0.21

g/l

3.43

176

1597

Osteogenesis imperfecta

1.53

0.59

3.3

5.9

0.25

0.21

g/l

—

Complications of anaesthesia during pregnancy

1.77

0.59

1.7

2.5

0.21

0.24

g/l

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.53

0.59

1.5

2.7

0.21

0.22

g/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

662

1.16

0.58

2.1

0.22

0.21

g/l

0.07

624

Benign neoplasm: Respiratory system, unspecified

1.72

0.58

1.2

1.7

0.20

g/l

—

Dental caries 1 and operation codes, only avohilmo

1268

6164

1.04

0.58

2.3

2.7

0.22

g/l

1.15

1184

5809

Central retinal artery occlusion

588

1.17

0.57

2.0

2.2

0.20

g/l

0.33

537

Acute myringitis

177

1.33

0.57

3.2

2.9

0.22

g/l

0.02

167

Major anomalies of jaw size

748

1.15

0.56

2.4

2.7

0.22

0.23

g/l

0.19

707

Benign neoplasm: Bones of skull and face

186

1.31

0.56

2.0

1.9

0.23

g/l

0.15

169

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

272

2540

1.08

0.56

2.2

0.21

g/l

0.23

256

2382

Alzheimer disease

954

7456

0.96

0.55

1.6

1.9

0.19

g/l

0.07

806

6793

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

145

1319

1.11

0.55

1.8

2.2

0.21

0.22

g/l

0.18

121

1240

Contraceptive management

1507

10905

0.97

0.55

2.5

2.4

0.23

g/l

3.72

1417

10201

Chronic inflammatory disorders of orbit

1.50

0.55

2.2

2.5

0.20

0.22

g/l

—

Effects of air pressure and water pressure

117

1.40

0.54

4.1

2.6

0.21

0.23

g/l

0.43

110

Benign neoplasm: Choroid

197

1821

1.09

0.54

2.4

2.1

0.21

g/l

0.03

183

1707

Lichenoid drug reaction

1.53

0.53

2.3

2.1

0.20

0.21

g/l

0.22

Occupational exposure to risk-factors

108

970

1.12

0.53

2.2

2.4

0.20

0.21

g/l

0.88

102

910

Dementia due to Parkinson's disease

640

1.16

0.53

1.6

2.0

0.19

0.20

g/l

0.23

582

LSIL lesion of the cervix uteri

297

2791

1.07

0.51

2.6

2.2

0.23

0.22

g/l

0.26

281

2643

Inguinal hernia, unilateral

755

1.14

0.51

2.5

2.1

0.21

g/l

0.02

706

Femoral hernia, unilateral

755

1.14

0.51

2.5

2.1

0.21

g/l

0.02

706

Inguinal of femoral hernia, unilateral

755

1.14

0.51

2.5

2.1

0.21

g/l

0.02

706

Benign neoplasm: Connective and other soft tissue of abdomen

1.50

0.50

2.5

2.2

0.21

0.22

g/l

0.24

Divergent concomitant strabismus

244

2281

1.08

0.50

2.2

2.4

0.22

g/l

0.12

232

2145

Inflammatory disease of cervix uteri

211

1963

1.08

0.50

2.5

2.0

0.22

0.21

g/l

0.30

199

1843

Benign neoplasm: Central nervous system, other parts/unspecified

102

1.42

0.50

1.9

2.6

0.22

g/l

0.02

Other specified/unspecified hearing loss

264

2476

1.07

0.50

2.2

0.22

0.21

g/l

2.25

250

2300

Other and unspecified disorders of vitreous body

1620

15713

1.03

0.49

2.2

0.22

0.21

g/l

4.68

1500

14668

Brain meningioma

142

1549

0.91

0.49

2.0

2.1

0.23

0.21

g/l

1.44

129

1450

Dislocation, sprain and strain of joints and ligaments of elbow

191

1771

1.08

0.49

3.0

2.5

0.22

g/l

0.11

172

1659

Haemorrhage in early pregnancy

905

8535

1.04

0.49

2.3

2.2

0.22

g/l

0.06

854

8048

Traumatic amputation of wrist and hand

142

1302

1.10

0.48

2.6

2.3

0.21

g/l

0.22

137

1218

Multiple gestation

219

2346

0.93

0.48

2.3

2.2

0.23

g/l

0.09

211

2229

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1.49

0.48

1.1

2.1

0.16

0.19

g/l

—

Hypersensitivity angiitis

147

1.33

0.47

1.8

2.4

0.24

0.22

g/l

0.66

134

Bicipital tendinitis

156

1438

1.09

0.47

1.9

2.2

0.22

0.21

g/l

0.04

147

1350

Benign neoplasm: Ribs, sternum and clavicle

1.47

0.47

1.3

2.1

0.22

0.21

g/l

—

Malignant neoplasm of bronchus and lung

585

5699

0.96

0.47

2.0

2.1

0.20

g/l

0.01

540

5192

Other congenital malformations of ear

255

1.23

0.47

1.8

3.5

0.23

g/l

0.07

242

Galactorrhea

228

1.25

0.46

1.9

2.4

0.24

0.23

g/l

0.57

219

Unspecified maternal hypertension

220

0.76

0.46

2.3

0.23

0.24

g/l

0.11

211

Struck by thrown, projected or falling objec

121

1324

0.91

0.46

3.1

2.5

0.23

0.22

g/l

0.34

112

1243

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

1.49

0.46

3.3

2.8

0.23

0.20

g/l

—

Accidental poisoning by and exposure to other gases and vapours

130

1.34

0.46

1.4

2.7

0.23

0.22

g/l

0.27

120

Male infertility

128

1172

1.10

0.45

2.4

2.5

0.24

g/l

0.02

120

1082

Glaucoma secondary to eye trauma

157

1.30

0.45

2.3

0.19

0.21

g/l

0.39

145

Postpartum haemorrhage due to retained placenta

269

2853

0.94

0.44

2.3

2.1

0.23

g/l

0.28

256

2701

Melanoma in situ of scalp and neck

1.48

0.44

2.0

2.1

0.26

0.19

g/l

—

Conductive hearing loss, unspecified

276

2606

1.06

0.44

2.3

2.4

0.21

g/l

0.57

247

2431

Malignant neoplasm of penis

1.42

0.44

2.0

2.2

0.21

g/l

0.02

Parkinson's disease

479

4997

0.95

0.43

2.0

2.1

0.20

g/l

0.07

437

4613

Vestibular neuronitis

301

2852

1.06

0.43

2.2

0.22

0.21

g/l

0.43

276

2664

Benign neoplasm: Lymph nodes

1.44

0.43

2.0

2.5

0.23

0.22

g/l

0.17

Beningn neoplasm: Meninges, unspecified

323

1.19

0.42

1.9

0.22

0.20

g/l

0.45

299

Type 1 diabetes, strict definition

192

2049

0.93

0.42

2.5

3.1

0.19

0.23

g/l

14.48

172

1938

Gastric ulcer - Acute with haemorrhage, drug-induced

1.56

0.42

2.6

2.2

0.25

0.21

g/l

—

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

249

0.79

0.41

1.8

1.9

0.29

0.21

g/l

3.01

220

Fibrosarcoma

196

1.25

0.41

2.7

2.1

0.21

g/l

0.03

181

Lesion of sciatic nerve

149

1383

1.08

0.41

2.3

2.1

0.21

0.20

g/l

0.59

144

1271

Surgical ablation of atrial fibrillation

160

1.28

0.40

2.4

2.5

0.19

0.22

g/l

1.22

146

Eccrine sweat disorders

1.43

0.40

1.2

3.1

0.22

g/l

—

Ectopic pregnancy

559

5387

1.04

0.40

2.1

2.2

0.23

0.22

g/l

0.33

514

5079

Mandibular retrognathia

174

1855

0.93

0.39

2.6

2.9

0.23

g/l

0.61

164

1756

Graves ophthalmopathy, strict

590

1.13

0.39

2.3

2.1

0.22

g/l

0.02

553

Pedal cyclist injured in collision with pedestrian or animal

189

1.24

0.37

2.8

2.3

0.21

0.22

g/l

0.17

175

Cholesteatoma of middle ear

173

1622

1.07

0.37

2.0

2.2

0.21

g/l

0.04

162

1508

Abnormal reflex

126

1.30

0.36

3.1

2.3

0.22

0.23

g/l

0.24

117

Benign neoplasm: Vertebral column

1.42

0.36

3.2

2.7

0.19

0.22

g/l

—

Subarachnoid haemorrhage

347

3321

1.05

0.36

2.1

0.21

g/l

0.14

323

3068

Acquired stenosis of external ear canal

264

1.19

0.36

1.9

2.5

0.22

0.21

g/l

0.60

242

Lens-induced iridocyclitis

1.40

0.35

2.3

2.5

0.26

0.21

g/l

—

Benign neoplasm: Respiratory system, unspecified

1.39

0.35

1.2

1.9

0.20

0.22

g/l

—

Parkinson's disease, including avohilmo

502

5199

0.96

0.35

2.0

2.1

0.20

g/l

0.09

459

4792

Other infective (teno)synovitis

109

1.31

0.35

1.8

1.9

0.25

0.23

g/l

0.56

103

Abnormal findings on antenatal screening of mother

168

1577

1.07

0.35

2.4

2.3

0.22

0.23

g/l

1.09

161

1491

Maternal care for known or suspected fetal abnormality and damage

377

3494

0.96

0.34

2.1

2.2

0.23

g/l

0.09

358

3300

Persons encountering health services in circumstances related to reproduction

2363

15756

1.02

0.34

2.5

0.23

0.22

g/l

3.56

2244

14745

Acromegaly and pituitary gigantism

173

1.23

0.34

2.1

2.2

0.20

0.22

g/l

0.84

159

Dental caries 3 and operation codes, only avohilmo

1439

7078

1.02

0.34

2.3

2.6

0.22

g/l

0.99

1346

6669

Use of rasagiline

770

1.10

0.33

2.1

2.2

0.20

g/l

0.06

716

Villonodular synovitis (pigmented)

201

1.21

0.33

4.8

2.4

0.24

0.22

g/l

0.81

192

Other and unspecified iridocyclitis

130

1214

1.08

0.33

2.2

0.22

g/l

0.17

123

1133

Sequelae of tuberculosis

474

1.13

0.33

1.9

2.0

0.20

g/l

0.07

423

L02BB Anti-androgens

259

2713

0.95

0.32

2.1

2.2

0.20

0.19

g/l

0.75

235

2478

Nontoxic goitre/thyroid nodule

1130

11058

1.02

0.32

2.0

2.1

0.22

0.21

g/l

2.54

1059

10294

Testicular dysfunction, other/unspecified

0.70

0.32

2.3

2.9

0.22

0.24

g/l

—

Embedded and impacted teeth

732

6056

1.03

0.31

2.8

2.6

0.23

g/l

0.23

691

5650

Medical treatment for female infertility

537

5193

1.03

0.30

2.3

2.2

0.23

g/l

0.14

515

4913

Kissing spine

1.28

0.30

2.4

2.1

0.26

0.22

g/l

—

Glaucoma suspect

1372

13465

1.02

0.30

2.0

2.2

0.21

g/l

0.28

1249

12506

Twin gestation

214

2247

0.95

0.30

2.3

2.2

0.23

g/l

0.07

206

2134

Disorders of lacrimal system and orbit in diseases classified elsewhere

660

1.10

0.29

2.2

2.0

0.21

0.22

g/l

0.11

622

Occlusion and stenosis of arteries, not leading to stroke

345

1.14

0.29

2.1

2.0

0.21

0.20

g/l

0.26

314

Non-small cell lung cancer, squamous, helper endpoint

124

1321

0.93

0.29

1.7

2.1

0.20

0.19

g/l

0.33

116

1207

Non-small cell lung cancer, squamous

124

1321

0.93

0.29

1.7

2.1

0.20

0.19

g/l

0.33

116

1207

Cerebral arteritis

1.27

0.28

1.6

2.5

0.25

0.22

g/l

—

Labour and delivery complicated by umbilical cord complications

132

1242

1.07

0.28

2.5

2.2

0.23

0.22

g/l

0.60

124

1177

Beningn neoplasm: Meninges, unspecified

427

0.88

0.28

1.9

2.0

0.22

0.21

g/l

0.13

402

Non-allergic asthma

301

2896

1.04

0.27

2.3

2.4

0.22

0.21

g/l

1.04

277

2713

Generalized pustular psoriasis

104

1.28

0.27

3.3

2.5

0.23

0.22

g/l

0.19

Macular cyst

760

1.09

0.27

2.2

2.1

0.20

0.21

g/l

0.14

701

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

863

0.92

0.27

2.0

2.1

0.20

g/l

0.18

792

Chondromalacia

799

1.08

0.27

2.5

2.3

0.22

g/l

0.11

754

Cicatricial alopecia [scarring hair loss]

207

1.18

0.26

1.8

2.2

0.20

0.22

g/l

0.66

193

Thyrotoxicosis factitia

1.24

0.26

2.1

2.4

0.25

0.21

g/l

—

Glaucoma, exfoliation

337

3486

0.96

0.26

1.8

2.0

0.20

g/l

0.93

304

3197

Abnormal spermatozoa

377

3892

0.97

0.26

2.0

2.4

0.21

0.20

g/l

0.53

343

3594

Exposure to ignition of highly flammable material

105

1.26

0.25

2.0

2.8

0.23

0.24

g/l

0.04

Other disorders of male genital organs

114

1073

1.07

0.25

2.4

0.22

g/l

0.21

104

989

Parkinson's disease, strict definition

445

4581

0.97

0.25

2.0

2.1

0.20

g/l

0.10

404

4224

Respiratory tuberculosis, not confirmed

124

1171

1.06

0.25

2.1

0.20

g/l

0.17

117

1079

Other obstructed labour

222

2129

1.05

0.25

2.1

2.2

0.22

g/l

0.02

205

2022

Contact with and exposure to communicable diseases

987

9645

1.02

0.24

2.6

2.5

0.22

g/l

0.01

921

9068

Glaucoma-related operations

165

1730

0.95

0.24

1.9

2.0

0.21

0.20

g/l

0.91

154

1604

Unspecified abortion

146

1387

1.06

0.24

2.4

2.2

0.22

0.23

g/l

0.25

136

1311

Benign leiomyoma with endometriosis

562

5483

1.03

0.24

2.2

2.1

0.22

0.21

g/l

1.07

530

5109

Migraine with aura, drug-induced

275

0.86

0.24

2.5

2.2

0.22

0.23

g/l

0.45

262

Acute disseminated encephalitis/encephalomyelitis

1.34

0.24

4.6

3.3

0.21

g/l

—

Normotensive glaucoma

279

2694

1.04

0.23

1.8

2.0

0.20

g/l

0.02

247

2501

Other congenital infectious and parasitic diseases

0.00

0.23

0.0

6.4

—

0.24

—

Brain astrocytoma

1.27

0.23

1.4

2.8

0.27

0.23

g/l

0.81

Injury of blood vessels at hip and thigh level

1.30

0.23

1.7

2.6

0.23

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

195

2032

0.96

0.23

2.1

2.2

0.21

g/l

0.41

183

1903

Pedal cyclist injured in collision with motor vehicle

835

1.07

0.23

1.9

2.2

0.22

g/l

0.11

781

Pregnancy examination and test

444

2849

0.97

0.23

2.2

2.3

0.23

g/l

0.04

420

2670

Congenital malformation of vitreous humour

0.00

0.22

0.0

1.8

—

0.24

—

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

343

1.11

0.22

2.1

1.9

0.18

0.20

g/l

0.87

299

Nontoxic single thyroid nodule

235

2265

1.04

0.22

2.1

0.22

0.21

g/l

0.89

222

2135

Sequelae of transport accidents

107

1.23

0.22

2.1

2.6

0.18

0.23

g/l

1.24

Other chorioretinal disorders in diseases classified elsewhere

0.00

0.22

0.0

2.3

—

0.21

—

Vertical strabismus

924

1.07

0.22

1.8

2.4

0.21

g/l

0.02

871

Ganglion

724

7095

1.02

0.22

2.0

2.2

0.22

g/l

1.64

669

6639

Fall on and from ladder

250

2414

1.04

0.22

2.4

2.3

0.21

g/l

0.28

231

2243

Injury of muscle and tendon at shoulder and upper arm level

1378

13584

1.02

0.22

2.2

2.3

0.21

g/l

0.65

1270

12653

Benign neoplasm: Skin of other and unspecified parts of face

357

3468

1.03

0.22

2.4

2.1

0.21

g/l

0.59

326

3225

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

230

1.14

0.21

2.3

2.4

0.23

0.21

g/l

0.48

216

Complications predominantly related to the puerperium

768

7826

0.98

0.21

2.2

0.22

g/l

0.05

709

7392

Episcleritis

151

1446

1.05

0.20

2.4

2.2

0.23

0.22

g/l

1.21

143

1359

Obstructed labour due to maternal pelvic abnormality

521

5096

1.02

0.20

2.2

0.22

g/l

0.51

489

4808

Certain zoonotic bacterial diseases

501

1.08

0.19

2.8

2.4

0.22

0.21

g/l

0.23

469

Erythema in diseases classified elsewhere

1.23

0.19

1.9

2.2

0.26

0.22

g/l

—

Mesothelioma

373

0.90

0.19

2.0

2.4

0.18

0.20

g/l

0.98

345

Use of dimethyl fumarate

174

0.86

0.18

1.2

2.4

0.25

0.24

g/l

0.16

168

Foreign body on external eye

460

4699

0.98

0.17

2.6

2.4

0.22

g/l

0.31

431

4371

Use of rivastigmine

416

4244

0.98

0.17

1.6

1.9

0.20

0.19

g/l

1.33

364

3838

Failed induction of labour

121

1158

1.05

0.17

2.5

2.3

0.23

g/l

0.31

112

1088

Impacted teeth

475

4329

1.02

0.17

2.7

0.23

g/l

0.66

452

4031

Other and unspecified corneal deformities and disorders

885

1.06

0.17

2.6

2.2

0.22

g/l

0.28

837

Dissection of cerebral arteries, nonruptured

183

0.87

0.16

1.8

2.3

0.24

0.22

g/l

0.34

173

Other appendicitis

268

2609

1.03

0.16

2.5

2.3

0.22

g/l

0.87

257

2446

Other obstetric trauma

123

1180

1.04

0.16

2.4

2.2

0.23

g/l

0.10

117

1114

Infections of breast associated with childbirth

771

0.94

0.16

1.9

2.2

0.22

0.23

g/l

0.45

730

Seropositive rheumatoid arthritis, strict definition

523

5138

1.02

0.15

2.2

0.21

g/l

1.25

475

4802

Foreign body or object entering through skin

184

1784

1.03

0.15

2.3

2.4

0.22

g/l

0.02

169

1666

Use of levodopa decarbox-comt-inhibitor

948

1.05

0.15

2.0

2.2

0.20

g/l

0.13

881

Carcinoma in situ of breast

1.20

0.15

3.2

2.0

0.24

0.21

g/l

0.67

Mumps

714

1.05

0.14

1.7

2.3

0.21

0.22

g/l

0.64

671

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.21

0.14

3.1

2.5

0.20

0.21

g/l

—

Mesial bite

237

1.10

0.14

2.3

3.3

0.23

g/l

0.00

224

Carcinoma in situ of breast

128

0.85

0.14

3.2

2.1

0.24

0.22

g/l

0.56

119

Dementia in Alzheimer disease

525

4561

0.98

0.14

1.6

1.9

0.19

g/l

0.97

426

4143

Lesion of medial popliteal nerve

105

0.85

0.13

1.0

2.2

0.19

0.23

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

308

3016

1.02

0.13

2.5

2.3

0.21

g/l

0.39

293

2822

Other disorders of prostate

999

0.96

0.13

1.9

2.4

0.20

g/l

0.06

914

Mononeuritis multiplex

1.20

0.13

3.1

2.0

0.18

0.21

g/l

—

Desensitization to allergens

136

1317

1.03

0.13

2.8

2.6

0.23

g/l

0.15

128

1238

Corneal pigmentations and deposits

104

1.17

0.13

3.0

2.2

0.25

0.21

g/l

0.55

Triptan medication for migraine, single purchase ok

3181

21401

1.01

0.12

2.3

2.4

0.23

0.22

g/l

9.86

2971

20038

Migraine, single triptan purchase ok & required. ICD-code if available is included

3181

21401

1.01

0.12

2.3

2.4

0.23

0.22

g/l

9.86

2971

20038

Retinal breaks without detachment

529

5367

0.98

0.12

2.2

0.21

g/l

0.38

503

5008

Nontoxic diffuse goitre

906

1.04

0.12

2.3

2.0

0.21

g/l

0.35

864

Other specified/unspecified diseases of inner ear

126

0.86

0.11

1.5

2.2

0.21

g/l

0.09

113

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

441

4343

1.02

0.11

2.4

2.2

0.22

0.21

g/l

0.31

420

4070

Dental caries 2, only avohilmo

3070

24071

1.01

0.11

2.5

2.4

0.23

0.22

g/l

5.56

2876

22522

141

1367

1.03

0.11

2.0

1.9

0.21

0.20

g/l

0.83

130

1234

Distal bite

116

1119

1.03

0.10

4.8

3.9

0.23

0.22

g/l

0.35

111

1067

Graves ophthalmopathy

673

1.04

0.10

2.3

2.1

0.21

0.22

g/l

0.24

632

Primary angle-closure glaucoma

139

1355

1.03

0.10

1.7

2.1

0.20

g/l

0.22

130

1263

Other and unspecified postprocedural disorders of eye and adnexa

1.05

0.09

1.0

2.1

0.23

0.21

g/l

—

Other and unspecified disorders of lacrimal system

1.04

0.09

1.8

0.19

0.23

g/l

—

Congenital malformations of anterior segment of eye

224

1.08

0.08

2.8

2.9

0.22

g/l

0.05

210

Hydrocephalus

238

2342

1.02

0.08

2.0

2.2

0.20

g/l

0.22

218

2152

Inhalation and ingestion of food causing obstruction of respiratory tract

244

1.07

0.08

1.6

2.8

0.23

0.21

g/l

0.68

230

Spermatocele

242

2382

1.02

0.08

2.3

2.4

0.20

g/l

0.08

223

2193

Use of other anti-dementia drugs

804

6940

1.01

0.08

1.5

1.9

0.19

g/l

0.28

692

6275

Use of memantine

804

6940

1.01

0.08

1.5

1.9

0.19

g/l

0.28

692

6275

Primary open-angle glaucoma, strict

944

9351

1.01

0.08

1.8

2.1

0.20

g/l

0.12

858

8611

Melanoma in situ of scalp and neck

1.03

0.07

2.0

2.4

0.26

0.21

g/l

—

Psoas tendinitis

108

1.12

0.07

2.3

1.9

0.25

0.22

g/l

0.46

100

Antepartum haemorrhage, not elsewhere classified

204

2074

0.98

0.07

1.9

2.2

0.23

g/l

0.33

194

1968

0.85

0.07

3.4

5.4

0.17

0.21

g/l

—

Endovascular or surgical operations to intracerebral aneurysms

192

1952

0.98

0.07

2.1

0.22

0.21

g/l

0.09

182

1828

Preterm labour and delivery

843

8367

1.01

0.07

2.3

2.2

0.22

g/l

1.19

792

7887

Other and unspecified water transport accidents

1.08

0.07

3.2

2.3

0.21

0.22

g/l

—

Presbyopia

184

1871

0.98

0.07

2.3

0.22

g/l

0.01

175

1767

Other disorders following mastoidectomy

0.87

0.07

1.3

2.1

0.21

g/l

—

Hand

128

1.10

0.07

1.5

2.4

0.24

0.22

g/l

0.87

116

Constitutional tall stature

128

1.10

0.07

1.8

4.5

0.22

g/l

0.14

122

Lesion of plantar nerve

198

1950

1.02

0.06

2.0

2.1

0.23

0.21

g/l

1.89

185

1826

Peripheral retinal degeneration

898

1.03

0.06

1.8

2.2

0.21

g/l

0.33

834

Purulent endophthalmitis

138

1.09

0.06

3.1

2.0

0.18

0.20

g/l

0.82

125

Primary open-angle glaucoma

1171

11347

1.01

0.06

1.8

2.1

0.20

g/l

0.17

1060

10441

Injury of muscle and tendon at ankle and foot level

651

1.03

0.06

1.8

2.2

0.22

g/l

0.25

620

Other maternal disorders predominantly related to pregnancy

2077

13004

1.00

0.06

2.2

0.22

g/l

0.77

1943

12227

Viral haemorrhagic fevers, not elsewhere classified/unspecified

244

2409

1.01

0.06

2.4

2.3

0.22

g/l

0.01

232

2253

Injury of blood vessels at lower leg level

119

1.10

0.06

2.3

2.4

0.21

0.22

g/l

0.12

112

Puerperal sepsis

414

4176

0.99

0.05

2.3

2.2

0.22

g/l

0.39

375

3948

Benign neoplasm: Bones of skull and face

253

0.94

0.05

2.0

2.2

0.23

g/l

0.10

237

Benign neoplasm: Cranial nerves

831

1.02

0.05

2.2

0.22

0.21

g/l

0.60

784

Prolapse and hernia of ovary and fallopian tube

125

1221

1.01

0.04

2.1

1.8

0.21

0.20

g/l

1.20

105

1104

Other disorders of amniotic fluid and membranes

338

3326

1.01

0.03

2.0

2.3

0.23

g/l

0.22

330

3149

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

128

1264

1.01

0.03

2.0

2.2

0.23

0.22

g/l

0.29

117

1191

Congenital malformations of posterior segment of eye

151

1.07

0.03

2.5

3.5

0.20

0.21

g/l

0.22

142

Inflammation of lacrimal passages (chronic)

431

0.97

0.03

2.3

2.0

0.23

0.21

g/l

1.12

400

Transient synovitis

191

1.05

0.03

3.2

2.9

0.23

0.22

g/l

0.21

178

Down's syndrome

102

1.09

0.03

2.8

4.1

0.21

0.22

g/l

0.11

Discontinuity and dislocation of ear ossicles

138

0.94

0.02

2.4

2.2

0.21

0.22

g/l

0.31

126

Torsion of testis

480

0.98

0.02

2.5

2.9

0.21

0.24

g/l

0.90

442

Carcinoma in situ of uteri, other/unspecified

158

0.95

0.02

1.4

2.2

0.24

0.23

g/l

0.41

153

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

319

0.97

0.02

1.6

2.1

0.28

0.21

g/l

3.77

281

Retained placenta and membranes, without haemorrhage

371

3694

1.00

0.02

2.3

2.2

0.21

0.22

g/l

1.20

347

3484

Ménière disease

316

3146

1.00

0.02

2.0

2.1

0.22

0.21

g/l

1.63

298

2931

Postpartum haemorrhage due to anatomy

198

1973

1.00

0.00

2.3

2.0

0.23

g/l

0.46

187

1862

Unspecific neurodegenerative disorder

1445

9967

1.00

0.00

1.6

2.0

0.20

g/l

0.12

1250

9148

Use of levodopa decarboxylase inhibitor

432

4314

1.00

0.00

2.0

2.1

0.20

g/l

0.10

390

3972

Congenital lens malformations

126

1.03

0.00

2.5

3.3

0.24

0.22

g/l

0.34

116

Additional codes for the location of defect, injury or illness

165

1646

1.00

0.00

3.1

2.2

0.22

g/l

0.04

158

1536

Type 1 diabetes, strict definition, subgroup 1

183

1823

1.00

0.00

2.4

3.0

0.19

0.23

g/l

15.40

164

1720

Myocardial infarction, unclassifiable

766

6832

1.00

0.00

1.9

2.0

0.19

0.20

g/l

0.58

695

6189

Use of ropinirole

112

1119

1.00

0.00

1.7

2.2

0.21

g/l

0.11

101

1046

Juvenile osteochondrosis

835

1.01

0.00

3.0

2.5

0.22

0.23

g/l

0.67

784

Migraine, unspecified, drug-induced

183

0.98

0.00

4.1

2.4

0.20

0.23

g/l

0.77

173

Melanocytic naevi of eyelid, including canthus

244

0.98

0.00

2.0

2.1

0.22

g/l

0.07

232

Use of fingolimod

174

0.98

0.00

1.7

2.6

0.25

0.24

g/l

0.37

167

Imbalance of constituents of food intake

0.00

0.0

1.6

—

0.25

—

Taeniasis

0.00

0.0

2.8

—

0.21

—

Abnormalities of ear ossicles

0.92

0.00

5.0

2.6

0.20

0.22

g/l

—

Traumatic shock

0.00

0.0

2.0

—

0.24

—

Bilateral

0.00

0.0

3.0

—

0.22

—

Total (external) ophthalmoplegia

0.00

0.0

1.8

—

0.16

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.97

0.00

1.9

2.5

0.23

0.22

g/l

—

Venous complications and haemorrhoids in the puerperium

280

1.00

0.00

2.6

2.1

0.22

g/l

0.11

268

Folliculitis ulerythematosa abscedens

0.00

0.0

4.8

—

0.25

—

Granuloma inguinale

0.00

0.0

1.8

—

0.20

—

Malignant neoplasm of placenta

0.00

0.0

2.2

—

0.18

—

Exposure to unspecified type of radiation

0.00

0.0

2.6

—

0.21

—

Anencephaly and similar malformations

0.00

0.0

3.0

—

0.22

—

Disorders of glossopharyngeal nerve

0.98

0.00

1.2

1.7

0.17

0.21

g/l

—

Carcinoma in situ of other and unspecified parts of intestine

0.00

0.0

4.8

—

0.23

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

0.0

1.3

—

0.26

—

Heredofamilial amyloidosis, unspecified

0.00

0.0

2.3

—

0.16

—

Congenital hydrocephalus

0.92

0.00

2.4

2.8

0.22

0.24

g/l

—

Radiological devices associated with adverse incidents

0.00

0.0

3.9

—

0.21

—

Colour vision deficiencies

0.89

0.00

1.4

2.9

0.23

0.22

g/l

—

Typhus fever

0.00

0.0

3.6

—

0.22

—

Chondrosarcoma

0.91

0.00

1.4

2.5

0.20

0.22

g/l

—

Toxic effect of soaps and detergents

0.00

0.0

1.7

—

0.21

—

Visual disturbances in diseases classified elsewhere

0.00

0.0

1.6

—

0.23

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.0

2.6

—

0.22

—

Other specified/unspecified disorders of tympanic membrane

0.90

0.00

1.9

2.7

0.19

0.22

g/l

—

Secondary thrombocytopenia, drug-induced

0.00

0.0

5.8

—

0.20

—

Maple-syrup-urine disease

0.00

0.0

1.6

—

0.23

—

Pseudofolliculitis barbae

0.00

0.0

3.4

—

0.24

—

Nonscarring hair loss, unspecified, drug-induced

0.00

0.0

5.0

—

0.18

—

Smallpox

0.00

0.0

2.0

—

0.23

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prealbumin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS